Document_and_Entity_Informatio
Document and Entity Information | 9 Months Ended | |
Sep. 30, 2013 | Nov. 06, 2013 | |
Document and Entity Information [Abstract] | ' | ' |
Entity Registrant Name | 'VALIDUS HOLDINGS LTD | ' |
Entity Central Index Key | '0001348259 | ' |
Document Type | '10-Q | ' |
Document Period End Date | 30-Sep-13 | ' |
Amendment Flag | 'false | ' |
Document Fiscal Year Focus | '2013 | ' |
Document Fiscal Period Focus | 'Q3 | ' |
Current Fiscal Year End Date | '--12-31 | ' |
Entity Well-known Seasoned Issuer | 'Yes | ' |
Entity Voluntary Filers | 'No | ' |
Entity Current Reporting Status | 'Yes | ' |
Entity Filer Category | 'Large Accelerated Filer | ' |
Entity Common Stock, Shares Outstanding | ' | 99,404,743 |
Consolidated_Balance_Sheets_Un
Consolidated Balance Sheets (Unaudited) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Assets | ' | ' |
Fixed maturities, at fair value (amortized cost: 2013—$5,415,864; 2012—$5,008,514) | $5,438,265 | $5,085,334 |
Short-term investments at fair value (amortized cost: 2013—$761,631; 2012—$1,112,929) | 761,642 | 1,114,250 |
Other investments at fair value (cost: 2013—$606,485; 2012—$583,068) | 559,472 | 564,448 |
Cash and cash equivalents | 1,254,618 | 1,219,379 |
Total investments and cash | 8,013,997 | 7,983,411 |
Investments in affiliates | 111,814 | 172,329 |
Premiums receivable | 1,050,073 | 802,159 |
Deferred acquisition costs | 166,539 | 146,588 |
Prepaid reinsurance premiums | 169,062 | 99,593 |
Securities lending collateral | 1,021 | 225 |
Loss reserves recoverable | 421,518 | 439,967 |
Paid losses recoverable | 30,074 | 46,435 |
Income taxes recoverable | 4,127 | 0 |
Intangible assets | 107,449 | 110,569 |
Goodwill | 20,393 | 20,393 |
Accrued investment income | 17,821 | 21,321 |
Other assets | 203,480 | 177,274 |
Total assets | 10,317,368 | 10,020,264 |
Liabilities | ' | ' |
Reserve for losses and loss expenses | 3,223,735 | 3,517,573 |
Unearned premiums | 1,169,830 | 894,362 |
Reinsurance balances payable | 159,590 | 138,550 |
Securities lending payable | 1,487 | 691 |
Deferred income taxes | 22,993 | 20,259 |
Net payable for investments purchased | 33,066 | 38,346 |
Accounts payable and accrued expenses | 139,098 | 167,577 |
Variable funding notes | 437,970 | 0 |
Senior notes payable | 247,171 | 247,090 |
Debentures payable | 541,127 | 540,709 |
Total liabilities | 5,976,067 | 5,565,157 |
Commitments and contingent liabilities | ' | ' |
Shareholders' equity | ' | ' |
Common shares, 571,428,571 authorized, par value $0.175 (Issued: 2013—154,386,316; 2012—152,698,191; Outstanding: 2013—99,897,996; 2012—107,921,259) | 27,018 | 26,722 |
Treasury shares (2013—54,488,320; 2012—44,776,932) | -9,535 | -7,836 |
Additional paid-in-capital | 1,824,342 | 2,160,478 |
Accumulated other comprehensive (loss) | -3,872 | -2,953 |
Retained earnings | 1,946,209 | 1,844,416 |
Total shareholders' equity attributable to Validus | 3,784,162 | 4,020,827 |
Noncontrolling interest | 557,139 | 434,280 |
Total shareholders' equity | 4,341,301 | 4,455,107 |
Total liabilities and shareholders' equity | $10,317,368 | $10,020,264 |
Consolidated_Balance_Sheets_Pa
Consolidated Balance Sheets (Parenthetical) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, except Share data, unless otherwise specified | ||
Assets | ' | ' |
Fixed maturities, at amortized cost | $5,415,864 | $5,008,514 |
Short-term investments, at amortized cost | 761,631 | 1,112,929 |
Other investments, at cost | $606,485 | $583,068 |
Shareholders' equity | ' | ' |
Common shares, shares authorized | 571,428,571 | 571,428,571 |
Common shares, par value | $0.18 | $0.18 |
Common shares, shares issued | 154,386,316 | 152,698,191 |
Common shares, shares outstanding | 99,897,996 | 107,921,259 |
Treasury stock, common shares | 54,488,320 | 44,776,932 |
Consolidated_Statements_of_Com
Consolidated Statements of Comprehensive Income (Unaudited) (USD $) | 3 Months Ended | 9 Months Ended | ||||
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | ||
Revenues | ' | ' | ' | ' | ||
Gross premiums written | $356,760 | $390,215 | $2,163,833 | $1,854,593 | ||
Reinsurance premiums ceded | -39,415 | -45,743 | -348,027 | -271,847 | ||
Net premiums written | 317,345 | 344,472 | 1,815,806 | 1,582,746 | ||
Change in unearned premiums | 213,943 | 130,632 | -205,999 | -208,816 | ||
Net premiums earned | 531,288 | 475,104 | 1,609,807 | 1,373,930 | ||
Net investment income | 20,009 | 25,489 | 71,868 | 79,134 | ||
Net realized (losses) gains on investments | -6,320 | 9,063 | -1,190 | 22,749 | ||
Net unrealized gains (losses) on investments | 69,967 | 86,345 | -78,618 | 53,442 | ||
Income (loss) from investment affiliate | 1,044 | -160 | 4,274 | -558 | ||
Other (loss) income | -2,806 | 7,324 | 4,297 | 22,209 | ||
Foreign exchange gains | 6,036 | 1,103 | 4,735 | 3,617 | ||
Total revenues | 619,218 | 604,268 | 1,615,173 | 1,554,523 | ||
Expenses | ' | ' | ' | ' | ||
Losses and loss expenses | 177,965 | 155,455 | 587,780 | 541,136 | ||
Policy acquisition costs | 94,900 | 98,623 | 275,663 | 252,884 | ||
General and administrative expenses | 81,089 | 70,547 | 232,335 | 198,557 | ||
Share compensation expenses | 10,527 | 7,345 | 19,483 | 19,583 | ||
Finance expenses | 27,132 | 9,362 | 89,408 | 39,347 | ||
Transaction expenses | 0 | 3,784 | [1] | 0 | 3,784 | [1] |
Total expenses | 391,613 | 345,116 | 1,204,669 | 1,055,291 | ||
Income before taxes and income from operating affiliates | 227,605 | 259,152 | 410,504 | 499,232 | ||
Tax (expense) benefit | -5 | -1,343 | 220 | -1,886 | ||
Income from operating affiliates | 1,463 | 6,235 | 8,779 | 13,194 | ||
Net income | 229,063 | 264,044 | 419,503 | 510,540 | ||
Net (income) loss attributable to noncontrolling interest | -45,694 | -56,746 | 17,831 | -11,386 | ||
Net income available to Validus | 183,369 | 207,298 | 437,334 | 499,154 | ||
Other comprehensive income (loss) | ' | ' | ' | ' | ||
Foreign currency translation adjustments | 4,390 | 1,400 | -5,209 | 2,036 | ||
Other comprehensive income (loss) | 4,390 | 1,400 | -5,209 | 2,036 | ||
Comprehensive income available to Validus | $187,759 | $208,698 | $432,125 | $501,190 | ||
Weighted average number of common shares and common share equivalents outstanding | ' | ' | ' | ' | ||
Basic | 99,834,563 | 93,368,775 | 103,451,396 | 97,016,034 | ||
Diluted | 103,613,766 | 98,236,490 | 105,264,913 | 102,333,515 | ||
Basic earnings per share available to common shareholders | $1.82 | $2.20 | $4.06 | $5.09 | ||
Diluted earnings per share available to common shareholders | $1.77 | $2.11 | $3.99 | $4.88 | ||
Cash dividends declared per share | $0.30 | $0.25 | $2.90 | $0.75 | ||
[1] | The transaction expenses relate to costs incurred in connection with the acquisition of Flagstone Reinsurance Holdings, S.A. |
Consolidated_Statements_of_Sha
Consolidated Statements of Shareholders' Equity (Unaudited) (USD $) | Total | Common shares | Treasury shares | Additional paid-in capital | Accumulated other comprehensive (loss) | Retained earnings |
In Thousands | ||||||
Beginning balance at Dec. 31, 2011 | ' | $23,538 | ($6,131) | $1,893,890 | ($6,601) | $1,543,729 |
Common shares (redeemed) issued, net | ' | 373 | ' | 2,551 | ' | ' |
Repurchase of common shares | ' | ' | -1,418 | -258,257 | ' | ' |
Share compensation expenses | ' | ' | ' | 19,583 | ' | ' |
Amounts reclassified from/to accumulated other comprehensive income | ' | ' | ' | ' | 0 | 0 |
Other comprehensive (loss) income | 2,036 | ' | ' | ' | 2,036 | ' |
Dividends | ' | ' | ' | ' | ' | -78,594 |
Net income | 510,540 | ' | ' | ' | ' | 510,540 |
Net (income) loss attributable to noncontrolling interest | -11,386 | ' | ' | ' | ' | -11,386 |
Noncontrolling interest | 461,486 | ' | ' | ' | ' | ' |
Total shareholders' equity at Sep. 30, 2012 | 4,095,339 | ' | ' | ' | ' | ' |
Ending balance at Sep. 30, 2012 | 3,633,853 | 23,911 | -7,549 | 1,657,767 | -4,565 | 1,964,289 |
Beginning balance at Dec. 31, 2012 | 4,020,827 | 26,722 | -7,836 | 2,160,478 | -2,953 | 1,844,416 |
Common shares (redeemed) issued, net | ' | 296 | ' | -134 | ' | ' |
Repurchase of common shares | ' | ' | -1,699 | -355,485 | ' | ' |
Share compensation expenses | ' | ' | ' | 19,483 | ' | ' |
Amounts reclassified from/to accumulated other comprehensive income | ' | ' | ' | ' | 4,290 | -4,290 |
Other comprehensive (loss) income | -5,209 | ' | ' | ' | -5,209 | ' |
Dividends | ' | ' | ' | ' | ' | -331,251 |
Net income | 419,503 | ' | ' | ' | ' | 419,503 |
Net (income) loss attributable to noncontrolling interest | 17,831 | ' | ' | ' | ' | 17,831 |
Noncontrolling interest | 557,139 | ' | ' | ' | ' | ' |
Total shareholders' equity at Sep. 30, 2013 | 4,341,301 | ' | ' | ' | ' | ' |
Ending balance at Sep. 30, 2013 | $3,784,162 | $27,018 | ($9,535) | $1,824,342 | ($3,872) | $1,946,209 |
Consolidated_Statements_of_Cas
Consolidated Statements of Cash Flows (Unaudited) (USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Cash flows provided by (used in) operating activities | ' | ' |
Net income | $419,503 | $510,540 |
Adjustments to reconcile net income to cash provided by (used in) operating activities: | ' | ' |
Share compensation expenses | 19,483 | 19,583 |
Amortization of discount on senior notes | 81 | 81 |
(Income) loss from investment affiliate | -4,274 | 558 |
Net realized losses (gains) on investments | 1,190 | -22,749 |
Net unrealized losses (gains) on investments | 78,618 | -53,442 |
Amortization of intangible assets | 3,120 | 3,120 |
(Income) from operating affiliates | -8,779 | -13,194 |
Foreign exchange losses (gains) included in net income | 4,927 | -17,064 |
Amortization of premium on fixed maturities | 14,870 | 19,214 |
Change in: | ' | ' |
Premiums receivable | -226,154 | -132,292 |
Deferred acquisition costs | -19,951 | -33,951 |
Prepaid reinsurance premiums | -69,469 | -53,407 |
Loss reserves recoverable | 20,411 | 57,574 |
Paid losses recoverable | 16,218 | 54,559 |
Income taxes recoverable | -3,099 | -5,041 |
Accrued investment income | 3,466 | 6,015 |
Other assets | -11,214 | -16,050 |
Reserve for losses and loss expenses | -293,673 | -80,954 |
Unearned premiums | 275,468 | 262,223 |
Reinsurance balances payable | -634 | -33,487 |
Deferred income taxes | 2,565 | 6,241 |
Accounts payable and accrued expenses | -37,183 | 4,948 |
Net cash provided by operating activities | 185,490 | 483,025 |
Cash flows provided by (used in) investing activities | ' | ' |
Proceeds on sales of investments | 3,598,080 | 2,528,442 |
Proceeds on maturities of investments | 406,079 | 385,642 |
Purchases of fixed maturities | -4,414,320 | -2,832,179 |
Sales of short-term investments, net | 348,554 | 5,123 |
(Purchases) of other investments | -21,793 | -499,178 |
(Increase) in securities lending collateral | -796 | -2,387 |
Redemption from (purchase of) investment in operating affiliates | 86,657 | -26,500 |
Purchase of investment in investment affiliate | -13,089 | -3,798 |
Net cash (used in) investing activities | -10,628 | -444,835 |
Cash flows provided by (used in) financing activities | ' | ' |
Net proceeds on issuance of variable funding notes | 418,299 | 0 |
Issuance of common shares, net | 162 | 2,924 |
Purchases of common shares under share repurchase program | -357,184 | -259,675 |
Dividends paid | -329,201 | -81,391 |
Increase in securities lending payable | 796 | 2,387 |
Third party investment in noncontrolling interest | 140,690 | 450,100 |
Net cash (used in) provided by financing activities | -126,438 | 114,345 |
Effect of foreign currency rate changes on cash and cash equivalents | -13,185 | 20,450 |
Net increase in cash | 35,239 | 172,985 |
Cash and cash equivalents - beginning of period | 1,219,379 | 832,844 |
Cash and cash equivalents - end of period | 1,254,618 | 1,005,829 |
Taxes paid during the period | 438 | 3,640 |
Interest paid during the period | $44,112 | $37,122 |
Basis_of_preparation_and_conso
Basis of preparation and consolidation | 9 Months Ended |
Sep. 30, 2013 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Basis of presentation and consolidation | ' |
Basis of preparation and consolidation | |
These unaudited consolidated financial statements include Validus Holdings, Ltd. and its subsidiaries (together, the "Company") and have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 in Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In addition, the year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. This Quarterly Report should be read in conjunction with the financial statements included in the Company's Annual Report on Form 10-K/A for the year ended December 31, 2012, as filed with the U.S. Securities and Exchange Commission (the "SEC"). | |
In the opinion of management, these unaudited consolidated financial statements reflect all adjustments (including normal recurring adjustments) considered necessary for a fair presentation of the Company's financial position and results of operations as at the end of and for the periods presented. Certain amounts in prior periods have been reclassified to conform to current period presentation. All intercompany accounts and transactions have been eliminated. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The significant estimates reflected in the Company's consolidated financial statements include the reserve for losses and loss expenses, premium estimates for business written on a line slip or proportional basis, reinsurance premiums ceded and reinsurance recoverable balances including the provision for unrecoverable reinsurance recoverable balances and investment valuation. Actual results could differ materially from those estimates. The results of operations for any interim period are not necessarily indicative of the results for a full year. The term "ASC" used in these notes refers to the Accounting Standard Codification issued by the United States Financial Accounting Standards Board ("FASB"). | |
On November 30, 2012, the Company acquired all of the outstanding common shares of Flagstone Reinsurance Holdings, S.A. ("Flagstone") in exchange for 0.1935 Company common shares and $2.00 in cash per Flagstone common share (the "Flagstone Acquisition"). For segmental reporting purposes, the results of Flagstone’s operations since the acquisition date have been included within the Validus Re segment in the consolidated financial statements. | |
On April 25, 2013, the Company acquired Longhorn Re, Ltd., a single contract Bermuda domiciled crop reinsurer. |
Recent_accounting_pronouncemen
Recent accounting pronouncements | 9 Months Ended |
Sep. 30, 2013 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | ' |
Recent accounting pronouncements | ' |
Recent accounting pronouncements | |
(a) Adoption of new accounting standards | |
Disclosures about Offsetting Assets and Liabilities | |
In December 2011, the FASB issued Accounting Standards Update No. 2011-11, "Disclosures about Offsetting Assets and Liabilities" ("ASU 2011-11"). The objective of ASU 2011-11 is to enhance disclosures by requiring improved information about financial instruments and derivative instruments in relation to netting arrangements. | |
Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities | |
In January 2013, the FASB issued Accounting Standards Update No. 2013-01, “Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities” (“ASU 2013-01”). The objective of ASU 2013-01 is to address implementation issues about the scope of ASU 2011-11, Disclosures about Offsetting Assets and Liabilities. The amendments clarify that the scope of ASU 2011-11 applies to derivatives, including bifurcated embedded derivatives, repurchase agreements and reverse repurchase agreements, and securities borrowing and securities lending transactions that are either or subject to an enforceable master netting arrangement or similar agreement. Entities with other types of financial assets and financial liabilities subject to a master netting arrangement or similar agreement also are affected because these amendments make them no longer subject to the disclosure requirements in ASU 2011-11. ASU 2011-11 and 2013-01 became effective for fiscal periods beginning on or after January 1, 2013, and as a result, the Company adopted ASU 2011-11 and 2013-01 effective January 1, 2013. The adoption of these new accounting standards impacts disclosures only; therefore they did not have an impact on the Company's consolidated financial statements. Please refer to Note 7: "Derivative instruments". | |
Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income | |
In February 2013, the FASB issued Accounting Standard Update No. 2013-02, “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income” (“ASU 2013-02”). The objective of this update is to improve the reporting of reclassifications out of accumulated other comprehensive income. The amendments do not change the current requirements for reporting net income or other comprehensive income in financial statements. However, the amendments require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. The amendments became effective for reporting periods beginning after December 15, 2012, and as a result, the Company adopted ASU 2013-02 effective January 1, 2013. Please refer to Note 14 "Accumulated other comprehensive income (loss)." | |
Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes | |
In July 2013, the FASB issued Accounting Standard Update No. 2013-10, “Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes” (“ASU 2013-10”). The amendments in this Update permit the Fed Funds Effective Swap Rate also referred to as the overnight index swap rate (“OIS”) to be used as a U.S. benchmark interest rate for hedge accounting purposes in addition to U.S. Treasury rate and LIBOR. The amendments also remove the restriction on using different benchmark rates for similar hedges. Before the amendments in this Update, only the U.S. Treasury rate and the LIBOR swap rate were considered benchmark interest rates in the United States. The amendments are effective prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013. The adoption of this standard update did not have an impact on the Company's consolidated financial statements. | |
(b) Recently issued accounting standards not yet adopted | |
In March 2013, the FASB issued Accounting Standard Update No. 2013-05, “Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity” (“ASU 2013-05”). The objective of this update is to resolve the diversity in practice about whether Subtopic 810-10, Consolidation-Overall, or Subtopic 830-30, Foreign Currency Matters-Translation of Financial Statements, applies to the release of the cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary within a foreign entity. The amendments in this Update are effective prospectively for fiscal years (and interim reporting periods within those years) beginning after December 15, 2013. Early adoption is permitted. The Company is currently evaluating the impact of this guidance; however it is not expected to have a material impact on the Company's consolidated financial statements. | |
In June 2013, the FASB issued Accounting Standard Update No. 2013-08, “Financial Services - Investment Companies - Amendments to the Scope, Measurement, and Disclosure Requirements” (“ASU 2013-08”). The amendments in this Update change the assessment of whether an entity is an investment company by developing a new two-tiered approach for that assessment, which requires an entity to possess certain fundamental characteristics while allowing judgment in assessing other typical characteristics. The new approach requires an entity to assess all of the characteristics of an investment company and consider its purpose and design to determine whether it is an investment company. The amendments in this Update are effective prospectively for fiscal years (and interim reporting periods within those years) beginning after December 15, 2013. Early adoption is prohibited. The Company is currently evaluating the impact of this guidance; however it is not expected to have a material impact on the Company's consolidated financial statements. | |
In July 2013, the FASB issued Accounting Standard Update No. 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists” (“ASU 2013-11”). This Update applies to all entities that have unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. An unrecognized tax benefit should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. To the extent a net operating loss carryforward is not available to settle any additional income taxes that would result from the disallowance of a tax position at the reporting date, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The amendments in this Update are effective for fiscal years beginning after December 15, 2013. The Company is currently evaluating the impact of this guidance; however it is not expected to have a material impact on the Company's consolidated financial statements. |
Investments
Investments | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Investments [Abstract] | ' | |||||||||||||||
Investments | ' | |||||||||||||||
Investments | ||||||||||||||||
(a) Trading Securities | ||||||||||||||||
The Company's investments in fixed maturities, short-term investments and other investments are classified as trading and carried at fair value, with related net unrealized gains or losses included in earnings. | ||||||||||||||||
The amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments at September 30, 2013 were as follows: | ||||||||||||||||
Amortized Cost or Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | |||||||||||||
U.S. government and government agency | $ | 1,319,499 | $ | 4,313 | $ | (3,329 | ) | $ | 1,320,483 | |||||||
Non-U.S. government and government agency | 401,149 | 4,028 | (1,180 | ) | 403,997 | |||||||||||
U.S. states, municipalities and political subdivisions | 43,912 | 440 | (423 | ) | 43,929 | |||||||||||
Agency residential mortgage-backed securities | 313,177 | 8,384 | (1,360 | ) | 320,201 | |||||||||||
Non-agency residential mortgage-backed securities | 24,029 | 164 | (1,062 | ) | 23,131 | |||||||||||
U.S. corporate | 1,363,418 | 10,616 | (6,889 | ) | 1,367,145 | |||||||||||
Non-U.S. corporate | 686,656 | 5,658 | (3,264 | ) | 689,050 | |||||||||||
Bank loans | 732,922 | 5,421 | (1,885 | ) | 736,458 | |||||||||||
Catastrophe bonds | 56,504 | 2,358 | — | 58,862 | ||||||||||||
Asset-backed securities | 474,598 | 1,279 | (868 | ) | 475,009 | |||||||||||
Total fixed maturities | 5,415,864 | 42,661 | (20,260 | ) | 5,438,265 | |||||||||||
Total short-term investments | 761,631 | 12 | (1 | ) | 761,642 | |||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | 3,274 | 97 | (921 | ) | 2,450 | |||||||||||
Private equity investments | 12,493 | 2,259 | (79 | ) | 14,673 | |||||||||||
Hedge funds (a) | 584,519 | 46,087 | (97,261 | ) | 533,345 | |||||||||||
Mutual funds | 6,199 | 2,805 | — | 9,004 | ||||||||||||
Total other investments | 606,485 | 51,248 | (98,261 | ) | 559,472 | |||||||||||
Total | $ | 6,783,980 | $ | 93,921 | $ | (118,522 | ) | $ | 6,759,379 | |||||||
Noncontrolling interest (a) | $ | (527,850 | ) | $ | (40,887 | ) | $ | 87,535 | $ | (481,202 | ) | |||||
Total investments excluding noncontrolling interest | $ | 6,256,130 | $ | 53,034 | $ | (30,987 | ) | $ | 6,278,177 | |||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. | |||||||||||||||
The amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments at December 31, 2012 were as follows: | ||||||||||||||||
Amortized Cost or Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | |||||||||||||
U.S. government and government agency | $ | 1,091,357 | $ | 7,957 | $ | (84 | ) | $ | 1,099,230 | |||||||
Non-U.S. government and government agency | 295,602 | 6,904 | (227 | ) | 302,279 | |||||||||||
U.S. states, municipalities and political subdivisions | 41,286 | 800 | (23 | ) | 42,063 | |||||||||||
Agency residential mortgage-backed securities | 375,368 | 13,708 | (202 | ) | 388,874 | |||||||||||
Non-agency residential mortgage-backed securities | 106,536 | 1,266 | (1,346 | ) | 106,456 | |||||||||||
U.S. corporate | 1,189,173 | 21,681 | (681 | ) | 1,210,173 | |||||||||||
Non-U.S. corporate | 582,115 | 11,373 | (223 | ) | 593,265 | |||||||||||
Bank loans | 663,217 | 10,593 | (427 | ) | 673,383 | |||||||||||
Catastrophe bonds | 56,757 | 481 | (291 | ) | 56,947 | |||||||||||
Asset-backed securities | 607,103 | 5,767 | (206 | ) | 612,664 | |||||||||||
Total fixed maturities | 5,008,514 | 80,530 | (3,710 | ) | 5,085,334 | |||||||||||
Total short-term investments | 1,112,929 | 1,349 | (28 | ) | 1,114,250 | |||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | 4,677 | 299 | (219 | ) | 4,757 | |||||||||||
Private equity investments | 12,857 | 94 | — | 12,951 | ||||||||||||
Hedge funds (a) | 559,335 | 21,814 | (42,623 | ) | 538,526 | |||||||||||
Mutual funds | 6,199 | 2,015 | — | 8,214 | ||||||||||||
Total other investments | 583,068 | 24,222 | (42,842 | ) | 564,448 | |||||||||||
Total | $ | 6,704,511 | $ | 106,101 | $ | (46,580 | ) | $ | 6,764,032 | |||||||
Noncontrolling interest (a) | (450,000 | ) | (19,427 | ) | 36,690 | (432,737 | ) | |||||||||
Total investments excluding noncontrolling interest | $ | 6,254,511 | $ | 86,674 | $ | (9,890 | ) | $ | 6,331,295 | |||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. | |||||||||||||||
The following table sets forth certain information regarding the investment ratings of the Company’s fixed maturities portfolio as at September 30, 2013 and December 31, 2012. Investment ratings are the lower of Moody’s or Standard & Poor’s rating for each investment security, presented in Standard & Poor’s equivalent rating. For investments where Moody’s and Standard & Poor’s ratings are not available, Fitch ratings are used and presented in Standard & Poor’s equivalent rating. | ||||||||||||||||
September 30, 2013 | December 31, 2012 | |||||||||||||||
Estimated Fair Value | % of Total | Estimated Fair Value | % of Total | |||||||||||||
AAA | $ | 776,896 | 14.3 | % | $ | 1,062,794 | 20.9 | % | ||||||||
AA | 2,256,592 | 41.5 | % | 1,862,322 | 36.6 | % | ||||||||||
A | 1,196,037 | 22 | % | 1,049,969 | 20.6 | % | ||||||||||
BBB | 423,228 | 7.8 | % | 374,447 | 7.4 | % | ||||||||||
Investment grade | 4,652,753 | 85.6 | % | 4,349,532 | 85.5 | % | ||||||||||
BB | 356,205 | 6.5 | % | 373,907 | 7.4 | % | ||||||||||
B | 397,888 | 7.3 | % | 330,416 | 6.5 | % | ||||||||||
CCC | 4,754 | 0.1 | % | 4,483 | 0.1 | % | ||||||||||
CC | 2,821 | 0.1 | % | 3,259 | 0.1 | % | ||||||||||
D/NR | 23,844 | 0.4 | % | 23,737 | 0.4 | % | ||||||||||
Non-Investment grade | 785,512 | 14.4 | % | 735,802 | 14.5 | % | ||||||||||
Total Fixed Maturities | $ | 5,438,265 | 100 | % | $ | 5,085,334 | 100 | % | ||||||||
The amortized cost and estimated fair value amounts for fixed maturity securities held at September 30, 2013 and December 31, 2012 are shown below by contractual maturity. Actual maturity may differ from contractual maturity because certain borrowers may have the right to call or prepay certain obligations with or without call or prepayment penalties. | ||||||||||||||||
September 30, 2013 | December 31, 2012 | |||||||||||||||
Amortized Cost | Estimated Fair Value | Amortized Cost | Estimated Fair Value | |||||||||||||
Due in one year or less | $ | 745,812 | $ | 750,992 | $ | 526,529 | $ | 530,499 | ||||||||
Due after one year through five years | 3,492,605 | 3,504,812 | 2,971,118 | 3,018,544 | ||||||||||||
Due after five years through ten years | 362,563 | 361,011 | 418,377 | 424,304 | ||||||||||||
Due after ten years | 3,080 | 3,109 | 3,483 | 3,993 | ||||||||||||
4,604,060 | 4,619,924 | 3,919,507 | 3,977,340 | |||||||||||||
Asset-backed and mortgage-backed securities | 811,804 | 818,341 | 1,089,007 | 1,107,994 | ||||||||||||
Total Fixed Maturities | $ | 5,415,864 | $ | 5,438,265 | $ | 5,008,514 | $ | 5,085,334 | ||||||||
(b) Net investment income | ||||||||||||||||
Net investment income was derived from the following sources: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Fixed maturities and short-term investments | $ | 20,936 | $ | 25,703 | $ | 74,618 | $ | 79,450 | ||||||||
Cash and cash equivalents | 1,079 | 1,770 | 3,241 | 5,536 | ||||||||||||
Securities lending income | 3 | 3 | 3 | 9 | ||||||||||||
Total gross investment income | 22,018 | 27,476 | 77,862 | 84,995 | ||||||||||||
Investment expenses | (2,009 | ) | (1,987 | ) | (5,994 | ) | (5,861 | ) | ||||||||
Net investment income | $ | 20,009 | $ | 25,489 | $ | 71,868 | $ | 79,134 | ||||||||
(c) | Net realized gains (losses) and change in net unrealized gains (losses) | |||||||||||||||
The following represents an analysis of net realized gains (losses) and the change in net unrealized (losses) on investments: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Fixed maturities, short-term and other investments and cash equivalents | ||||||||||||||||
Gross realized gains | $ | 7,706 | $ | 10,187 | $ | 25,578 | $ | 29,610 | ||||||||
Gross realized (losses) | (14,026 | ) | (1,124 | ) | (26,768 | ) | (6,861 | ) | ||||||||
Net realized (losses) gains on investments | (6,320 | ) | 9,063 | (1,190 | ) | 22,749 | ||||||||||
Net unrealized gains on securities lending | — | 223 | — | 260 | ||||||||||||
Change in net unrealized gains (losses) on investments | 69,967 | 86,122 | (78,618 | ) | 53,182 | |||||||||||
Net change in unrealized gains (losses) on investments | $ | 69,967 | $ | 86,345 | $ | (78,618 | ) | $ | 53,442 | |||||||
Total net realized (losses) gains and change in net unrealized gains (losses) on investments | $ | 63,647 | $ | 95,408 | $ | (79,808 | ) | $ | 76,191 | |||||||
Noncontrolling interest (a) | (42,578 | ) | (55,806 | ) | 25,767 | (10,924 | ) | |||||||||
Total net realized gains and change in net unrealized (losses) on investments excluding noncontrolling interest | $ | 21,069 | $ | 39,602 | $ | (54,041 | ) | $ | 65,267 | |||||||
(a) | Includes change in net unrealized (gains) losses on investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. | |||||||||||||||
(d) Pledged investments | ||||||||||||||||
The following tables outline investments pledged as collateral under the Company's credit facilities. For further details of the credit facilities, please refer to Note 12: “Debt and financing arrangements.” | ||||||||||||||||
September 30, 2013 | ||||||||||||||||
Description | Commitment | Issued and Outstanding | Investments pledged as collateral | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | $ | 400,000 | $ | — | $ | — | ||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 371,990 | 491,761 | |||||||||||||
$200,000 secured bi-lateral letter of credit facility | 200,000 | 77,626 | 129,768 | |||||||||||||
Talbot FAL Facility | 25,000 | 25,000 | 36,996 | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 258 | — | |||||||||||||
IPC bi-lateral facility | 40,000 | 26,019 | 98,260 | |||||||||||||
$375,000 Flagstone bi-lateral facility | 375,000 | 297,996 | 453,241 | |||||||||||||
$ | 1,575,000 | $ | 798,889 | $ | 1,210,026 | |||||||||||
31-Dec-12 | ||||||||||||||||
Description | Commitment | Issued and Outstanding | Investments pledged as collateral | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | $ | 400,000 | $ | — | $ | — | ||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 376,570 | 517,210 | |||||||||||||
$500,000 secured bi-lateral letter of credit facility | 500,000 | 92,402 | 125,991 | |||||||||||||
Talbot FAL Facility | 25,000 | 25,000 | 41,372 | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 219 | — | |||||||||||||
IPC bi-lateral facility | 80,000 | 40,613 | 98,593 | |||||||||||||
$550,000 Flagstone bi-lateral facility | 550,000 | 381,019 | 416,414 | |||||||||||||
$ | 2,090,000 | $ | 915,823 | $ | 1,199,580 | |||||||||||
Fair_value_measurements
Fair value measurements | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||
Fair value measurements | ' | |||||||||||||||
Fair value measurements | ||||||||||||||||
The Company has adopted all authoritative guidance in effect as of the balance sheet date regarding certain market conditions that allow for fair value measurements that incorporate unobservable inputs where active market transaction based measurements are unavailable. | ||||||||||||||||
(a) | Classification within the fair value hierarchy | |||||||||||||||
Under U.S. GAAP, a company must determine the appropriate level in the fair value hierarchy for each fair value measurement. The fair value hierarchy prioritizes the inputs, which refer broadly to assumptions market participants would use in pricing an asset or liability, into three levels. It gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety. | ||||||||||||||||
The three levels of the fair value hierarchy are described below: | ||||||||||||||||
• | Level 1 - Fair values are measured based on unadjusted quoted prices in active markets for identical assets or liabilities that we have the ability to access. | |||||||||||||||
• | Level 2 - Fair values are measured based on quoted prices in active markets for similar assets or liabilities, quoted prices for identical assets or liabilities in inactive markets, or for which significant inputs are observable (e.g. interest rates, yield curves, prepayment speeds, default rates, loss severities, etc.) or can be corroborated by observable market data. | |||||||||||||||
• | Level 3 - Fair values are measured based on inputs that are unobservable and significant to the overall fair value measurement. The unobservable inputs reflect our own judgments about assumptions where there is little, if any, market activity for that asset or liability that market participants might use. | |||||||||||||||
The availability of observable inputs can vary from financial instrument to financial instrument and is affected by a wide variety of factors including, for example, the type of financial instrument, whether the financial instrument is new and not yet established in the marketplace, and other characteristics particular to the instrument. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires significantly more judgment. | ||||||||||||||||
Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in Level 3. In periods of market dislocation, the observability of prices and inputs may be reduced for many instruments. This may lead us to change the selection of our valuation technique (for example, from market to cash flow approach) or may cause us to use multiple valuation techniques to estimate the fair value of a financial instrument. These circumstances could cause an instrument to be reclassified between levels within the fair value hierarchy. | ||||||||||||||||
There have been no material changes in the Company's valuation techniques during the period, or periods, represented by these consolidated financial statements. The following methods and assumptions were used in estimating the fair value of each class of financial instrument recorded in the Consolidated Balance Sheets. | ||||||||||||||||
(b) Level 1 and Level 2 assets measured at fair value | ||||||||||||||||
Fixed maturity investments | ||||||||||||||||
Fixed maturity investments included in Level 2 are U.S. government and government agency, non-U.S. government and government agency, U.S. states, municipalities and political subdivisions, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, U.S. corporate, non-U.S. corporate, bank loans, catastrophe bonds and asset backed securities. | ||||||||||||||||
In general, the Company's fixed maturity investment portfolios are priced using pricing services, such as index providers and pricing vendors, as well as broker quotations. The pricing vendors provide pricing for a high volume of liquid securities that are actively traded. For securities that do not trade on an exchange, the pricing services generally utilize market data and other observable inputs in matrix pricing models to determine month end prices. Prices are generally verified using third party data. Securities which are priced by an index provider are generally included in the index. | ||||||||||||||||
In general, broker-dealers value securities through their trading desks based on observable inputs. The methodologies include mapping securities based on trade data, bids or offers, observed spreads, and performance on newly issued securities. Broker-dealers also determine valuations by observing secondary trading of similar securities. Prices obtained from broker quotations are considered non-binding, however they are based on observable inputs and by observing secondary trading of similar securities obtained from active, non-distressed markets. | ||||||||||||||||
The Company considers these Level 2 inputs as they are corroborated with other market observable inputs. The techniques generally used to determine the fair value of the Company's fixed maturity investments are detailed below by asset class. | ||||||||||||||||
U.S. government and government agency | ||||||||||||||||
Level 2 - U.S. government and government agency securities consist primarily of debt securities issued by the U.S. Treasury and mortgage pass-through agencies such as the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Government National Mortgage Association. Fixed maturity investments included in U.S. government and government agency securities are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources and integrate other observations from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The fair value of each security is individually computed using analytical models which incorporate option adjusted spreads and other daily interest rate data. | ||||||||||||||||
Non-U.S. government and government agency | ||||||||||||||||
Level 2 - Non-U.S. government and government agency securities consist of debt securities issued by non-U.S. governments and their agencies along with supranational organizations (also known as sovereign debt securities). Securities held in these sectors are primarily priced by pricing services who employ proprietary discounted cash flow models to value the securities. Key quantitative inputs for these models are daily observed benchmark curves for treasury, swap and high issuance credits. The pricing services then apply a credit spread for each security which is developed by in-depth and real time market analysis. For securities in which trade volume is low, the pricing services utilize data from more frequently traded securities with similar attributes. These models may also be supplemented by daily market and credit research for international markets. | ||||||||||||||||
U.S. states, municipalities and political subdivisions | ||||||||||||||||
Level 2 - The Company's U.S. states, municipalities and political subdivisions portfolio contains debt securities issued by U.S. domiciled state and municipal entities. These securities are generally priced by independent pricing services using the techniques described for U.S. government and government agency securities described above. | ||||||||||||||||
Agency residential mortgage-backed securities | ||||||||||||||||
Level 2 - The Company's agency residential mortgage-backed investments are primarily priced by pricing services using a mortgage pool specific model which utilizes daily inputs from the active to be announced ("TBA") market which is very liquid, as well as the U.S. treasury market. The model also utilizes additional information, such as the weighted average maturity, weighted average coupon and other available pool level data which is provided by the sponsoring agency. Valuations are also corroborated with daily active market quotes. | ||||||||||||||||
Non-agency residential mortgage-backed securities | ||||||||||||||||
Level 2 - The Company's non-agency mortgage-backed investments include non-agency prime residential mortgage-backed fixed maturity investments. The Company has no fixed maturity investments classified as sub-prime held in its fixed maturity investments portfolio. Securities held in these sectors are primarily priced by pricing services using an option adjusted spread ("OAS") model or other relevant models, which principally utilize inputs including benchmark yields, available trade information or broker quotes, and issuer spreads. The pricing services also review collateral prepayment speeds, loss severity and delinquencies among other collateral performance indicators for the securities valuation, when applicable. | ||||||||||||||||
U.S. corporate | ||||||||||||||||
Level 2 - Corporate debt securities consist primarily of investment-grade debt of a wide variety of U.S. corporate issuers and industries. The Company's corporate fixed maturity investments are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources regarding the issuer of the security and obtain credit data, as well as other observations, from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The pricing services also consider the specific terms and conditions of the securities, including any specific features which may influence risk. In certain instances, securities are individually evaluated using a spread which is added to the U.S. treasury curve or a security specific swap curve as appropriate. | ||||||||||||||||
Non - U.S. corporate | ||||||||||||||||
Level 2 - Non - U.S. corporate debt securities consist primarily of investment-grade debt of a wide variety of non-U.S. corporate issuers and industries. The Company's non - U.S. corporate fixed maturity investments are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources regarding the issuer of the security and obtain credit data, as well as other observations, from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The pricing services also consider the specific terms and conditions of the securities, including any specific features which may influence risk. | ||||||||||||||||
Bank loans | ||||||||||||||||
Level 2 - The Company's bank loan investments consist primarily of below-investment-grade debt of a wide variety of corporate issuers and industries. The Company's bank loans are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources regarding the issuer of the security and obtain credit data, as well as other observations, from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The pricing services also consider the specific terms and conditions of the securities, including any specific features which may influence risk. | ||||||||||||||||
Catastrophe bonds | ||||||||||||||||
Level 2 - Catastrophe bonds are based on broker or underwriter bid indications. | ||||||||||||||||
Asset-backed securities | ||||||||||||||||
Level 2 - Asset backed securities include mostly investment-grade debt securities backed by pools of loans with a variety of underlying collateral, including automobile loan receivables, student loans, credit card receivables, and collateralized loan obligations originated by a variety of financial institutions. Securities held in these sectors are primarily priced by pricing services. The pricing services apply dealer quotes and other available trade information such as bids and offers, prepayment speeds which may be adjusted for the underlying collateral or current price data, the U.S. treasury curve and swap curve as well as cash settlement. The pricing services determine the expected cash flows for each security held in this sector using historical prepayment and default projections for the underlying collateral and current market data. In addition, a spread is applied to the relevant benchmark and used to discount the cash flows noted above to determine the fair value of the securities held in this sector. | ||||||||||||||||
Short term investments | ||||||||||||||||
Level 1 & Level 2 - Short term investments consist primarily of highly liquid securities, all with maturities less than one year from the date of purchase. The fair value of the Company's portfolio of short term investments are generally determined using amortized cost which approximates fair value. The Company determined that certain of its short-term investments held in highly liquid money market-type funds would be included in Level 1 as their fair values are based on quoted market prices in active markets. The remaining securities are classified within Level 2 because these securities are typically not actively traded due to their approaching maturity and, as such, their amortized cost approximates fair value. | ||||||||||||||||
Mutual funds | ||||||||||||||||
Level 2 -Mutual funds consist of two investment funds which are invested in various quoted investments. The fair value of units in the mutual funds is based on the net asset value of the fund as reported by the fund manager. | ||||||||||||||||
(c) Level 3 assets measured at fair value | ||||||||||||||||
Other investments | ||||||||||||||||
Level 3 includes financial instruments that are valued using market approach and income approach valuation techniques. These models incorporate both observable and unobservable inputs. The Company's hedge funds, a fund of hedge funds and private equity investments are the only financial instruments in this category as at September 30, 2013. For each respective hedge fund investment, the Company obtains and reviews the valuation methodology used by the fund administrators and investment managers to ensure that the hedge fund investments are following fair value principles consistent with U.S. GAAP in determining the net asset value (“NAV”). | ||||||||||||||||
Within the hedge fund industry, there is a general lack of transparency necessary to facilitate a detailed independent assessment of the values placed on the securities underlying the NAV provided by the fund manager or fund administrator. To address this, on a quarterly basis, we perform a number of monitoring procedures designed to assist us in the assessment of the quality of the information provided by managers and administrators. These procedures include, but are not limited to, regular review and discussion of each fund's performance with its manager and regular evaluation of fund performance against applicable benchmarks. | ||||||||||||||||
Hedge funds | ||||||||||||||||
The hedge funds were valued at $533,345 at September 30, 2013. The hedge funds consist of an investment in four Paulson & Co. managed funds (the "Paulson hedge funds") and two investment funds assumed from the Flagstone Acquisition (the "Flagstone investment funds"). The Paulson hedge funds' administrator provides monthly reported NAVs with a one-month delay in its valuation. As a result, the funds' administrator's August 31, 2013 NAV was used as a partial basis for fair value measurement in the Company's September 30, 2013 balance sheet. The fund manager provides an estimate of the NAV at September 30, 2013 based on estimated performance. The Company adjusts fair value to the fund manager's estimated NAV that incorporates relevant valuation sources on a timely basis. To determine the reasonableness of the estimated NAV, the Company assesses the variance between the fund manager's estimated NAV and the fund administrator's NAV. Material variances are recorded in the current reporting period while immaterial variances are recorded in the following reporting period. Historically, our valuation estimates have not materially differed from the subsequent NAVs. The Flagstone investment fund administrators provide either monthly or quarterly reported NAVs with a one-month or one-quarter delay in valuation, respectively. As a result, the August 31, 2013 NAV or the June 30, 2013 NAV was used as a basis for fair value measurement in the Company's September 30, 2013 balance sheet. As these valuation techniques incorporate both observable and significant unobservable inputs, both the Paulson hedge funds and the Flagstone investment funds are classified as Level 3 assets. The Paulson hedge funds are subject to quarterly liquidity. | ||||||||||||||||
Private equity investments | ||||||||||||||||
Private equity investments consist of investments in three private equity funds assumed from the Flagstone Acquisition. The private equity investments respective fund administrator provides either monthly or quarterly NAVs with a one-month or one-quarter delay in valuation, respectively. As a result, the August 31, 2013 NAV or the June 30, 2013 NAV was used as a basis for fair value measurement in the Company's September 30, 2013 balance sheet. As this valuation technique incorporates both observable and significant unobservable inputs, the private equity investments are classified as Level 3 assets. | ||||||||||||||||
Fund of hedge funds | ||||||||||||||||
The fund of hedge funds includes a side pocket. While a redemption request has been submitted, the timing of receipt of proceeds on the side pocket is unknown. The fund's administrator provides a monthly reported NAV with a one-month delay in its valuation. As a result, the fund administrator's August 31, 2013 NAV was used as a basis for fair value measurement in the Company's September 30, 2013 balance sheet. The fund manager provides an estimate of the fund NAV at September 30, 2013 based on the estimated performance provided from the underlying funds. To determine the reasonableness of the NAV, the Company compares the one-month delayed fund administrator's NAV to the fund manager's estimated NAV that incorporates relevant valuation sources on a timely basis. Material variances are recorded in the current reporting period while immaterial variances are recorded in the following reporting period. As this valuation technique incorporates both observable and significant unobservable inputs, the fund of hedge funds is classified as a Level 3 asset. | ||||||||||||||||
At September 30, 2013, the Company’s investments were allocated between Levels 1, 2 and 3 as follows: | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
U.S. government and government agency | $ | — | $ | 1,320,483 | $ | — | $ | 1,320,483 | ||||||||
Non-U.S. government and government agency | — | 403,997 | — | 403,997 | ||||||||||||
States, municipalities, political subdivision | — | 43,929 | — | 43,929 | ||||||||||||
Agency residential mortgage-backed securities | — | 320,201 | — | 320,201 | ||||||||||||
Non-agency residential mortgage-backed securities | — | 23,131 | — | 23,131 | ||||||||||||
U.S. corporate | — | 1,367,145 | — | 1,367,145 | ||||||||||||
Non-U.S. corporate | — | 689,050 | — | 689,050 | ||||||||||||
Bank loans | — | 736,458 | — | 736,458 | ||||||||||||
Catastrophe bonds | — | 58,862 | — | 58,862 | ||||||||||||
Asset-backed securities | — | 475,009 | — | 475,009 | ||||||||||||
Total fixed maturities | — | 5,438,265 | — | 5,438,265 | ||||||||||||
Short-term investments | 755,747 | 5,895 | — | 761,642 | ||||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | — | — | 2,450 | 2,450 | ||||||||||||
Private equity investments | — | — | 14,673 | 14,673 | ||||||||||||
Hedge funds (a) | — | — | 533,345 | 533,345 | ||||||||||||
Mutual funds | — | 9,004 | — | 9,004 | ||||||||||||
Total other investments | — | 9,004 | 550,468 | 559,472 | ||||||||||||
Total | $ | 755,747 | $ | 5,453,164 | $ | 550,468 | $ | 6,759,379 | ||||||||
Noncontrolling interest (a) | (15,730 | ) | — | (465,472 | ) | (481,202 | ) | |||||||||
Total investments excluding noncontrolling interest | $ | 740,017 | $ | 5,453,164 | $ | 84,996 | $ | 6,278,177 | ||||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. | |||||||||||||||
At December 31, 2012, the Company’s investments were allocated between Levels 1, 2 and 3 as follows: | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
U.S. government and government agency | $ | — | $ | 1,099,230 | $ | — | $ | 1,099,230 | ||||||||
Non-U.S. government and government agency | — | 302,279 | — | 302,279 | ||||||||||||
States, municipalities, political subdivision | — | 42,063 | — | 42,063 | ||||||||||||
Agency residential mortgage-backed securities | — | 388,874 | — | 388,874 | ||||||||||||
Non-agency residential mortgage-backed securities | — | 106,456 | — | 106,456 | ||||||||||||
U.S. corporate | — | 1,210,173 | — | 1,210,173 | ||||||||||||
Non-U.S. corporate | — | 593,265 | — | 593,265 | ||||||||||||
Bank loans | — | 673,383 | — | 673,383 | ||||||||||||
Catastrophe bonds | — | 56,947 | — | 56,947 | ||||||||||||
Asset-backed securities | — | 612,664 | — | 612,664 | ||||||||||||
Total fixed maturities | — | 5,085,334 | — | 5,085,334 | ||||||||||||
Short-term investments | 1,063,175 | 51,075 | — | 1,114,250 | ||||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | — | — | 4,757 | 4,757 | ||||||||||||
Private equity investments | — | — | 12,951 | 12,951 | ||||||||||||
Hedge funds (a) | — | — | 538,526 | 538,526 | ||||||||||||
Mutual funds | — | 8,214 | — | 8,214 | ||||||||||||
Total other investments | — | 8,214 | 556,234 | 564,448 | ||||||||||||
Total | $ | 1,063,175 | $ | 5,144,623 | $ | 556,234 | $ | 6,764,032 | ||||||||
Noncontrolling interest (a) | — | — | (432,737 | ) | (432,737 | ) | ||||||||||
Total investments excluding noncontrolling interest | $ | 1,063,175 | $ | 5,144,623 | $ | 123,497 | $ | 6,331,295 | ||||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. | |||||||||||||||
At September 30, 2013, Level 3 investments excluding the noncontrolling interest totaled $84,996 (December 31, 2012: $123,497), representing 1.4% (December 31, 2012: 2.0%) of total investments, excluding noncontrolling interest, measured at fair value on a recurring basis. | ||||||||||||||||
The following tables present a reconciliation of the beginning and ending balances for all investments measured at fair value on a recurring basis using Level 3 inputs during the three and nine months ended September 30, 2013 and 2012: | ||||||||||||||||
Three Months Ended September 30, 2013 | Three Months Ended September 30, 2012 | |||||||||||||||
Total Fair Market Value | Total Fair Market Value | |||||||||||||||
Level 3 investments - Beginning of period | $ | 505,158 | $ | 454,793 | ||||||||||||
Purchases | 33,154 | — | ||||||||||||||
Sales | (35,264 | ) | (218 | ) | ||||||||||||
Net realized gains | 4,503 | 13 | ||||||||||||||
Net unrealized gains | 42,917 | 61,746 | ||||||||||||||
Transfers | — | 921 | ||||||||||||||
Level 3 investments - End of period | $ | 550,468 | $ | 517,255 | ||||||||||||
Noncontrolling interest (a) | (465,472 | ) | (460,924 | ) | ||||||||||||
Level 3 investments excluding noncontrolling interest | $ | 84,996 | $ | 56,331 | ||||||||||||
Nine Months Ended September 30, 2013 | Nine Months Ended September 30, 2012 | |||||||||||||||
Total Fair Market Value | Total Fair Market Value | |||||||||||||||
Level 3 investments - Beginning of period | $ | 556,234 | $ | 8,880 | ||||||||||||
Purchases | 98,669 | 500,000 | ||||||||||||||
Sales | (80,095 | ) | (1,115 | ) | ||||||||||||
Net realized gains | 4,843 | 61 | ||||||||||||||
Net unrealized (losses) gains | (29,183 | ) | 11,762 | |||||||||||||
Transfers | — | (2,333 | ) | |||||||||||||
Level 3 investments - End of period | $ | 550,468 | $ | 517,255 | ||||||||||||
Noncontrolling interest (a) | (465,472 | ) | (460,924 | ) | ||||||||||||
Level 3 investments excluding noncontrolling interest | $ | 84,996 | $ | 56,331 | ||||||||||||
(a) | Includes Level 3 investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. | |||||||||||||||
There have not been any transfers between Levels 1 and 2 during the three and nine months ended September 30, 2013 or 2012. There have not been any transfers into or out of Level 3 during the three and nine months ended September 30, 2013. During the three months ended September 30, 2012, there was a transfer of an investment into Level 3 of the fair value hierarchy. This transfer was due to the conversion of a bank loan to other investments. During the three months ended June 30, 2012, there was a transfer of a private equity investment out of Level 3 “Other investments” to “Investments in affiliates.” Refer to Note 5 “Investments in affiliates.” |
Investments_in_affilates
Investments in affilates | 9 Months Ended | |||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||
Equity Method Investments and Joint Ventures [Abstract] | ' | |||||||||||||||||||
Investments in affiliates | ' | |||||||||||||||||||
Investments in affiliates | ||||||||||||||||||||
(a) Operating affiliates | ||||||||||||||||||||
AlphaCat Re 2011, Ltd. | ||||||||||||||||||||
On May 25, 2011, the Company joined with other investors in capitalizing AlphaCat Re 2011, Ltd. ("AlphaCat Re 2011"), a special purpose reinsurer formed for the purpose of writing collateralized reinsurance and retrocessional reinsurance. At the time of formation, Validus Reinsurance, Ltd. ("Validus Re"), a wholly owned subsidiary of the Company, had a majority voting equity interest in AlphaCat Re 2011 and as a result, the financial statements of AlphaCat Re 2011 were included in the consolidated financial statements of the Company. | ||||||||||||||||||||
On December 23, 2011, AlphaCat Re 2011 completed a secondary offering of its common shares to third party investors, along with a partial sale of Validus Re's common shares to one of the third party investors. | ||||||||||||||||||||
As a result of these transactions, Validus Re maintained an equity interest in AlphaCat Re 2011, however its share of AlphaCat Re 2011's outstanding voting rights decreased to 43.7%. As a result of the Company's voting interest falling below 50%, the individual assets and liabilities and corresponding noncontrolling interest of AlphaCat Re 2011 were derecognized from the consolidated balance sheet of the Company as at December 31, 2011 and the remaining investment in AlphaCat Re 2011 has been treated as an equity method investment with effect from December 23, 2011. | ||||||||||||||||||||
AlphaCat Re 2011 is now considered "off-risk" as the risk periods for all reinsurance contracts written by the company have expired. As a result, on January 4, 2013, January 23, 2013, May 1, 2013, May 28, 2013 and July 22, 2013 partial returns of investment were made to the investors of AlphaCat Re 2011. Validus Re's corresponding portion of the return of investment was $54,914. | ||||||||||||||||||||
AlphaCat Re 2012, Ltd. | ||||||||||||||||||||
On May 29, 2012, the Company joined with other investors in capitalizing AlphaCat Re 2012, Ltd. ("AlphaCat Re 2012"), a special purpose reinsurer formed for the purpose of writing collateralized reinsurance with a particular focus on windstorm risks for Florida domiciled insurance companies. The Company holds an equity interest of 37.9% and a voting interest of 49.0% in AlphaCat Re 2012, therefore the investment has been treated as an equity method investment. | ||||||||||||||||||||
AlphaCat Re 2012 is now considered "off-risk" as the risk periods for all reinsurance contracts written by the company have expired. As a result, on February 22, 2013, June 20, 2013 and July 22, 2013, partial returns of investment were made to the investors of AlphaCat Re 2012. Validus Re's corresponding portion of the return of investment was $31,743. | ||||||||||||||||||||
AlphaCat 2013, Ltd. | ||||||||||||||||||||
On December 17, 2012, the Company joined with other investors in capitalizing AlphaCat 2013, Ltd. ("AlphaCat 2013"), a special purpose vehicle formed for the purpose of investing in collateralized reinsurance. The Company holds an equity interest of 19.7% and a voting interest of 40.9% in AlphaCat 2013, therefore the investment has been treated as an equity method investment. | ||||||||||||||||||||
Investment in Insurance Linked Securities ("ILS") | ||||||||||||||||||||
The Company received $219,400 of third party subscriptions in three of the AlphaCat ILS funds as of December 31, 2012. During the three and nine months ended September 30, 2013, the Company received $13,000 and $82,190 in additional third party subscriptions, respectively. The AlphaCat ILS funds invest in instruments with returns linked to property catastrophe reinsurance, retrocession and ILS contracts. Two of the funds are variable interest entities and are consolidated by the Company as Validus Re is deemed to be the primary beneficiary. The third fund is also a variable interest entity, however, it is not consolidated by the Company as Validus Re is not deemed to be the primary beneficiary. As a result, the investment in this fund is included in "Investments in affiliates" as at September 30, 2013. Income from this fund was $1,155 and $1,481 for the three and nine months ended September 30, 2013. The Company's carrying value of this fund amounted to $21,481 and $20,000 as at September 30, 2013 and December 31, 2012, respectively. The Company's maximum exposure to loss with respect to this investment is limited to the investment carrying value reported in the Company's Consolidated Balance Sheets. | ||||||||||||||||||||
The following table presents a reconciliation of the beginning and ending investment in operating affiliates balances for the three and nine months ended September 30, 2013 and 2012: | ||||||||||||||||||||
Three Months Ended September 30, 2013 | ||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | AlphaCat 2013 | AlphaCat ILS funds | Total | ||||||||||||||||
As at June 30, 2013 | $ | 11,054 | $ | 5,204 | $ | 48,536 | $ | 20,326 | $ | 85,120 | ||||||||||
Return of investment | (2,800 | ) | (4,550 | ) | — | — | (7,350 | ) | ||||||||||||
(Loss) income from operating affiliates | (270 | ) | (7 | ) | 585 | 1,155 | 1,463 | |||||||||||||
As at September 30, 2013 | $ | 7,984 | $ | 647 | $ | 49,121 | $ | 21,481 | $ | 79,233 | ||||||||||
Three Months Ended September 30, 2012 | ||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | Total | ||||||||||||||||||
As at June 30, 2012 | $ | 59,238 | $ | 27,252 | $ | 86,490 | ||||||||||||||
Income from operating affiliates | 4,079 | 2,156 | 6,235 | |||||||||||||||||
As at September 30, 2012 | $ | 63,317 | $ | 29,408 | $ | 92,725 | ||||||||||||||
Nine Months Ended September 30, 2013 | ||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | AlphaCat 2013 | AlphaCat ILS funds | Total | ||||||||||||||||
As at December 31, 2012 | $ | 62,792 | $ | 29,319 | $ | 45,000 | $ | 20,000 | $ | 157,111 | ||||||||||
Return of investment | (54,914 | ) | (31,743 | ) | — | — | (86,657 | ) | ||||||||||||
Income from operating affiliates | 106 | 3,071 | 4,121 | 1,481 | 8,779 | |||||||||||||||
As at September 30, 2013 | $ | 7,984 | $ | 647 | $ | 49,121 | $ | 21,481 | $ | 79,233 | ||||||||||
Nine Months Ended September 30, 2012 | ||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | Total | ||||||||||||||||||
As at December 31, 2011 | $ | 53,031 | $ | — | $ | 53,031 | ||||||||||||||
Purchase of shares | — | 26,500 | 26,500 | |||||||||||||||||
Income from operating affiliates | 10,286 | 2,908 | 13,194 | |||||||||||||||||
As at September 30, 2012 | $ | 63,317 | $ | 29,408 | $ | 92,725 | ||||||||||||||
The following table presents the Company's investments in operating affiliates as at September 30, 2013: | ||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||
Investment at cost | Voting ownership % | Equity ownership % | Carrying value | |||||||||||||||||
AlphaCat Re 2011 | $ | 8,254 | 43.7 | % | 22.3 | % | $ | 7,984 | ||||||||||||
AlphaCat Re 2012 | 652 | 49 | % | 37.9 | % | 647 | ||||||||||||||
AlphaCat 2013 | 45,000 | 40.9 | % | 19.7 | % | 49,121 | ||||||||||||||
AlphaCat ILS Funds | 20,000 | — | % | 9.1 | % | 21,481 | ||||||||||||||
Total | $ | 73,906 | $ | 79,233 | ||||||||||||||||
The following table presents the Company's investments in operating affiliates as at December 31, 2012: | ||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||
Investment at cost | Voting ownership % | Equity ownership % | Carrying value | |||||||||||||||||
AlphaCat Re 2011 | $ | 41,389 | 43.7 | % | 22.3 | % | $ | 62,792 | ||||||||||||
AlphaCat Re 2012 | 26,500 | 49 | % | 37.9 | % | 29,319 | ||||||||||||||
AlphaCat 2013 | 45,000 | 40.9 | % | 19.7 | % | 45,000 | ||||||||||||||
AlphaCat ILS Fund | $ | 20,000 | — | % | 11.8 | % | $ | 20,000 | ||||||||||||
Total | $ | 132,889 | $ | 157,111 | ||||||||||||||||
(b) Investment affiliate | ||||||||||||||||||||
Aquiline Financial Services Fund II L.P. | ||||||||||||||||||||
On December 20, 2011, Validus Re entered into an Assignment and Assumption Agreement (the "Agreement") with Aquiline Capital Partners LLC, a Delaware limited liability company (the "Assignor") and Aquiline Capital Partners II GP (Offshore) Ltd., a Cayman Islands company limited by shares (the "General Partner") pursuant to which Validus Re has assumed 100% of the Assignor's interest in Aquiline Financial Services Fund II L.P. (the "Partnership") representing a total capital commitment of $50,000 (the "Commitment"), as a limited partner in the Partnership (the "Transferred Interest"). The Transferred Interest is governed by the terms of an Amended and Restated Exempted Limited Partnership Agreement dated as of July 2, 2010 (the "Limited Partnership Agreement"). Pursuant to the terms of the Limited Partnership Agreement, the Commitment will expire on July 2, 2015. | ||||||||||||||||||||
The Partnership provides quarterly capital account statements with a three-month delay in its valuation. As a result, the Partnership's June 30, 2013 capital account statement was used as the basis for calculating the Company's share of partnership income for the period. | ||||||||||||||||||||
The following table presents a reconciliation of the beginning and ending investment in the Company's investment affiliate balance for the three and nine months ended September 30, 2013 and 2012: | ||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||
Investment affiliate, beginning of period | $ | 25,352 | $ | 6,317 | $ | 15,218 | $ | 3,253 | ||||||||||||
Capital contributions | 6,185 | 430 | 13,089 | 5,328 | ||||||||||||||||
Net unrealized (loss) on investments (a) | — | — | — | (1,436 | ) | |||||||||||||||
Income (loss) from investment affiliate | 1,044 | (160 | ) | 4,274 | (558 | ) | ||||||||||||||
Investment affiliate, end of period | $ | 32,581 | $ | 6,587 | $ | 32,581 | $ | 6,587 | ||||||||||||
(a) | Until March 31, 2012, this investment was included in " Other investments" as a level 3 investment in the fair value hierarchy, hence the change in fair value was included in net unrealized (losses) gains on investments. | |||||||||||||||||||
The following table presents the Company's investment in the Partnership as at September 30, 2013: | ||||||||||||||||||||
Investment in investment affiliate | ||||||||||||||||||||
Investment at cost | Voting ownership % | Equity Ownership | Carrying Value | |||||||||||||||||
Aquiline Financial Services Fund II L.P | $ | 30,707 | — | % | 6.59 | % | $ | 32,581 | ||||||||||||
Noncontrolling_interest
Noncontrolling interest | 9 Months Ended | |||||||||||
Sep. 30, 2013 | ||||||||||||
Noncontrolling Interest [Abstract] | ' | |||||||||||
Noncontrolling interest | ' | |||||||||||
Noncontrolling interest | ||||||||||||
On April 2, 2012, the Company joined with other investors in capitalizing PaCRe, a new Class 4 Bermuda reinsurer formed for the purpose of writing high excess property catastrophe reinsurance. On May 1, 2013, PaCRe received additional capital contributions of $6,500 from Validus Re and $58,500 from a third party investor. Validus Re continues to have an equity interest of 10% and the remaining 90% interest is held by third party investors. Validus Re has a majority voting equity interest in PaCRe and as a result, the financial statements of PaCRe are included in the consolidated financial statements of the Company. The portion of PaCRe's earnings attributable to third party investors for the three and nine months ended September 30, 2013 and 2012 is recorded in the Consolidated Statements of Comprehensive Income as net (income) loss attributable to noncontrolling interest. | ||||||||||||
The Company received $219,400 of third party subscriptions in three AlphaCat ILS funds as of December 31, 2012. During the three and nine months ended September 30, 2013, the Company received $13,000 and $82,190 in additional third party subscriptions, respectively. The AlphaCat ILS funds invest in instruments with returns linked to property catastrophe reinsurance, retrocession and ILS contracts. Two of the funds are variable interest entities and are consolidated by the Company as Validus Re is deemed to be the primary beneficiary. Validus Re has a majority participating interest in these two funds and as a result, the financial statements of these funds are included in the consolidated financial statements of the Company. The portion of these two funds' earnings attributable to third party investors for the three and nine months ended September 30, 2013 is recorded in the Consolidated Statements of Comprehensive Income within net (income) loss attributable to noncontrolling interest. | ||||||||||||
The following table presents a reconciliation of the beginning and ending balances of noncontrolling interest for the three and nine months ended September 30, 2013 and 2012: | ||||||||||||
Three Months Ended September 30, 2013 | ||||||||||||
PaCRe | AlphaCat ILS funds | Total | ||||||||||
As at June 30, 2013 | $ | 427,755 | $ | 70,690 | $ | 498,445 | ||||||
Purchase of shares by noncontrolling interest | — | 13,000 | 13,000 | |||||||||
Net income attributable to noncontrolling interest | 44,178 | 1,516 | 45,694 | |||||||||
As at September 30, 2013 | $ | 471,933 | $ | 85,206 | $ | 557,139 | ||||||
Three Months Ended September 30, 2012 | ||||||||||||
PaCRe | Total | |||||||||||
As at June 30, 2012 | $ | 404,740 | $ | 404,740 | ||||||||
Net income attributable to noncontrolling interest | 56,746 | 56,746 | ||||||||||
As at September 30, 2012 | $ | 461,486 | $ | 461,486 | ||||||||
Nine Months Ended September 30, 2013 | ||||||||||||
PaCRe | AlphaCat ILS funds | Total | ||||||||||
As at December 31, 2012 | $ | 434,280 | $ | — | $ | 434,280 | ||||||
Purchase of shares by noncontrolling interest | 58,500 | 82,190 | 140,690 | |||||||||
Net (loss) income attributable to noncontrolling interest | (20,847 | ) | 3,016 | (17,831 | ) | |||||||
As at September 30, 2013 | $ | 471,933 | $ | 85,206 | $ | 557,139 | ||||||
Nine Months Ended September 30, 2012 | ||||||||||||
PaCRe | Total | |||||||||||
As at December 31, 2011 | $ | — | $ | — | ||||||||
Purchase of shares by noncontrolling interest | 450,100 | 450,100 | ||||||||||
Net income attributable to noncontrolling interest | 11,386 | 11,386 | ||||||||||
As at September 30, 2012 | $ | 461,486 | $ | 461,486 | ||||||||
Derivative_instruments
Derivative instruments | 9 Months Ended | ||||||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ||||||||||||||||||||||||
Derivative instruments | ' | ||||||||||||||||||||||||
Derivative instruments | |||||||||||||||||||||||||
The Company enters into derivative instruments for risk management purposes, specifically to hedge unmatched foreign currency exposures and interest rate exposures. As at September 30, 2013, the Company held foreign currency forward contracts to mitigate the risk of fluctuations in the Euro, Chilean Peso, Australian Dollar, New Zealand Dollar and British Pound Sterling to U.S. dollar exchange rates. As at September 30, 2013, the Company held two interest rate swap contracts to mitigate the risk of interest rate exposure on the payment of interest on the Company's 2006 and 2007 Junior Subordinated Deferrable Debentures, as well as three interest rate swaps and one cross-currency interest rate swap to mitigate the risk of interest rate and foreign exchange rate exposure on the payment of interest on Flagstone's 2006 and 2007 Junior Subordinated Deferrable Debentures. | |||||||||||||||||||||||||
As part of the Flagstone Acquisition, the Company assumed foreign currency forward contracts which were not designated as hedging instruments. The contracts expired on July 15, 2013. | |||||||||||||||||||||||||
The following table summarizes information on the location and amount of the fair value of derivatives not designated as hedging instruments on the consolidated balance sheet at September 30, 2013 and December 31, 2012: | |||||||||||||||||||||||||
At September 30, 2013 | At December 31, 2012 | ||||||||||||||||||||||||
Derivatives not designated as hedging instruments: | Net notional exposure | Asset Derivative at Fair Value (a) | Liability Derivative at Fair Value (a) | Net notional exposure | Asset Derivative at Fair Value (a) | Liability Derivative at Fair Value (a) | |||||||||||||||||||
Currency swaps | $ | — | $ | — | $ | — | $ | 17,153 | $ | — | $ | 772 | |||||||||||||
Foreign currency forward contracts | $ | — | $ | — | $ | — | $ | 310,541 | $ | — | $ | 394 | |||||||||||||
(a) | Asset and liability derivatives are classified within other assets and accounts payable and accrued expenses respectively on the Consolidated Balance Sheets. | ||||||||||||||||||||||||
The following table summarizes information on the location and amount of the fair value of derivatives designated as hedging instruments on the consolidated balance sheets at September 30, 2013 and December 31, 2012: | |||||||||||||||||||||||||
At September 30, 2013 | At December 31, 2012 | ||||||||||||||||||||||||
Derivatives designated as hedging instruments: | Net notional exposure | Asset Derivative at Fair Value (a) | Liability Derivative at Fair Value (a) | Net notional exposure | Asset Derivative at Fair Value (a) | Liability Derivative at Fair Value (a) | |||||||||||||||||||
Foreign currency forward contracts | $ | 168,722 | $ | 4,977 | $ | 1,115 | $ | 35,976 | $ | — | $ | 223 | |||||||||||||
Interest rate swap contracts | $ | 552,263 | $ | — | 873 | $ | 289,800 | $ | — | $ | 220 | ||||||||||||||
(a) | Asset and liability derivatives are classified within other assets and accounts payable and accrued expenses respectively on the Consolidated Balance Sheets. | ||||||||||||||||||||||||
(a) Classification within the fair value hierarchy | |||||||||||||||||||||||||
As described in Note 4: "Fair value measurements," under U.S. GAAP, a company must determine the appropriate level in the fair value hierarchy for each fair value measurement. The assumptions used within the valuation are observable in the marketplace, can be derived from observable data or are supported by observable levels at which other similar transactions are executed in the marketplace. Accordingly, these derivatives were classified within Level 2 of the fair value hierarchy. | |||||||||||||||||||||||||
(b)Derivative instruments designated as a fair value hedge | |||||||||||||||||||||||||
The Company designates its foreign currency forward contract derivative instruments as fair value hedges and formally and contemporaneously documents all relationships between the hedging instruments and hedged items and links the hedging derivatives to specific assets or liabilities. The Company assesses the effectiveness of the hedges, both at inception and on an on-going basis and determines whether the hedges are highly effective in offsetting changes in fair value of the linked hedged items. | |||||||||||||||||||||||||
The following table provides the total impact on earnings relating to the derivative instruments formally designated as fair value hedges along with the impact of the related hedged items for the three and nine months ended September 30, 2013 and 2012: | |||||||||||||||||||||||||
Foreign currency forward contracts | Three Months Ended September 30, 2013 | Three Months Ended September 30, 2012 | Nine Months Ended September 30, 2013 | Nine Months Ended September 30, 2012 | |||||||||||||||||||||
Amount of gain (loss) recognized in income on derivative | $ | 3,116 | $ | 1,749 | $ | 2,670 | $ | 130 | |||||||||||||||||
Amount of gain (loss) on hedged item recognized in income attributable to risk being hedged | $ | (3,116 | ) | $ | (1,749 | ) | $ | (2,670 | ) | $ | (130 | ) | |||||||||||||
Amount of gain (loss) recognized in income on derivative (ineffective portion) | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||
The gain (loss) is recognized in income within foreign exchange gains (losses). | |||||||||||||||||||||||||
(c) Derivative instruments designated as a cash flow hedge | |||||||||||||||||||||||||
The Company designates its interest rate derivative instruments as cash flow hedges and formally and contemporaneously documents all relationships between the hedging instruments and hedged items and links the hedging derivatives to specific assets and liabilities. The Company assesses the effectiveness of the hedges, both at inception and on an on-going basis (as required) and determines whether the hedges are highly effective in offsetting changes in fair value of the linked hedged items. The Company currently applies the long haul method when assessing the hedge's effectiveness. | |||||||||||||||||||||||||
The following table provides the total impact on other comprehensive income and earnings relating to the derivative instruments formally designated as cash flow hedges along with the impact of the related hedged items for the three and nine months ended September 30, 2013: | |||||||||||||||||||||||||
Interest rate swap contracts | Three Months Ended September 30, 2013 | Three Months Ended September 30, 2012 | Nine Months Ended September 30, 2013 | Nine Months Ended September 30, 2012 | |||||||||||||||||||||
Amount of effective portion recognized in other comprehensive income | $ | 3,268 | $ | 195 | $ | 7,838 | $ | 195 | |||||||||||||||||
Amount of effective portion subsequently reclassified to earnings | $ | (3,268 | ) | $ | (195 | ) | $ | (7,838 | ) | $ | (195 | ) | |||||||||||||
Amount of ineffective portion excluded from effectiveness testing | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||
The above balances relate to interest paid and have been classified as finance expenses in the consolidated statements of comprehensive income. There was no interest rate swap contract activity for the three and nine months ended September 30, 2012. | |||||||||||||||||||||||||
(d) Balance sheet offsetting | |||||||||||||||||||||||||
There was no balance sheet offsetting activity as at September 30, 2013 or December 31, 2012. | |||||||||||||||||||||||||
The Company currently provides cash collateral as security for interest rate swap contracts. The Company does not provide cash collateral or financial instruments as security for foreign currency forward contracts. Our derivative instruments are generally traded under International Swaps and Derivatives Association master netting agreements, which establish terms that apply to all transactions. On a periodic basis, the amounts receivable from or payable to the counterparties are settled in cash. The Company has not elected to settle multiple transactions with an individual counterparty on a net basis. |
Reserve_for_losses_and_loss_ex
Reserve for losses and loss expenses | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | ' | |||||||||||||||
Reserve for losses and loss expenses | ' | |||||||||||||||
Reserve for losses and loss expenses | ||||||||||||||||
Reserves for losses and loss expenses are based in part upon the estimation of case reserves reported from brokers, insureds and ceding companies. The Company also uses statistical and actuarial methods to estimate ultimate expected losses and loss expenses. The period of time from the occurrence of a loss to the reporting of a loss to the Company and to the settlement of the Company's liability may be several months or years. During this period, additional facts and trends may be revealed. As these factors become apparent, reserves will be adjusted, sometimes requiring an increase or decrease in the overall reserves of the Company, and at other times requiring a reallocation of incurred but not reported reserves to specific case reserves. These estimates are reviewed and adjusted regularly, and such adjustments, if any, are reflected in earnings in the period in which they become known. While management believes that it has made a reasonable estimate of ultimate losses, there can be no assurances that ultimate losses and loss expenses will not exceed this estimate. | ||||||||||||||||
The following table represents an analysis of paid and unpaid losses and loss expenses incurred and a reconciliation of the beginning and ending unpaid losses and loss expenses for the three and nine months ended September 30, 2013 and 2012: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Reserve for losses and loss expenses, beginning of period | $ | 3,283,450 | $ | 2,591,299 | $ | 3,517,573 | $ | 2,631,143 | ||||||||
Losses and loss expenses recoverable | (418,693 | ) | (371,484 | ) | (439,967 | ) | (372,485 | ) | ||||||||
Net reserves for losses and loss expenses, beginning of period | 2,864,757 | 2,219,815 | 3,077,606 | 2,258,658 | ||||||||||||
Net reserves acquired | — | — | 948 | — | ||||||||||||
Increase (decrease) in net losses and loss expenses incurred in respect of losses occurring in: | ||||||||||||||||
Current year | 243,015 | 205,219 | 759,617 | 658,884 | ||||||||||||
Prior years | (65,050 | ) | (49,764 | ) | (171,837 | ) | (117,748 | ) | ||||||||
Total incurred losses and loss expenses | 177,965 | 155,455 | 587,780 | 541,136 | ||||||||||||
Total net paid losses | (274,868 | ) | (144,628 | ) | (847,192 | ) | (569,380 | ) | ||||||||
Foreign exchange | 34,363 | 14,710 | (16,925 | ) | 14,938 | |||||||||||
Net reserve for losses and loss expenses, end of period | 2,802,217 | 2,245,352 | 2,802,217 | 2,245,352 | ||||||||||||
Losses and loss expenses recoverable | 421,518 | 317,252 | 421,518 | 317,252 | ||||||||||||
Reserve for losses and loss expenses, end of period | $ | 3,223,735 | $ | 2,562,604 | $ | 3,223,735 | $ | 2,562,604 | ||||||||
Reinsurance
Reinsurance | 9 Months Ended | |||||||||||||
Sep. 30, 2013 | ||||||||||||||
Reinsurance Disclosures [Abstract] | ' | |||||||||||||
Reinsurance | ' | |||||||||||||
Reinsurance | ||||||||||||||
The Company enters into reinsurance and retrocession agreements in order to mitigate its accumulation of loss, reduce its liability on individual risks, enable it to underwrite policies with higher limits and increase its aggregate capacity. The cession of insurance and reinsurance does not legally discharge the Company from its primary liability for the full amount of the policies, and the Company is required to pay the loss and bear collection risk if the reinsurer fails to meet its obligations under the reinsurance or retrocession agreement. Amounts recoverable from reinsurers are estimated in a manner consistent with the underlying liabilities. | ||||||||||||||
Credit risk | ||||||||||||||
The Company evaluates the financial condition of its reinsurers and monitors concentration of credit risk arising from its exposure to individual reinsurers. The reinsurance program is generally placed with reinsurers whose rating, at the time of placement, was A- or better by Standard & Poor's or the equivalent with other rating agencies. Exposure to a single reinsurer is also controlled with restrictions dependent on rating. At September 30, 2013, 97.7% (December 31, 2012: 97.9%) of reinsurance recoverables (which includes loss reserves recoverable and recoverables on paid losses) were fully collateralized or from reinsurers rated A- or better and included $211,864 of total IBNR recoverable (December 31, 2012: $185,255). Reinsurance recoverables by reinsurer are as follows: | ||||||||||||||
September 30, 2013 | December 31, 2012 | |||||||||||||
Reinsurance Recoverable | % of Total | Reinsurance Recoverable | % of Total | |||||||||||
Top 10 reinsurers | $ | 340,988 | 75.5 | % | $ | 360,234 | 74.1 | % | ||||||
Other reinsurers’ balances > $1 million | 102,714 | 22.7 | % | 115,262 | 23.7 | % | ||||||||
Other reinsurers’ balances < $1 million | 7,890 | 1.8 | % | 10,906 | 2.2 | % | ||||||||
Total | $ | 451,592 | 100 | % | $ | 486,402 | 100 | % | ||||||
September 30, 2013 | ||||||||||||||
Top 10 Reinsurers | Rating | Reinsurance Recoverable | % of Total | |||||||||||
Lloyd's Syndicates | A+ | $ | 74,586 | 21.9 | % | |||||||||
Everest Re | A+ | 52,372 | 15.3 | % | ||||||||||
National Indemnity | AA+ | 50,984 | 14.9 | % | ||||||||||
Hannover Re | AA- | 45,975 | 13.5 | % | ||||||||||
Fully Collateralized | NR | 34,293 | 10.1 | % | ||||||||||
Swiss Re | AA- | 20,728 | 6.1 | % | ||||||||||
Third Point Reinsurance Ltd | A- | 20,049 | 5.9 | % | ||||||||||
Transatlantic Re | A+ | 15,887 | 4.7 | % | ||||||||||
XL Re | A | 14,062 | 4.1 | % | ||||||||||
Munich Re | AA- | 12,052 | 3.5 | % | ||||||||||
Total | $ | 340,988 | 100 | % | ||||||||||
December 31, 2012 | ||||||||||||||
Top 10 Reinsurers | Rating | Reinsurance Recoverable | % of Total | |||||||||||
Lloyd’s Syndicates | A+ | $ | 71,469 | 19.9 | % | |||||||||
National Indemnity | AA+ | 59,941 | 16.6 | % | ||||||||||
Everest Re | A+ | 51,340 | 14.3 | % | ||||||||||
Fully Collateralized | NR | 47,445 | 13.2 | % | ||||||||||
Hannover Re | AA- | 40,552 | 11.3 | % | ||||||||||
Munich Re | AA- | 20,954 | 5.8 | % | ||||||||||
Transatlantic Re | A+ | 20,320 | 5.6 | % | ||||||||||
Swiss Re | AA- | 16,992 | 4.7 | % | ||||||||||
Allianz | AA- | 16,367 | 4.5 | % | ||||||||||
XL Re | A | 14,854 | 4.1 | % | ||||||||||
Total | $ | 360,234 | 100 | % | ||||||||||
NR: Not rated | ||||||||||||||
At September 30, 2013 and December 31, 2012, the provision for uncollectible reinsurance relating to losses recoverable was $6,209 and $6,602, respectively. To estimate the provision for uncollectible reinsurance recoverable, the reinsurance recoverable is first allocated to applicable reinsurers. This determination is based on a process rather than an estimate, although an element of judgment is applied. As part of this process, ceded IBNR is allocated by reinsurer. The Company uses a default analysis to estimate uncollectible reinsurance. The primary components of the default analysis are reinsurance recoverable balances by reinsurer and default factors used to determine the portion of a reinsurer's balance deemed to be uncollectible. Default factors require considerable judgment and are determined using the current rating, or rating equivalent, of each reinsurer as well as other key considerations and assumptions. | ||||||||||||||
Of the $451,592 reinsurance recoverable at September 30, 2013 (December 31, 2012: $486,402), $34,293 was fully collateralized (December 31, 2012: $47,445). |
Share_capital
Share capital | 9 Months Ended | ||
Sep. 30, 2013 | |||
Stockholders' Equity Note [Abstract] | ' | ||
Share capital | ' | ||
Share capital | |||
(a) | Authorized and issued | ||
The Company’s authorized share capital is 571,428,571 common shares with a par value of $0.175 per share. The holders of common shares are entitled to receive dividends. Holders of common shares are allocated one vote per share, provided that, if the controlled shares of any shareholder or group of related shareholders constitute more than 9.09 percent of the outstanding common shares of the Company, their voting power will be reduced to 9.09 percent. | |||
The Company may from time to time repurchase its securities, including common shares, Junior Subordinated Deferrable Debentures and Senior Notes. On February 6, 2013, the Board of Directors of the Company approved an increase in the Company's common share purchase authorization to $500,000. This amount is in addition to the $1,206,845 of common shares repurchased by the Company through February 6, 2013 under its previously authorized share repurchase programs. | |||
There were no additional share repurchases during the three months ended September 30, 2013. The Company has repurchased 52,849,445 common shares for an aggregate purchase price of $1,564,029 from the inception of its share repurchase program to September 30, 2013. The Company had $142,816 remaining under its authorized share repurchase program as of September 30, 2013. | |||
The Company expects the purchases under its share repurchase program to be made from time to time in the open market or in privately negotiated transactions. The timing, form and amount of the share repurchases under the program will depend on a variety of factors, including market conditions, the Company’s capital position relative to internal and rating agency targets, legal requirements and other factors. The repurchase program may be modified, extended or terminated by the Board of Directors at any time. | |||
On November 30, 2012, the Company acquired all of the outstanding shares of Flagstone from a group of institutional and other investors. Pursuant to the merger agreement, the Company acquired all of Flagstone's outstanding common shares in exchange for the Company's common shares and cash. The Company issued 14,202,664 common shares, net of 87,725 shares withheld for income taxes, valued at $34.87 per share as partial consideration for the acquisition. In addition, 1,638,875 common shares recorded in treasury are owned by Flagstone (Bermuda) Holdings Limited, a wholly-owned subsidiary of Validus Holdings, Ltd. As part of the Flagstone Acquisition, warrants to acquire Flagstone shares were converted into 121,942 warrants to acquire the Company's common shares. In accordance with the merger agreement, these warrants have a $62.02 strike price and expire on December 31, 2013. | |||
The following table is a summary of the common shares issued and outstanding: | |||
Common Shares | |||
Common shares issued, December 31, 2012 | 152,698,191 | ||
Restricted share awards vested, net of shares withheld | 768,889 | ||
Restricted share units vested, net of shares withheld | 14,381 | ||
Options exercised | 277,615 | ||
Warrants exercised | 591,480 | ||
Direct issuance of common stock | 928 | ||
Performance share awards vested, net of shares withheld | 31,897 | ||
Deferred share units vested, net of shares withheld | 2,935 | ||
Common shares issued, September 30, 2013 | 154,386,316 | ||
Shares repurchased, September 30, 2013 | (54,488,320 | ) | |
Common shares outstanding, September 30, 2013 | 99,897,996 | ||
Common Shares | |||
Common shares issued, December 31, 2011 | 134,503,065 | ||
Restricted share awards vested, net of shares withheld | 1,545,024 | ||
Restricted share units vested, net of shares withheld | 15,173 | ||
Options exercised | 439,065 | ||
Warrants exercised | 130,121 | ||
Common shares issued, September 30, 2012 | 136,632,448 | ||
Shares repurchased, September 30, 2012 | (43,138,057 | ) | |
Common shares outstanding, September 30, 2012 | 93,494,391 | ||
(b) | Warrants | ||
During the three months ended September 30, 2013, 163,772 warrants were exercised which resulted in the issuance of 83,287 common shares. During the nine months ended September 30, 2013, 1,114,416 warrants were exercised which resulted in the issuance of 591,480 common shares. During the three and nine months ended September 30, 2012, 264,127 warrants were exercised which resulted in the issuance of 130,121 shares. Holders of the outstanding warrants are entitled to exercise the warrants in whole or in part at any time until the expiration date. The total outstanding warrants at September 30, 2013 were 5,296,056 (December 31, 2012: 6,410,472). No further warrants are anticipated to be issued. | |||
(c) | Deferred share units | ||
Under the terms of the Company’s Director Stock Compensation Plan, non-management directors may elect to receive their director fees in deferred share units rather than cash. The number of share units distributed in case of election under the plan is equal to the amount of the annual retainer fee otherwise payable to the director on such payment date divided by 100% of the fair market value of a share on such payment date. Additional deferred share units are issued in lieu of dividends that accrue on these deferred share units. There were no outstanding deferred share units at September 30, 2013 (December 31, 2012: 5,001). | |||
As of February 16, 2013, John Hendrickson became an employee director. As a result, his 5,039 deferred share units vested and 2,935 common shares were issued to him, net of shares withheld for taxes. | |||
(d) | Dividends | ||
On February 6, 2013, the Company announced a special dividend in the amount of $2.00 per common share and $2.00 per common share equivalent for which each outstanding warrant is exercisable (the "2013 Special Dividend"). The 2013 Special Dividend was paid on February 26, 2013 to shareholders and warrant holders of record as of February 19, 2013. | |||
In addition, the Company announced a quarterly cash dividend of $0.30 (2012: $0.25) per common share and $0.30 per common share equivalent for which each outstanding warrant is exercisable. This dividend was paid on March 29, 2013 to holders of record on March 15, 2013. | |||
On May 1, 2013, the Company announced a quarterly cash dividend of $0.30 (2012: $0.25) per common share and $0.30 per common share equivalent for which each outstanding warrant is exercisable. This dividend was paid on June 28, 2013 to holders of record on June 14, 2013. | |||
On July 30, 2013, the Company announced a quarterly cash dividend of $0.30 (2012: $0.25) per common share and $0.30 per common share equivalent for which each outstanding warrant is exercisable. This dividend was paid on September 30, 2013 to holders of record on September 13, 2013. |
Stock_plans
Stock plans | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||||||
Stock plans | ' | |||||||||||||||
Stock plans | ||||||||||||||||
Long Term Incentive Plan and Short Term Incentive Plan | ||||||||||||||||
The Company’s Amended and Restated 2005 Long Term Incentive Plan (“LTIP”) provides for grants to employees of options, stock appreciation rights (“SARs”), restricted shares, restricted share units, performance shares, dividend equivalents or other share-based awards. In addition, the Company may issue restricted share awards or restricted share units in connection with awards issued under its annual Short Term Incentive Plan (“STIP”). The total number of shares reserved for issuance under the LTIP and STIP are 13,126,896 shares of which 1,783,462 shares are remaining. The LTIP and STIP are administered by the Compensation Committee of the Board of Directors. No SARs have been granted to date. Grant prices are established at the fair market value of the Company’s common shares at the date of grant. | ||||||||||||||||
i.Options | ||||||||||||||||
Options may be exercised for voting common shares upon vesting. Options have a life of 10 years and vest either ratably or at the end of the required service period from the date of grant. Fair value of the option awards at the date of grant is determined using the Black-Scholes option-pricing model. | ||||||||||||||||
Expected volatility is based on stock price volatility of comparable publicly-traded companies. The Company used the simplified method consistent with U.S. GAAP authoritative guidance on stock compensation expenses to estimate expected lives for options granted during the period as historical exercise data was not available and the options met the requirement as set out in the guidance. | ||||||||||||||||
The Company has not granted any stock options since September 4, 2009. | ||||||||||||||||
Share compensation expenses in respect of options of $nil were recorded for the three months ended September 30, 2013 (2012: $nil). Share compensation expenses in respect of options of $nil were recorded for the nine months ended September 30, 2013 (2012: $142). The expenses represent the proportionate accrual of the fair value of each grant based on the remaining vesting period. | ||||||||||||||||
A modification event was triggered as a result of the 2013 Special Dividend. In accordance with the terms of the LTIP under which the options were issued, an adjustment was required to protect the holders of such stock options from changes in the value of the stock options following the declaration of the 2013 Special Dividend. The modification of the options included a decrease in the exercise price of each stock option and an increase in the number of shares underlying each stock option. The fair value of the options before and after the modification was unchanged. | ||||||||||||||||
Activity with respect to options for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Options | Weighted Average Grant Date Fair Value | Weighted Average Grant Date Exercise Price | ||||||||||||||
Options outstanding, December 31, 2012 | 1,823,947 | $ | 6.52 | $ | 20.69 | |||||||||||
Options regranted (modified) | 1,833,414 | 6.76 | 19.02 | |||||||||||||
Options exercised | (277,615 | ) | 5.24 | 23.58 | ||||||||||||
Options cancelled (modified) | (1,733,139 | ) | 6.76 | 20.12 | ||||||||||||
Options outstanding, September 30, 2013 | 1,646,607 | $ | 6.75 | $ | 18.94 | |||||||||||
Options exercisable, September 30, 2013 | 1,646,607 | $ | 6.75 | $ | 18.94 | |||||||||||
Activity with respect to options for the nine months ended September 30, 2012 was as follows: | ||||||||||||||||
Options | Weighted Average Grant Date Fair Value | Weighted Average Grant Date Exercise Price | ||||||||||||||
Options outstanding, December 31, 2011 | 2,263,012 | $ | 6.69 | $ | 20.12 | |||||||||||
Options exercised | (439,065 | ) | 7.44 | 17.73 | ||||||||||||
Options outstanding, September 30, 2012 | 1,823,947 | $ | 6.52 | $ | 20.69 | |||||||||||
Options exercisable, September 30, 2012 | 1,823,947 | $ | 6.52 | $ | 20.69 | |||||||||||
ii.Restricted share awards | ||||||||||||||||
Restricted shares granted under the LTIP and STIP vest either pro rata or at the end of the required service period and contain certain restrictions during the vesting period, relating to, among other things, forfeiture in the event of termination of employment and transferability. Share compensation expenses of $10,041 were recorded for the three months ended September 30, 2013 (2012: $6,626). Share compensation expenses of $20,035 were recorded for the nine months ended September 30, 2013 (2012: $18,742). The expenses represent the proportionate accrual of the fair value of each grant based on the remaining vesting period. | ||||||||||||||||
Activity with respect to unvested restricted share awards for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Restricted Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share awards outstanding, December 31, 2012 | 2,170,547 | $ | 29.24 | |||||||||||||
Restricted share awards granted | 1,580,117 | 36.06 | ||||||||||||||
Restricted share awards vested | (930,296 | ) | 28.08 | |||||||||||||
Restricted share awards forfeited | (110,912 | ) | 28.34 | |||||||||||||
Restricted share awards outstanding, September 30, 2013 | 2,709,456 | $ | 33.65 | |||||||||||||
Activity with respect to unvested restricted share awards for the nine months ended September 30, 2012 was as follows: | ||||||||||||||||
Restricted Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share awards outstanding, December 31, 2011 | 3,003,547 | $ | 25.77 | |||||||||||||
Restricted share awards granted | 901,506 | 31.38 | ||||||||||||||
Restricted share awards vested | (1,678,905 | ) | 24.36 | |||||||||||||
Restricted share awards forfeited | (30,801 | ) | 28.1 | |||||||||||||
Restricted share awards outstanding, September 30, 2012 | 2,195,347 | $ | 29.12 | |||||||||||||
At September 30, 2013, there were $76,084 (December 31, 2012: $43,952) of total unrecognized share compensation expenses in respect of restricted share awards that are expected to be recognized over a weighted-average period of 3.4 years (December 31, 2012: 2.6 years ). | ||||||||||||||||
iii.Restricted share units | ||||||||||||||||
Restricted share units under the LTIP and STIP vest either ratably or at the end of the required service period and contain certain restrictions during the vesting period, relating to, among other things, forfeiture in the event of termination of employment and transferability. Share compensation expenses of $168 were recorded for the three months ended September 30, 2013 (2012: $132). Share compensation expenses of $419 were recorded for the nine months ended September 30, 2013 (2012: $363). The expenses represent the proportionate accrual of the fair value of each grant based on the remaining vesting period. | ||||||||||||||||
Activity with respect to unvested restricted share units for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Restricted Share Units | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share units outstanding, December 31, 2012 | 47,238 | $ | 29.61 | |||||||||||||
Restricted share units granted | 36,635 | 36.11 | ||||||||||||||
Restricted share units vested | (21,814 | ) | 28.17 | |||||||||||||
Restricted share units issued in lieu of cash dividends | 3,924 | 30.29 | ||||||||||||||
Restricted share units outstanding, September 30, 2013 | 65,983 | $ | 33.74 | |||||||||||||
Activity with respect to unvested restricted share units for the nine months ended September 30, 2012 was as follows: | ||||||||||||||||
Restricted Share Units | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share units outstanding, December 31, 2011 | 53,312 | $ | 27.6 | |||||||||||||
Restricted share units granted | 16,633 | 31.77 | ||||||||||||||
Restricted share units vested | (22,818 | ) | 26.49 | |||||||||||||
Restricted share units issued in lieu of cash dividends | 1,162 | 28.36 | ||||||||||||||
Restricted share units forfeited | (1,393 | ) | 28.57 | |||||||||||||
Restricted share units outstanding, September 30, 2012 | 46,896 | $ | 29.61 | |||||||||||||
At September 30, 2013, there were $1,839 (December 31, 2012: $978) of total unrecognized share compensation expenses in respect of restricted share units that are expected to be recognized over a weighted-average period of 3.5 years (December 31, 2012: 2.6 years). | ||||||||||||||||
iv.Performance share awards | ||||||||||||||||
The performance share awards contain a performance based component. The performance component relates to the compounded growth in the Dividend Adjusted Diluted Book Value per Share (“DBVPS”) over a three year period. For performance share awards granted during the period, the grant date Diluted Book Value per Share is based on the DBVPS at the end of the most recent financial reporting year. The Dividend Adjusted Performance Period End DBVPS will be the DBVPS three years after the grant date DBVPS. The fair value estimate earns over the requisite attribution period and the estimate will be reassessed at the end of each performance period which will reflect any adjustments in the consolidated statements of comprehensive income in the period in which they are determined. | ||||||||||||||||
Share compensation expenses of $318 were recorded for the three months ended September 30, 2013 (2012: $587). Share compensation expenses of ($971) were recorded for the nine months ended September 30, 2013 (2012: $336). The negative expense is due to a reversal of expenses on unvested performance share awards based on a review of current and projected performance criteria. | ||||||||||||||||
Activity with respect to unvested performance share awards for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Performance Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Performance share awards outstanding, December 31, 2012 | 220,845 | $ | 31.81 | |||||||||||||
Performance share awards granted | 38,386 | 36.11 | ||||||||||||||
Performance share awards vested | (39,094 | ) | 28.7 | |||||||||||||
Performance share awards forfeited | (18,701 | ) | 31.05 | |||||||||||||
Performance share awards conversion adjustment | (99,616 | ) | $ | 33.05 | ||||||||||||
Performance share awards outstanding, September 30, 2013 | 101,820 | $ | 33.56 | |||||||||||||
Activity with respect to unvested performance share awards for the nine months ended September 30, 2012 was as follows: | ||||||||||||||||
Performance Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Performance share awards outstanding, December 31, 2011 | 279,019 | $ | 30.77 | |||||||||||||
Performance share awards granted | 41,128 | 31.38 | ||||||||||||||
Performance share awards forfeited | (99,302 | ) | 28.7 | |||||||||||||
Performance share awards outstanding, September 30, 2012 | 220,845 | $ | 31.81 | |||||||||||||
At September 30, 2013, there were $1,893 (December 31, 2012: $3,328) of total unrecognized share compensation expenses in respect of performance share awards that are expected to be recognized over a weighted-average period of 2.2 years (December 31, 2012: 1.7 years). | ||||||||||||||||
Total share compensation expenses | ||||||||||||||||
The breakdown of share compensation expenses by award type was as follows: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Options | $ | — | $ | — | $ | — | $ | 142 | ||||||||
Restricted share awards | 10,041 | 6,626 | 20,035 | 18,742 | ||||||||||||
Restricted share units | 168 | 132 | 419 | 363 | ||||||||||||
Performance share awards | 318 | 587 | (971 | ) | 336 | |||||||||||
Total | $ | 10,527 | $ | 7,345 | $ | 19,483 | $ | 19,583 | ||||||||
Debt_and_financing_arrangement
Debt and financing arrangements | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Debt Disclosure [Abstract] | ' | |||||||||||||||
Debt and financing arrangements | ' | |||||||||||||||
Debt and financing arrangements | ||||||||||||||||
(a) | Financing structure and finance expenses | |||||||||||||||
The financing structure at September 30, 2013 was: | ||||||||||||||||
Commitment | Outstanding (a) | Drawn | ||||||||||||||
2006 Junior Subordinated Deferrable Debentures | $ | 150,000 | $ | 150,000 | $ | 150,000 | ||||||||||
2007 Junior Subordinated Deferrable Debentures | 200,000 | 139,800 | 139,800 | |||||||||||||
2010 Senior Notes due 2040 | 250,000 | 250,000 | 247,171 | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | 400,000 | — | — | |||||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 371,990 | — | |||||||||||||
$200,000 bi-lateral secured letter of credit facility | 200,000 | 77,626 | — | |||||||||||||
Talbot FAL Facility (b) | 25,000 | 25,000 | — | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 258 | — | |||||||||||||
IPC bi-lateral facility | 40,000 | 26,019 | — | |||||||||||||
$375,000 Flagstone bi-lateral facility | 375,000 | 297,996 | — | |||||||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | 137,577 | 137,577 | 137,577 | |||||||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 113,750 | 113,750 | 113,750 | |||||||||||||
Total | $ | 2,426,327 | $ | 1,590,016 | $ | 788,298 | ||||||||||
The financing structure at December 31, 2012 was: | ||||||||||||||||
Commitment | Outstanding (a) | Drawn | ||||||||||||||
2006 Junior Subordinated Deferrable Debentures | $ | 150,000 | $ | 150,000 | $ | 150,000 | ||||||||||
2007 Junior Subordinated Deferrable Debentures | 200,000 | 139,800 | 139,800 | |||||||||||||
2010 Senior Notes due 2040 | 250,000 | 250,000 | 247,090 | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | 400,000 | — | — | |||||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 376,570 | — | |||||||||||||
$500,000 secured letter of credit facility | 500,000 | 92,402 | — | |||||||||||||
Talbot FAL Facility (b) | 25,000 | 25,000 | — | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 219 | — | |||||||||||||
IPC bi-lateral facility | 80,000 | 40,613 | — | |||||||||||||
$550,000 Flagstone bi-lateral facility | 550,000 | 381,019 | — | |||||||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | 137,159 | 137,159 | 137,159 | |||||||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 113,750 | 113,750 | 113,750 | |||||||||||||
Total | $ | 2,940,909 | $ | 1,706,532 | $ | 787,799 | ||||||||||
(a) | Indicates utilization of commitment amount, not drawn borrowings. | |||||||||||||||
(b) | Talbot operates in the Lloyd’s market ("Lloyds") through a corporate member, Talbot 2002 Underwriting Capital Ltd (“T02”), which is the sole participant in Syndicate 1183. Lloyd’s sets T02’s required capital annually based on Syndicate 1183’s business plan, rating environment, reserving environment together with input arising from Lloyd’s discussions with, inter alia, regulatory and rating agencies. Such capital, called Funds at Lloyd’s (“FAL”), comprises: cash, investments and undrawn letters of credit provided by various banks. | |||||||||||||||
Finance expenses consist of interest on our junior subordinated deferrable debentures, senior notes, variable funding notes, the amortization of debt offering costs, fees relating to our credit facilities, bank charges and the costs of FAL as follows: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
2006 Junior Subordinated Deferrable Debentures | $ | 2,235 | $ | 1,628 | $ | 6,633 | $ | 4,729 | ||||||||
2007 Junior Subordinated Deferrable Debentures | 1,848 | 1,211 | 5,492 | 7,072 | ||||||||||||
2010 Senior Notes due 2040 | 5,597 | 5,597 | 16,792 | 16,792 | ||||||||||||
Variable Funding Notes (a) | 11,893 | — | 44,562 | — | ||||||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | 2,285 | — | 5,988 | — | ||||||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 1,807 | — | 4,426 | — | ||||||||||||
Credit facilities | 1,248 | 948 | 5,001 | 10,530 | ||||||||||||
Bank charges | 187 | (52 | ) | 419 | 131 | |||||||||||
Talbot FAL Facility | 32 | 30 | 95 | 93 | ||||||||||||
Total | $ | 27,132 | $ | 9,362 | $ | 89,408 | $ | 39,347 | ||||||||
(a) | Includes variable funding note expense and other AlphaCat related fees. Refer to Note 13: "Variable funding notes" for further details. | |||||||||||||||
(b) | $250,000 2010 Senior Notes due 2040 | |||||||||||||||
On January 21, 2010, the Company offered and sold $250,000 of Senior Notes due 2040 (the “2010 Senior Notes”) in a registered public offering. The 2010 Senior Notes mature on January 26, 2040, and are redeemable at the Company’s option in whole any time or in part from time to time at a make-whole redemption price. The Company may redeem the notes in whole, but not in part, at any time upon the occurrence of certain tax events as described in the prospectus supplement of the 2010 Senior Notes. The 2010 Senior Notes bear interest at the rate of 8.875% per annum from January 26, 2010 to maturity or early redemption. Interest on the 2010 Senior Notes is payable semi-annually in arrears on January 26 and July 26 of each year, commencing on July 26, 2010. The net proceeds of $243,967 from the sale of the 2010 Senior Notes, after the deduction of commissions paid to the underwriters in the transaction and other expenses, was used by the Company for general corporate purposes, which included the repurchase of its outstanding capital stock and payment of dividends to shareholders. Debt issuance costs of $2,808 were deferred as an asset and amortized over the life of the 2010 Senior Notes. There were no redemptions made during the nine months ended September 30, 2013 and 2012. | ||||||||||||||||
The 2010 Senior Notes are unsecured and unsubordinated obligations of the Company and rank equally in right of payment with all of the Company’s existing and future unsecured and unsubordinated indebtedness. The 2010 Senior Notes will be effectively junior to all of the Company’s future secured debt, to the extent of the value of the collateral securing such debt, and will rank senior to all our existing and future subordinated debt. The 2010 Senior Notes are structurally subordinated to all obligations of the Company’s subsidiaries. | ||||||||||||||||
Future expected payments of principal on the 2010 Senior Notes are as follows: | ||||||||||||||||
2013 | $ | — | ||||||||||||||
2014 | — | |||||||||||||||
2015 | — | |||||||||||||||
2016 | — | |||||||||||||||
2017 and thereafter | 250,000 | |||||||||||||||
Total minimum future payments | $ | 250,000 | ||||||||||||||
(c) | Junior subordinated deferrable debentures | |||||||||||||||
On June 15, 2006, the Company participated in a private placement of $150,000 of junior subordinated deferrable interest debentures due 2036 (the “2006 Junior Subordinated Deferrable Debentures”). The 2006 Junior Subordinated Deferrable Debentures mature on June 15, 2036, are redeemable at the Company’s option at par as of June 15, 2011, and require quarterly interest payments by the Company to the holders of the 2006 Junior Subordinated Deferrable Debentures. Interest was payable at 9.069% per annum through June 15, 2011, and thereafter at a floating rate of three-month LIBOR plus 355 basis points, reset quarterly. The proceeds of $150,000 from the sale of the 2006 Junior Subordinated Deferrable Debentures, after the deduction of commissions paid to the placement agents in the transaction and other expenses, were used by the Company to fund Validus Re segment operations and for general working capital purposes. Debt issuance costs of $3,750 were deferred as an asset and were amortized to income over the five year optional redemption period. There were no redemptions made during the nine months ended September 30, 2013 and 2012. | ||||||||||||||||
On June 21, 2007, the Company participated in a private placement of $200,000 of junior subordinated deferrable interest debentures due 2037 (the “2007 Junior Subordinated Deferrable Debentures”). The 2007 Junior Subordinated Deferrable Debentures mature on June 15, 2037, are redeemable at the Company’s option at par as of June 15, 2012, and require quarterly interest payments by the Company to the holders of the 2007 Junior Subordinated Deferrable Debentures. Interest was payable at 8.480% per annum through June 15, 2012, and thereafter at a floating rate of three-month LIBOR plus 295 basis points, reset quarterly. The proceeds of $200,000 from the sale of the 2007 Junior Subordinated Deferrable Debentures, after the deduction of commissions paid to the placement agents in the transaction and other expenses, were used by the Company to fund the purchase of Talbot Holdings Ltd. Debt issuance costs of $2,000 were deferred as an asset and were amortized to income over the five year optional redemption period. There were no redemptions made during the nine months ended September 30, 2013 and 2012. | ||||||||||||||||
As part of the Flagstone Acquisition, the Company assumed $137,577 of junior subordinated deferrable debentures due 2036 (the “Flagstone 2006 Junior Subordinated Deferrable Debentures”). The Flagstone 2006 Junior Subordinated Deferrable Debentures mature on September 15, 2036, are redeemable at the Company's option at par beginning as of September 15, 2011, and require quarterly interest payments by the Company to the holders of the Flagstone 2006 Junior Subordinated Deferrable Debentures. Interest is payable at a floating rate of three-month LIBOR plus 354 basis points, reset quarterly. There were no redemptions made during the nine months ended September 30, 2013 and 2012. | ||||||||||||||||
As part of the Flagstone Acquisition, the Company assumed $113,750 of junior subordinated deferrable debentures due 2037 (the “Flagstone 2007 Junior Subordinated Deferrable Debentures”). Of these, $88,750 of the Flagstone 2007 Junior Subordinated Deferrable Debentures mature on July 30, 2037, are redeemable at the Company's option at par as of July 30, 2012, and require quarterly interest payments by the Company to the holders of the Flagstone 2007 Junior Subordinated Deferrable Debentures. Interest is payable at a floating rate of three-month LIBOR plus 300 basis points, reset quarterly. The remaining $25,000 of the Flagstone 2007 Junior Subordinated Deferrable Debentures mature on September 15, 2037, are redeemable at the Company's option at par as of September 15, 2012, and require quarterly interest payments by the Company to the holders of the Flagstone 2007 Junior Subordinated Deferrable Debentures. Interest is payable at a floating rate of three-month LIBOR plus 310 basis points, reset quarterly. There were no redemptions made during the nine months ended September 30, 2013 and 2012. | ||||||||||||||||
Future expected payments of principal on the 2006 and 2007 Junior Subordinated Deferrable Debentures and Flagstone 2006 and 2007 Junior Subordinated Deferrable Debentures are as follows: | ||||||||||||||||
2013 | $ | — | ||||||||||||||
2014 | — | |||||||||||||||
2015 | — | |||||||||||||||
2016 | — | |||||||||||||||
2017 and thereafter | 540,709 | |||||||||||||||
Total minimum future payments | $ | 540,709 | ||||||||||||||
(d) | Credit facilities | |||||||||||||||
(i) | $400,000 syndicated unsecured letter of credit facility and $525,000 syndicated secured letter of credit facility | |||||||||||||||
On March 9, 2012, the Company, IPCRe Limited ("IPC"), (formerly Validus Re Americas, Ltd.), PaCRe and Validus Re entered into a $400,000 four year unsecured credit facility with Deutsche Bank Securities Inc., as syndication agent, JPMorgan Chase Bank, N.A. as administrative agent, Lloyds Securities Inc. and Suntrust Bank, as co-documentation agents and the lenders party thereto, which provides for letter of credit availability for the Company and certain designated subsidiaries of the Company and revolving credit availability for the Company (the "Four Year Unsecured Facility") (the full $400,000 of which is available for letters of credit and/or revolving loans). The Four Year Unsecured Facility was provided by a syndicate of commercial banks arranged by J.P. Morgan Securities LLC, Deutsche Bank Securities Inc., Lloyds Securities Inc. and SunTrust Robinson Humphrey, Inc. Letters of credit under the Four Year Unsecured Facility are available to support obligations in connection with the insurance business of the Company and its subsidiaries. Loans under the Four Year Unsecured Facility are available for the general corporate and working capital purposes of the Company. The Company may request that existing lenders under the Four Year Unsecured Facility or prospective additional lenders agree to make available additional commitments from time to time so long as the aggregate commitments under the Four Year Unsecured Facility do not exceed $500,000. Letter of credit fees are payable on account of each letter of credit issued under the Four Year Unsecured Facility at a rate per annum equal to an applicable rate. Borrowings under the Four Year Unsecured Facility bear interest, at the option of the Company, at the base rate (the higher of the prime rate announced by JPMorgan Chase Bank, N.A., the federal funds effective rate plus 0.5%, and the adjusted LIBOR rate plus 1.0%) or the adjusted LIBOR rate applicable to such loans, plus an applicable rate. | ||||||||||||||||
Also on March 9, 2012, the Company, IPC and Validus Re entered into a $525,000 four-year secured credit facility with Deutsche Bank Securities Inc., as syndication agent, JPMorgan Chase Bank, N.A. as administrative agent, Lloyds Securities Inc. and Suntrust Bank, as co-documentation agents and the lenders party thereto, which provides for letter of credit availability for the Company and certain designated subsidiaries of the Company (the "Four Year Secured Facility" and together with the Four Year Unsecured Facility, the "Credit Facilities"). The Four Year Secured Facility was provided by a syndicate of commercial banks arranged by J.P. Morgan Securities LLC, Deutsche Bank Securities Inc., Lloyds Securities Inc. and SunTrust Robinson Humphrey, Inc. Letters of credit under the Four Year Secured Facility will be available to support obligations in connection with the insurance business of the Company and its subsidiaries. The Company may request that existing lenders under the Four Year Secured Facility or prospective additional lenders agree to make available additional commitments from time to time so long as the aggregate commitments under the Four Year Secured Facility do not exceed $700,000. The obligations of the Company and its designated subsidiaries under the Four Year Secured Facility are secured by cash and securities deposited into cash collateral accounts from time to time with The Bank of New York Mellon. Letter of credit fees are payable on account of each letter of credit issued under the Four Year Secured Facility at a rate per annum equal to an applicable rate. Borrowings under the Four Year Secured Facility bear interest at the base rate (the higher of the prime rate announced by JPMorgan Chase Bank, N.A., the federal funds effective rate plus 0.5%, and the adjusted LIBOR rate plus 1.0%). | ||||||||||||||||
The Credit Facilities contain covenants that include, among other things (i) the requirement that the Company initially maintain a minimum level of consolidated net worth of at least $2,600,000 and, commencing with the end of the fiscal quarter ending March 31, 2012, to be increased quarterly by an amount equal to 50.0% of the Company's consolidated net income (if positive) for such quarter plus 50.0% of the aggregate increases in the consolidated shareholders' equity of the Company during such fiscal quarter by reason of the issuance and sale of common equity interests of the Company, including upon any conversion of debt securities of the Company into such equity interests, (ii) the requirement that the Company maintain at all times a consolidated total debt to consolidated total capital ratio not greater than 0.35:1.00, and (iii) the requirement that Validus Re and any other material insurance subsidiaries maintain a financial strength rating by A.M. Best of not less than "B++" (Fair). In addition, the Credit Facilities contain customary negative covenants applicable to the Company and its subsidiaries, including limitations on the ability to pay dividends and other payments in respect of equity interests at any time that the Company is otherwise in default with respect to certain provisions under the respective Credit Facilities, limitations on the ability to incur liens, sell assets, merge or consolidate with others, enter into transactions with affiliates, and limitations on the ability of its subsidiaries to incur indebtedness. The Credit Facilities also contain customary affirmative covenants, representations and warranties and events of default for credit facilities of its type. | ||||||||||||||||
As of September 30, 2013, there was $371,990 in outstanding letters of credit under the Four Year Secured Facility (December 31, 2012: $376,570) and $nil outstanding under the Four Year Unsecured Facility (December 31, 2012: $nil). | ||||||||||||||||
As of September 30, 2013, and throughout the reporting periods presented, the Company was in compliance with all covenants and restrictions under the Credit Facilities. | ||||||||||||||||
On March 9, 2012, upon entering into the Credit Facilities, the Company terminated its (a) three-year bi-lateral $60,000 unsecured revolving credit facility, dated March 12, 2010 with Lloyds TSB Bank plc, (b) $340,000 three-year unsecured credit facility, dated March 12, 2010 with Deutsche Bank Securities Inc., as syndication agent and JPMorgan Chase Bank, N.A. as administrative agent, and (c) $500,000 five-year secured credit facility, dated March 12, 2007 with Deutsche Bank Securities Inc., as syndication agent and JPMorgan Chase Bank, N.A. as administrative agent. No early termination penalties were incurred. | ||||||||||||||||
(ii) | Talbot FAL Facility | |||||||||||||||
On November 29, 2007, Talbot entered into a $100,000 standby Letter of Credit facility (the “Talbot FAL Facility”) to provide Funds at Lloyd’s for the 2008 and 2009 underwriting years of account; this facility is guaranteed by the Company and is secured against the assets of Validus Re. The Talbot FAL Facility was provided by a syndicate of commercial banks arranged by Lloyds TSB Bank plc and ING Bank N.V., London Branch. | ||||||||||||||||
On November 19, 2009, the Company entered into an Amendment and Restatement of the Talbot FAL Facility to reduce the commitment from $100,000 to $25,000, and to extend the support to the 2010 and 2011 underwriting years of account. On November 18, 2011, the Company entered into an Amendment and Restatement of the Talbot FAL Facility to extend the support to the 2012 and 2013 underwriting years of account. | ||||||||||||||||
As amended, the Talbot FAL Facility contains affirmative covenants that include, among other things, (i) the requirement that the Company initially maintain a minimum level of consolidated net worth of at least $2,589,615, and commencing with the end of the fiscal quarter ended December 31, 2011 to be increased quarterly by an amount equal to 50% of our consolidated net income (if positive) for such quarter plus 50% of any net proceeds received from any issuance of common shares during such quarter, and (ii) the requirement that we maintain at all times a consolidated total debt to consolidated total capitalization ratio not greater than 0.35:1.00. | ||||||||||||||||
The Talbot FAL Facility also contains restrictions on our ability to incur debt at our subsidiaries, incur liens, sell assets and merge or consolidate with others. Other than in respect of existing and future preferred and hybrid securities, the payment of dividends and other payments in respect of equity interests are not permitted at any time that we are in default with respect to certain provisions under the Talbot FAL Facility. As of September 30, 2013, the Company had $25,000 (December 31, 2012: $25,000) in outstanding letters of credit under this facility. | ||||||||||||||||
As of September 30, 2013, and throughout the reporting periods presented, the Company was in compliance with all covenants and restrictions under the Talbot FAL Facility. | ||||||||||||||||
(iii) | IPC Syndicated Facility and IPC bi-lateral facility | |||||||||||||||
IPC obtained letters of credit through the IPC Syndicated Facility and the IPC Bi-Lateral Facility. In July 2009, certain terms of these facilities were amended including suspending IPC’s ability to increase existing letters of credit or to issue new letters of credit. Effective March 31, 2010, the IPC Syndicated Facility was closed. As of September 30, 2013, $26,019 of outstanding letters of credit were issued under the IPC bi-lateral facility (December 31, 2012: $40,613). | ||||||||||||||||
As of September 30, 2013, and throughout the reporting periods presented, the Company was in compliance with all covenants and restrictions under the IPC bi-lateral facility. | ||||||||||||||||
(iv) $200,000 secured bi-lateral letter of credit facility | ||||||||||||||||
On August 10, 2009, Validus Re entered into an uncommitted secured bi-lateral letter of credit facility with Citibank Europe plc (the “secured bi-lateral letter of credit facility”). Letters of credit were first issued under the Secured Bi-Lateral Letter of Credit Facility during the first quarter of 2012. As of September 30, 2013, $77,626 of letters of credit were outstanding under the Secured Bi-Lateral Letter of Credit Facility (December 31, 2012: $92,402). The secured bi-lateral letter of credit facility has no fixed termination date and as of September 30, 2013, Validus Re was in compliance with all terms and covenants thereof. | ||||||||||||||||
(v) $10,000 PaCRe Senior secured letter of credit facility | ||||||||||||||||
On May 11, 2012, PaCRe (as Borrower) and its subsidiary, PaCRe Investments, Ltd. (as Guarantor) entered into a 364-Day secured revolving credit and letter of credit facility with JPMorgan Chase Bank, N.A. This facility provides for revolving borrowings by the Borrower and for letters of credit issued by the Borrower to be used to support its reinsurance obligations in an aggregate amount of $10,000. As of September 30, 2013, $258 of letters of credit were outstanding under this facility (December 31, 2012: $219). | ||||||||||||||||
As of September 30, 2013, and throughout the reporting periods presented, the Company was in compliance with all covenants and restrictions under the PaCRe Senior secured letter of credit facility. | ||||||||||||||||
(vi) $375,000 Flagstone bi-lateral facility | ||||||||||||||||
As part of the Flagstone Acquisition, the Company assumed a Letter of Credit Master Agreement between Citibank Europe Plc and Flagstone Reassurance Suisse, S.A. (the “Flagstone bi-lateral facility”). At September 30, 2013, the Flagstone bi-lateral facility had $297,996 letters of credit issued and outstanding (December 31, 2012: $381,019). | ||||||||||||||||
As of September 30, 2013, and throughout the reporting periods presented, the Company was in compliance with all covenants and restrictions under the Flagstone bi-lateral facility. |
Variable_funding_notes
Variable funding notes | 9 Months Ended | |||
Sep. 30, 2013 | ||||
Variable Funding Notes Disclosure [Abstract] | ' | |||
Variable funding notes | ' | |||
Variable funding notes | ||||
AlphaCat Master Fund Ltd. (“Master Fund”), a wholly-owned Bermuda registered exempt mutual fund company and AlphaCat Reinsurance Ltd. (“AlphaCat Re”), a wholly-owned Bermuda Class 3 licensed insurance company, issued Variable Funding Notes (“VFNs”) to the AlphaCat ILS funds and AlphaCat 2013. | ||||
The purpose of the VFNs is to enable the AlphaCat ILS funds and AlphaCat 2013 to invest in specific contracts or cat bonds through the market facing entities. The economic benefit of the investments is transferred to the AlphaCat ILS funds and AlphaCat 2013 by way of interim payments, which accrue to the AlphaCat ILS funds and AlphaCat 2013 according to the earnings in AlphaCat Re and Master Fund. | ||||
The following table presents a summary of the VFNs on the balance sheet as at September 30, 2013: | ||||
September 30, | ||||
2013 | ||||
AlphaCat 2013 | $ | 214,639 | ||
AlphaCat ILS funds | 223,331 | |||
Total | $ | 437,970 | ||
For details on the VFNs interest expense which is included in the Company's Consolidated Statements of Comprehensive Income, refer to Note 12: "Debt and financing arrangements." |
Accumulated_Other_Comprehensiv
Accumulated Other Comprehensive Income (Loss) | 9 Months Ended | |||
Sep. 30, 2013 | ||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | |||
Accumulated other comprehensive income (loss) | ' | |||
Accumulated other comprehensive income (loss) | ||||
The changes in accumulated other comprehensive income ("AOCI"), by component for the three and nine months ended September 30, 2013 are as follows: | ||||
Three Months Ended | ||||
30-Sep-13 | ||||
Foreign currency translation adjustments | ||||
Beginning Balance - June 30, 2013 | (8,262 | ) | ||
Amounts reclassified to retained earnings | — | |||
Current period foreign currency translation adjustments | 4,390 | |||
Ending balance - September 30, 2013 | (3,872 | ) | ||
Nine Months Ended | ||||
30-Sep-13 | ||||
Foreign currency translation adjustments | ||||
Beginning Balance - December 31, 2012 | (2,953 | ) | ||
Amounts reclassified to retained earnings | 4,290 | |||
Current period foreign currency translation adjustments | (5,209 | ) | ||
Ending balance - September 30, 2013 | (3,872 | ) |
Commitments_and_contingencies
Commitments and contingencies | 9 Months Ended | |
Sep. 30, 2013 | ||
Commitments and Contingencies Disclosure [Abstract] | ' | |
Commitments and contingencies | ' | |
Commitments and contingencies | ||
(a) | Concentrations of credit risk | |
The Company's investments are managed following prudent standards of diversification. The Company attempts to limit its credit exposure by purchasing high quality fixed income investments to maintain an average portfolio, excluding bank loans, credit quality of AA- or higher, with mortgage and commercial mortgage-backed issues having an aggregate weighted average credit quality of AAA. In addition, the Company limits its exposure to any single issuer to 3% of its investment portfolio or less, excluding government and agency securities. With the exception of the Company's bank loan portfolio, which represents 10.9% of the Company's total investments as at September 30, 2013, the minimum credit rating of any security purchased is Baa3/BBB-. In the case where currently held investments are downgraded below Baa3/BBB-, the Company tolerates a holding of up to 2% of its investment portfolio in aggregate market value, or 10% with written authorization. Excluding bank loans, 1.3% of the portfolio had a split rating below Baa3/BBB- as at September 30, 2013. The Company did not have an aggregate exposure to any single issuer of more than 1.0% of its investment portfolio, other than with respect to government and agency securities as at September 30, 2013. | ||
(b) | Funds at Lloyd's | |
Talbot operates in Lloyd's through a corporate member, Talbot 2002 Underwriting Capital Ltd ("T02"), which is the sole participant in Syndicate 1183. Lloyd's sets T02's required capital annually based on Syndicate 1183's business plan, rating environment and reserving environment together with input arising from Lloyd's discussions with, inter alia, regulatory and rating agencies. Such capital, called Funds at Lloyd's (“FAL”), comprises: cash, investments and undrawn letters of credit provided by various banks. The amounts of cash, investments and letters of credit at September 30, 2013 amounted to $428,700 (December 31, 2012: $428,700) of which $25,000 is provided under the Talbot FAL Facility (December 31, 2012: $25,000). | ||
The amounts which the Company provides as FAL are not available for distribution to the Company for the payment of dividends. Talbot’s corporate member may also be required to maintain funds under the control of Lloyd’s in excess of its capital requirement and such funds also may not be available for distribution to the Company for the payment of dividends. The amounts provided under the Talbot FAL Facility would become a liability of the Company in the event of Syndicate 1183 declaring a loss at a level between $403,700 and $428,700 which would call on this arrangement. | ||
(c)Lloyd's Central Fund | ||
Whenever a member of Lloyd's is unable to pay its debts to policyholders, such debts may be payable by the Lloyd's Central Fund. If Lloyd's determines that the Central Fund needs to be increased, it has the power to assess premium levies on current Lloyd's members up to 3% of a member's underwriting capacity in any one year. The Company does not believe that any assessment is likely in the foreseeable future and has not provided any allowance for such an assessment. However, based on the Company's 2013 underwriting capacity at Lloyd's of £620,000, at the September 30, 2013 exchange rate of £1 equals $1.6192 and assuming the maximum 3% assessment, the Company would be assessed approximately $30,117. | ||
(d) Aquiline Commitment | ||
On December 20, 2011, Validus Re entered into an Assignment and Assumption Agreement (the "Agreement") with Aquiline Capital Partners LLC, a Delaware limited liability company (the "Assignor") and Aquiline Capital Partners II GP (Offshore) Ltd., a Cayman Islands company limited by shares (the "General Partner") pursuant to which Validus Re has assumed 100% of the Assignor's interest in Aquiline Financial Services Fund II L.P. (the "Partnership") representing a total capital commitment of $50,000 (the "Commitment"), as a limited partner in the Partnership (the "Transferred Interest"). The Transferred Interest is governed by the terms of an Amended and Restated Exempted Limited Partnership Agreement dated as of July 2, 2010 (the "Limited Partnership Agreement"). Pursuant to the terms of the Limited Partnership Agreement, the Commitment will expire on July 2, 2015. The Company's remaining commitment at September 30, 2013 was $19,292. |
Related_party_transactions
Related party transactions | 9 Months Ended |
Sep. 30, 2013 | |
Related Party Transactions [Abstract] | ' |
Related party transactions | ' |
Related party transactions | |
The transactions listed below are classified as related party transactions as each counter party has either a direct or indirect shareholding in the Company. | |
Aquiline Capital Partners, LLC and its related companies ("Aquiline"), which own 4,946,643 shares in the Company, hold warrants to purchase 2,756,088 shares, and have two employees on the Company's Board of Directors who do not receive compensation from the Company and are shareholders of Group Ark Insurance Holdings Ltd. ("Group Ark"). Christopher E. Watson, a director of the Company, also serves as a director of Group Ark. Pursuant to reinsurance agreements with a subsidiary of Group Ark, the Company recognized gross premiums written during the three and nine months ended September 30, 2013 of $nil (2012: $6,167) and $2,848 (2012: $7,582) respectively, with $603 included in premiums receivable at September 30, 2013 (December 31, 2012: $251). The Company also recognized reinsurance premiums ceded during the three and nine months ended September 30, 2013 of $19 (2012: $nil) and $23 (2012: $nil) respectively. The Company recorded $4,420 of loss reserves recoverable at September 30, 2013 (December 31, 2012: $3,694). Earned premium adjustments of $718 (2012: $5,019) and $2,147 (2012: $5,751) were recorded during the three and nine months ended September 30, 2013 respectively. | |
Aquiline was previously a shareholder of Tiger Risk Partners LLC (“Tiger Risk”). Christopher E. Watson, a director of the Company serves as a director of Tiger Risk. As of March 31, 2013, Tiger Risk was no longer a related party due to Aquiline's disposal of its investment. Pursuant to certain reinsurance contracts, the Company recognized brokerage expenses paid to Tiger Risk for the three and nine months ended September 30, 2012 of $58 and $2,418 of which $964 was included in accounts payable and accrued expenses at December 31, 2012. | |
On November 24, 2009, the Company entered into an Investment Management Agreement with Conning, Inc. ("Conning") to manage a portion of the Company's investment portfolio. Aquiline acquired Conning on June 16, 2009. Jeffrey W. Greenberg, a director of the Company, serves as a director of Conning Holdings Corp., the parent company of Conning and Michael Carpenter, the Chairman of Talbot Holdings Ltd. and a director of the Company, serves as a director of a subsidiary company of Conning Holdings Corp. Investment management fees earned by Conning for the three and nine months ended September 30, 2013 were $165 (2012: $207) and $396 (2012: $611) respectively with $179 included in accounts payable and accrued expenses at September 30, 2013 (December 31, 2012: $201). | |
On December 20, 2011, Validus Re entered into an Assignment and Assumption Agreement (the "Agreement") with Aquiline Capital Partners LLC, a Delaware limited liability company (the "Assignor") and Aquiline Capital Partners II GP (Offshore) Ltd., a Cayman Islands company limited by shares (the "General Partner") pursuant to which Validus Re has assumed 100% of the Assignor's interest in Aquiline Financial Services Fund II L.P. (the "Partnership") representing a total capital commitment of $50,000 (the "Commitment"), as a limited partner in the Partnership (the "Transferred Interest"). Messrs. Greenberg and Watson, directors of the Company, serve as managing principal and senior principal, respectively, of Aquiline Capital Partners LLC. For the three and nine months ended September 30, 2013, the Company incurred $505 (2012: $674) and $625 (2012: $2,560) in partnership fees and made $6,185 (2012: $430) and $13,089 (2012: $5,328) of capital contributions respectively, of which $nil was included in accounts payable and accrued expenses at September 30, 2013 (December 31, 2012: $nil). | |
Certain shareholders of the Company and their affiliates, as well as the employers or entities otherwise associated with certain directors and officers or their affiliates, have purchased insurance and/or reinsurance from the Company in the ordinary course of business on terms the Company believes were no more favorable to these (re)insureds than those made available to other customers. |
Earnings_per_share
Earnings per share | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Earnings Per Share [Abstract] | ' | |||||||||||||||
Earnings per share | ' | |||||||||||||||
Earnings per share | ||||||||||||||||
The following table sets forth the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2013 and 2012: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Basic earnings per share | ||||||||||||||||
Net income | $ | 229,063 | $ | 264,044 | $ | 419,503 | $ | 510,540 | ||||||||
Loss attributable to noncontrolling interest | (45,694 | ) | (56,746 | ) | 17,831 | (11,386 | ) | |||||||||
Net income available to Validus | 183,369 | 207,298 | 437,334 | 499,154 | ||||||||||||
Less: Dividends and distributions declared on outstanding warrants | (1,552 | ) | (1,663 | ) | (17,662 | ) | (5,121 | ) | ||||||||
Net income available to common shareholders | $ | 181,817 | $ | 205,635 | $ | 419,672 | $ | 494,033 | ||||||||
Weighted average number of common shares outstanding | 99,834,563 | 93,368,775 | 103,451,396 | 97,016,034 | ||||||||||||
Basic earnings per share available to common shareholders | $ | 1.82 | $ | 2.2 | $ | 4.06 | $ | 5.09 | ||||||||
Diluted earnings per share | ||||||||||||||||
Net income | $ | 229,063 | $ | 264,044 | $ | 419,503 | $ | 510,540 | ||||||||
(Income) loss attributable to noncontrolling interest | (45,694 | ) | (56,746 | ) | 17,831 | (11,386 | ) | |||||||||
Net income available to Validus | 183,369 | 207,298 | 437,334 | 499,154 | ||||||||||||
Less: Dividends and distributions declared on outstanding warrants | — | — | (17,662 | ) | — | |||||||||||
Net income available to common shareholders | $ | 183,369 | $ | 207,298 | $ | 419,672 | $ | 499,154 | ||||||||
Weighted average number of common shares outstanding | 99,834,563 | 93,368,775 | 103,451,396 | 97,016,034 | ||||||||||||
Share equivalents: | ||||||||||||||||
Warrants | 2,606,669 | 3,248,788 | — | 3,116,298 | ||||||||||||
Stock options | 782,158 | 716,693 | 1,090,298 | 777,245 | ||||||||||||
Unvested restricted shares | 390,376 | 902,234 | 723,219 | 1,423,938 | ||||||||||||
Weighted average number of diluted common shares outstanding | 103,613,766 | 98,236,490 | 105,264,913 | 102,333,515 | ||||||||||||
Diluted earnings per share available to common shareholders | $ | 1.77 | $ | 2.11 | $ | 3.99 | $ | 4.88 | ||||||||
Share equivalents that would result in the issuance of common shares of 125,728 (2012: 2,724) and 464,516 (2012: 231,621) were outstanding for the three and nine months ended September 30, 2013, respectively, but were not included in the computation of diluted earnings per share because the effect would be antidilutive. |
Segment_information
Segment information | 9 Months Ended | ||||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||||||||||||
Segment information | ' | ||||||||||||||||||||||
Segment information | |||||||||||||||||||||||
The Company conducts its operations worldwide through two wholly-owned subsidiaries, Validus Reinsurance, Ltd. and Talbot Holdings Ltd. from which three operating segments have been determined under U.S. GAAP segment reporting. During the first quarter of 2012, to better align the Company's operating and reporting structure with its current strategy, there was a change in the segment structure. This change included the AlphaCat group of companies as a separate operating segment. "AlphaCat segment" was included as an additional segment and includes the Company's investments in AlphaCat Re 2011, AlphaCat Re 2012, AlphaCat 2013, PaCRe and the AlphaCat ILS funds. The Company's operating segments are strategic business units that offer different products and services. They are managed and have capital allocated separately because each business requires different strategies. | |||||||||||||||||||||||
Validus Re Segment | |||||||||||||||||||||||
The Validus Re segment is focused on short-tail lines of reinsurance. The primary lines in which the segment conducts business are property, marine and specialty which includes agriculture, aerospace and aviation, financial lines of business, nuclear, terrorism, life, accident & health, workers' compensation, crisis management, contingency, motor, technical lines and composite. | |||||||||||||||||||||||
AlphaCat Segment | |||||||||||||||||||||||
The AlphaCat segment manages strategic relationships that leverage the Company's underwriting and investment expertise and earns management, performance and underwriting fees primarily from the Company's operating affiliates, AlphaCat Re 2011, AlphaCat Re 2012 and AlphaCat 2013 as well as investments in PaCRe and the AlphaCat ILS funds. | |||||||||||||||||||||||
Talbot Segment | |||||||||||||||||||||||
The Talbot segment focuses on a wide range of marine and energy, war, political violence, commercial property, financial institutions, contingency, accident & health and aviation classes of business on an insurance or facultative reinsurance basis and principally property, aerospace and marine classes of business on a treaty reinsurance basis. | |||||||||||||||||||||||
Corporate and other reconciling items | |||||||||||||||||||||||
The Company has a "Corporate" function, which includes the activities of the parent company, and which carries out certain functions for the group. "Corporate" includes non-core underwriting expenses, predominantly general and administrative and stock compensation expenses. "Corporate" also denotes the activities of certain key executives such as the Chief Executive Officer and Chief Financial Officer. For internal reporting purposes, "Corporate" is reflected separately, however "Corporate" is not considered an operating segment under these circumstances. Other reconciling items include, but are not limited to, the elimination of intersegment revenues and expenses and unusual items that are not allocated to segments. | |||||||||||||||||||||||
The following tables summarize the results of our operating segments and "Corporate": | |||||||||||||||||||||||
Three Months Ended September 30, 2013 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 130,925 | $ | 3,481 | $ | 246,468 | $ | (24,114 | ) | $ | 356,760 | ||||||||||||
Reinsurance premiums ceded | (13,006 | ) | (525 | ) | (49,998 | ) | 24,114 | (39,415 | ) | ||||||||||||||
Net premiums written | 117,919 | 2,956 | 196,470 | — | 317,345 | ||||||||||||||||||
Change in unearned premiums | 157,873 | 34,210 | 21,860 | — | 213,943 | ||||||||||||||||||
Net premiums earned | 275,792 | 37,166 | 218,330 | — | 531,288 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 62,250 | 15,615 | 100,100 | — | 177,965 | ||||||||||||||||||
Policy acquisition costs | 47,662 | 3,787 | 44,899 | (1,448 | ) | 94,900 | |||||||||||||||||
General and administrative expenses | 19,785 | 5,728 | 37,402 | 18,174 | 81,089 | ||||||||||||||||||
Share compensation expenses | 2,479 | 152 | 2,992 | 4,904 | 10,527 | ||||||||||||||||||
Total underwriting deductions | 132,176 | 25,282 | 185,393 | 21,630 | 364,481 | ||||||||||||||||||
Underwriting income (loss) | $ | 143,616 | $ | 11,884 | $ | 32,937 | $ | (21,630 | ) | $ | 166,807 | ||||||||||||
Net investment income | 15,628 | 967 | 4,395 | (981 | ) | 20,009 | |||||||||||||||||
Other (loss) income | (1,892 | ) | 3,791 | 73 | (4,778 | ) | (2,806 | ) | |||||||||||||||
Finance expenses | (3,640 | ) | (11,895 | ) | (107 | ) | (11,490 | ) | (27,132 | ) | |||||||||||||
Operating income (loss) before taxes and income from operating affiliates | 153,712 | 4,747 | 37,298 | (38,879 | ) | 156,878 | |||||||||||||||||
Tax benefit (expense) | 143 | — | (513 | ) | 365 | (5 | ) | ||||||||||||||||
Income from operating affiliates | — | 1,463 | — | — | 1,463 | ||||||||||||||||||
Net operating income (loss) | $ | 153,855 | $ | 6,210 | $ | 36,785 | $ | (38,514 | ) | $ | 158,336 | ||||||||||||
Net realized (losses) gains on investments | (10,137 | ) | 4,084 | (267 | ) | — | (6,320 | ) | |||||||||||||||
Net unrealized gains on investments | 23,144 | 44,145 | 2,678 | — | 69,967 | ||||||||||||||||||
Income from investment affiliate | 1,044 | — | — | — | 1,044 | ||||||||||||||||||
Foreign exchange gains (losses) | 2,168 | 388 | 4,238 | (758 | ) | 6,036 | |||||||||||||||||
Net income (loss) | $ | 170,074 | $ | 54,827 | $ | 43,434 | $ | (39,272 | ) | $ | 229,063 | ||||||||||||
Net loss attributable to noncontrolling interest | — | (45,694 | ) | — | — | (45,694 | ) | ||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 170,074 | $ | 9,133 | $ | 43,434 | $ | (39,272 | ) | $ | 183,369 | ||||||||||||
Selected ratios: | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 90.1 | % | 84.9 | % | 79.7 | % | 89 | % | |||||||||||||||
Losses and loss expenses (a) | 22.6 | % | 42 | % | 45.8 | % | 33.5 | % | |||||||||||||||
Policy acquisition costs (a) | 17.3 | % | 10.2 | % | 20.6 | % | 17.9 | % | |||||||||||||||
General and administrative expenses (a) (b) | 8.1 | % | 15.8 | % | 18.5 | % | 17.2 | % | |||||||||||||||
Expense ratio (a) | 25.4 | % | 26 | % | 39.1 | % | 35.1 | % | |||||||||||||||
Combined ratio (a) | 48 | % | 68 | % | 84.9 | % | 68.6 | % | |||||||||||||||
Total assets | $ | 5,854,354 | $ | 1,446,941 | $ | 2,892,477 | $ | 123,596 | $ | 10,317,368 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
Three Months Ended September 30, 2012 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 145,010 | $ | 2,934 | $ | 260,755 | $ | (18,484 | ) | $ | 390,215 | ||||||||||||
Reinsurance premiums ceded | (10,426 | ) | — | (53,801 | ) | 18,484 | (45,743 | ) | |||||||||||||||
Net premiums written | 134,584 | 2,934 | 206,954 | — | 344,472 | ||||||||||||||||||
Change in unearned premiums | 107,728 | 2,591 | 20,313 | — | 130,632 | ||||||||||||||||||
Net premiums earned | 242,312 | 5,525 | 227,267 | — | 475,104 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 66,890 | — | 88,565 | — | 155,455 | ||||||||||||||||||
Policy acquisition costs | 37,785 | 547 | 61,640 | (1,349 | ) | 98,623 | |||||||||||||||||
General and administrative expenses | 16,938 | 2,087 | 36,605 | 14,917 | 70,547 | ||||||||||||||||||
Share compensation expenses | 2,076 | 84 | 2,200 | 2,985 | 7,345 | ||||||||||||||||||
Total underwriting deductions | 123,689 | 2,718 | 189,010 | 16,553 | 331,970 | ||||||||||||||||||
Underwriting income (loss) | $ | 118,623 | $ | 2,807 | $ | 38,257 | $ | (16,553 | ) | $ | 143,134 | ||||||||||||
Net investment income | 19,644 | 1,193 | 5,260 | (608 | ) | 25,489 | |||||||||||||||||
Other income | 1,543 | 7,674 | 680 | (2,573 | ) | 7,324 | |||||||||||||||||
Finance expenses | (789 | ) | (56 | ) | (73 | ) | (8,444 | ) | (9,362 | ) | |||||||||||||
Operating income (loss) before taxes and income from operating affiliates | 139,021 | 11,618 | 44,124 | (28,178 | ) | 166,585 | |||||||||||||||||
Tax expense | (2 | ) | — | (11 | ) | (1,330 | ) | (1,343 | ) | ||||||||||||||
Income from operating affiliates | — | 6,235 | — | — | 6,235 | ||||||||||||||||||
Net operating income (loss) | $ | 139,019 | $ | 17,853 | $ | 44,113 | $ | (29,508 | ) | $ | 171,477 | ||||||||||||
Net realized gains on investments | 6,643 | 300 | 2,120 | — | 9,063 | ||||||||||||||||||
Net unrealized on investments | 19,232 | 62,432 | 4,681 | — | 86,345 | ||||||||||||||||||
(Loss) from investment affiliate | (160 | ) | — | — | — | (160 | ) | ||||||||||||||||
Foreign exchange gains (losses) | 8 | 30 | 1,146 | (81 | ) | 1,103 | |||||||||||||||||
Transaction expenses (c) | — | — | — | (3,784 | ) | (3,784 | ) | ||||||||||||||||
Net income (loss) | $ | 164,742 | $ | 80,615 | $ | 52,060 | $ | (33,373 | ) | $ | 264,044 | ||||||||||||
Net loss attributable to noncontrolling interest | — | (56,746 | ) | — | — | (56,746 | ) | ||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 164,742 | $ | 23,869 | $ | 52,060 | $ | (33,373 | ) | $ | 207,298 | ||||||||||||
Selected ratios: | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 92.8 | % | 100 | % | 79.4 | % | 88.3 | % | |||||||||||||||
Losses and loss expenses (a) | 27.6 | % | 0 | % | 39 | % | 32.7 | % | |||||||||||||||
Policy acquisition costs (a) | 15.6 | % | 9.9 | % | 27.1 | % | 20.8 | % | |||||||||||||||
General and administrative expenses (a) (b) | 7.8 | % | 39.3 | % | 17.1 | % | 16.4 | % | |||||||||||||||
Expense ratio (a) | 23.4 | % | 49.2 | % | 44.2 | % | 37.2 | % | |||||||||||||||
Combined ratio (a) | 51 | % | 49.2 | % | 83.2 | % | 69.9 | % | |||||||||||||||
Total assets | $ | 4,729,344 | $ | 768,612 | $ | 2,931,174 | $ | 34,690 | $ | 8,463,820 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
(c) | The transaction expenses relate to costs incurred in connection with the acquisition of Flagstone Reinsurance Holdings, S.A. | ||||||||||||||||||||||
Nine Months Ended September 30, 2013 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 1,232,272 | $ | 146,757 | $ | 855,516 | $ | (70,712 | ) | $ | 2,163,833 | ||||||||||||
Reinsurance premiums ceded | (226,292 | ) | (525 | ) | (191,922 | ) | 70,712 | (348,027 | ) | ||||||||||||||
Net premiums written | 1,005,980 | 146,232 | 663,594 | — | 1,815,806 | ||||||||||||||||||
Change in unearned premiums | (122,303 | ) | (46,459 | ) | (37,237 | ) | — | (205,999 | ) | ||||||||||||||
Net premiums earned | 883,677 | 99,773 | 626,357 | — | 1,609,807 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 319,298 | 16,928 | 251,554 | — | 587,780 | ||||||||||||||||||
Policy acquisition costs | 142,195 | 10,011 | 127,092 | (3,635 | ) | 275,663 | |||||||||||||||||
General and administrative expenses | 69,649 | 13,757 | 100,506 | 48,423 | 232,335 | ||||||||||||||||||
Share compensation expenses | 5,421 | 314 | 6,754 | 6,994 | 19,483 | ||||||||||||||||||
Total underwriting deductions | 536,563 | 41,010 | 485,906 | 51,782 | 1,115,261 | ||||||||||||||||||
Underwriting income (loss) | $ | 347,114 | $ | 58,763 | $ | 140,451 | $ | (51,782 | ) | $ | 494,546 | ||||||||||||
Net investment income | 61,770 | 2,821 | 13,496 | (6,219 | ) | 71,868 | |||||||||||||||||
Other income (loss) | 11,237 | 17,439 | 564 | (24,943 | ) | 4,297 | |||||||||||||||||
Finance expenses | (12,133 | ) | (46,429 | ) | (256 | ) | (30,590 | ) | (89,408 | ) | |||||||||||||
Operating income (loss) before taxes and income from operating affiliates | 407,988 | 32,594 | 154,255 | (113,534 | ) | 481,303 | |||||||||||||||||
Tax benefit (expense) | 1,755 | — | (1,184 | ) | (351 | ) | 220 | ||||||||||||||||
Income from operating affiliates | — | 8,779 | — | — | 8,779 | ||||||||||||||||||
Net operating income (loss) | $ | 409,743 | $ | 41,373 | $ | 153,071 | $ | (113,885 | ) | $ | 490,302 | ||||||||||||
Net realized (losses) gains on investments | (5,790 | ) | 4,084 | 516 | — | (1,190 | ) | ||||||||||||||||
Net unrealized (losses) on investments | (36,883 | ) | (31,029 | ) | (10,706 | ) | — | (78,618 | ) | ||||||||||||||
Income from investment affiliate | 4,274 | — | — | — | 4,274 | ||||||||||||||||||
Foreign exchange gains (losses) | 7,448 | (663 | ) | (1,877 | ) | (173 | ) | 4,735 | |||||||||||||||
Net income (loss) | $ | 378,792 | $ | 13,765 | $ | 141,004 | $ | (114,058 | ) | $ | 419,503 | ||||||||||||
Net loss attributable to noncontrolling interest | — | 17,831 | — | — | 17,831 | ||||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 378,792 | $ | 31,596 | $ | 141,004 | $ | (114,058 | ) | $ | 437,334 | ||||||||||||
Selected ratios: | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 81.6 | % | 99.6 | % | 77.6 | % | 83.9 | % | |||||||||||||||
Losses and loss expenses (a) | 36.1 | % | 17 | % | 40.2 | % | 36.5 | % | |||||||||||||||
Policy acquisition costs (a) | 16.1 | % | 10 | % | 20.3 | % | 17.2 | % | |||||||||||||||
General and administrative expenses (a) (b) | 8.5 | % | 14.1 | % | 17.1 | % | 15.6 | % | |||||||||||||||
Expense ratio (a) | 24.6 | % | 24.1 | % | 37.4 | % | 32.8 | % | |||||||||||||||
Combined ratio (a) | 60.7 | % | 41.1 | % | 77.6 | % | 69.3 | % | |||||||||||||||
Total assets | $ | 5,854,354 | $ | 1,446,941 | $ | 2,892,477 | $ | 123,596 | $ | 10,317,368 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
Nine Months Ended September 30, 2012 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 1,052,726 | $ | 21,607 | $ | 837,536 | $ | (57,276 | ) | $ | 1,854,593 | ||||||||||||
Reinsurance premiums ceded | (137,504 | ) | — | (191,619 | ) | 57,276 | (271,847 | ) | |||||||||||||||
Net premiums written | 915,222 | 21,607 | 645,917 | — | 1,582,746 | ||||||||||||||||||
Change in unearned premiums | (177,215 | ) | (9,832 | ) | (21,769 | ) | — | (208,816 | ) | ||||||||||||||
Net premiums earned | 738,007 | 11,775 | 624,148 | — | 1,373,930 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 244,286 | — | 296,850 | — | 541,136 | ||||||||||||||||||
Policy acquisition costs | 113,659 | 1,185 | 142,181 | (4,141 | ) | 252,884 | |||||||||||||||||
General and administrative expenses | 48,332 | 5,521 | 100,910 | 43,794 | 198,557 | ||||||||||||||||||
Share compensation expenses | 5,914 | 195 | 5,347 | 8,127 | 19,583 | ||||||||||||||||||
Total underwriting deductions | 412,191 | 6,901 | 545,288 | 47,780 | 1,012,160 | ||||||||||||||||||
Underwriting income (loss) | $ | 325,816 | $ | 4,874 | $ | 78,860 | $ | (47,780 | ) | $ | 361,770 | ||||||||||||
Net investment income | 64,915 | 2,672 | 16,475 | (4,928 | ) | 79,134 | |||||||||||||||||
Other income | 4,229 | 22,237 | 2,033 | (6,290 | ) | 22,209 | |||||||||||||||||
Finance expenses | (6,628 | ) | (495 | ) | (224 | ) | (32,000 | ) | (39,347 | ) | |||||||||||||
Operating income (loss) before taxes and income from operating affiliates | 388,332 | 29,288 | 97,144 | (90,998 | ) | 423,766 | |||||||||||||||||
Tax (expense) benefit | (11 | ) | — | (562 | ) | (1,313 | ) | (1,886 | ) | ||||||||||||||
Income from operating affiliates | — | 13,194 | — | — | 13,194 | ||||||||||||||||||
Net operating income (loss) | $ | 388,321 | $ | 42,482 | $ | 96,582 | $ | (92,311 | ) | $ | 435,074 | ||||||||||||
Net realized gains on investments | 17,708 | 216 | 4,825 | — | 22,749 | ||||||||||||||||||
Net unrealized gains on investments | 35,400 | 12,316 | 5,726 | — | 53,442 | ||||||||||||||||||
(Loss) from investment affiliate | (558 | ) | — | — | — | (558 | ) | ||||||||||||||||
Foreign exchange gains (losses) | 2,461 | 47 | 1,334 | (225 | ) | 3,617 | |||||||||||||||||
Transaction expenses (c) | — | — | — | (3,784 | ) | (3,784 | ) | ||||||||||||||||
Net income (loss) | $ | 443,332 | $ | 55,061 | $ | 108,467 | $ | (96,320 | ) | $ | 510,540 | ||||||||||||
Net loss attributable to noncontrolling interest | — | (11,386 | ) | — | — | (11,386 | ) | ||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 443,332 | $ | 43,675 | $ | 108,467 | $ | (96,320 | ) | $ | 499,154 | ||||||||||||
Selected ratios: | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 86.9 | % | 100 | % | 77.1 | % | 85.3 | % | |||||||||||||||
Losses and loss expenses (a) | 33.1 | % | 0 | % | 47.6 | % | 39.4 | % | |||||||||||||||
Policy acquisition costs (a) | 15.4 | % | 10.1 | % | 22.8 | % | 18.4 | % | |||||||||||||||
General and administrative expenses (a) (b) | 7.4 | % | 48.5 | % | 17 | % | 15.9 | % | |||||||||||||||
Expense ratio (a) | 22.8 | % | 58.6 | % | 39.8 | % | 34.3 | % | |||||||||||||||
Combined ratio (a) | 55.9 | % | 58.6 | % | 87.4 | % | 73.7 | % | |||||||||||||||
Total assets | $ | 4,729,344 | $ | 768,612 | $ | 2,931,174 | $ | 34,690 | $ | 8,463,820 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
(c) | The transaction expenses relate to costs incurred in connection with the acquisition of Flagstone Reinsurance Holdings, S.A. | ||||||||||||||||||||||
The Company’s exposures are generally diversified across geographic zones. The following tables set forth the gross premiums written allocated to the territory of coverage exposure for the periods indicated: | |||||||||||||||||||||||
Three Months Ended September 30, 2013 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 39,618 | $ | 2,546 | $ | 21,573 | $ | (2,105 | ) | $ | 61,632 | 17.3 | % | ||||||||||
Worldwide excluding United States (a) | 16,973 | — | 34,751 | (4,138 | ) | 47,586 | 13.3 | % | |||||||||||||||
Australia and New Zealand | (9,482 | ) | 33 | 2,905 | (236 | ) | (6,780 | ) | (1.9 | )% | |||||||||||||
Europe | 4,252 | 377 | 9,778 | (986 | ) | 13,421 | 3.8 | % | |||||||||||||||
Latin America and Caribbean | 5,902 | — | 38,084 | (3,353 | ) | 40,633 | 11.4 | % | |||||||||||||||
Japan | (2,637 | ) | — | 1,066 | (117 | ) | (1,688 | ) | (0.5 | )% | |||||||||||||
Canada | 1,469 | 500 | 2,749 | (740 | ) | 3,978 | 1.1 | % | |||||||||||||||
Rest of the world (b) | 5,641 | — | 22,167 | (1,830 | ) | 25,978 | 7.3 | % | |||||||||||||||
Sub-total, non United States | 22,118 | 910 | 111,500 | (11,400 | ) | 123,128 | 34.5 | % | |||||||||||||||
Worldwide including United States (a) | 29,611 | 25 | 18,246 | (1,665 | ) | 46,217 | 13 | % | |||||||||||||||
Other location non-specific (c) | 39,578 | — | 95,149 | (8,944 | ) | 125,783 | 35.3 | % | |||||||||||||||
Total | $ | 130,925 | $ | 3,481 | $ | 246,468 | $ | (24,114 | ) | $ | 356,760 | 100 | % | ||||||||||
Three Months Ended September 30, 2012 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 53,138 | $ | 2,211 | $ | 21,004 | $ | (1,482 | ) | $ | 74,871 | 19.2 | % | ||||||||||
Worldwide excluding United States (a) | 7,085 | — | 28,113 | (2,029 | ) | 33,169 | 8.5 | % | |||||||||||||||
Australia and New Zealand | 4,887 | 217 | 5,356 | (369 | ) | 10,091 | 2.6 | % | |||||||||||||||
Europe | 10,251 | 512 | 10,426 | (748 | ) | 20,441 | 5.2 | % | |||||||||||||||
Latin America and Caribbean | 3,299 | — | 36,735 | (2,621 | ) | 37,413 | 9.6 | % | |||||||||||||||
Japan | 781 | — | 1,916 | (136 | ) | 2,561 | 0.7 | % | |||||||||||||||
Canada | 260 | — | 3,696 | (258 | ) | 3,698 | 0.9 | % | |||||||||||||||
Rest of the world (b) | 6,303 | — | 30,572 | (2,133 | ) | 34,742 | 8.9 | % | |||||||||||||||
Sub-total, non United States | 32,866 | 729 | 116,814 | (8,294 | ) | 142,115 | 36.4 | % | |||||||||||||||
Worldwide including United States (a) | 17,375 | (6 | ) | 17,571 | (1,238 | ) | 33,702 | 8.6 | % | ||||||||||||||
Other location non-specific (c) | 41,631 | — | 105,366 | (7,470 | ) | 139,527 | 35.8 | % | |||||||||||||||
Total | $ | 145,010 | $ | 2,934 | $ | 260,755 | $ | (18,484 | ) | $ | 390,215 | 100 | % | ||||||||||
(a) | Represents risks in two or more geographic zones. | ||||||||||||||||||||||
(b) | Represents risks in one geographic zone. | ||||||||||||||||||||||
(c) | The Other location non-specific category refers to business for which an analysis of exposure by geographic zone is not applicable such as marine and aerospace risks and can span multiple geographic areas and are not fixed locations in some instances. | ||||||||||||||||||||||
Nine Months Ended September 30, 2013 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 470,745 | $ | 50,935 | $ | 77,630 | $ | (10,599 | ) | $ | 588,711 | 27.2 | % | ||||||||||
Worldwide excluding United States (a) | 69,482 | 14,801 | 109,562 | (9,065 | ) | 184,780 | 8.4 | % | |||||||||||||||
Australia and New Zealand | 21,116 | 2,216 | 7,930 | (467 | ) | 30,795 | 1.4 | % | |||||||||||||||
Europe | 64,986 | 2,514 | 41,523 | (3,892 | ) | 105,131 | 4.9 | % | |||||||||||||||
Latin America and Caribbean | 5,885 | — | 124,120 | (7,312 | ) | 122,693 | 5.7 | % | |||||||||||||||
Japan | 41,939 | 653 | 5,258 | (963 | ) | 46,887 | 2.2 | % | |||||||||||||||
Canada | 4,503 | 818 | 8,790 | (1,336 | ) | 12,775 | 0.6 | % | |||||||||||||||
Rest of the world (b) | 29,211 | — | 62,803 | (3,700 | ) | 88,314 | 4.1 | % | |||||||||||||||
Sub-total, non United States | 237,122 | 21,002 | 359,986 | (26,735 | ) | 591,375 | 27.3 | % | |||||||||||||||
Worldwide including United States (a) | 180,621 | 74,820 | 63,998 | (10,214 | ) | 309,225 | 14.3 | % | |||||||||||||||
Other location non-specific (c) | 343,784 | — | 353,902 | (23,164 | ) | 674,522 | 31.2 | % | |||||||||||||||
Total | $ | 1,232,272 | $ | 146,757 | $ | 855,516 | $ | (70,712 | ) | $ | 2,163,833 | 100 | % | ||||||||||
Nine Months Ended September 30, 2012 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 347,492 | $ | 12,643 | $ | 62,812 | $ | (4,764 | ) | $ | 418,183 | 22.5 | % | ||||||||||
Worldwide excluding United States (a) | 51,289 | 278 | 115,836 | (10,681 | ) | 156,722 | 8.5 | % | |||||||||||||||
Australia and New Zealand | 37,474 | 217 | 9,798 | (721 | ) | 46,768 | 2.5 | % | |||||||||||||||
Europe | 67,206 | 1,332 | 39,871 | (2,703 | ) | 105,706 | 5.7 | % | |||||||||||||||
Latin America and Caribbean | 8,456 | — | 112,329 | (7,634 | ) | 113,151 | 6.1 | % | |||||||||||||||
Japan | 31,597 | — | 6,003 | (407 | ) | 37,193 | 2 | % | |||||||||||||||
Canada | 2,753 | — | 9,366 | (634 | ) | 11,485 | 0.6 | % | |||||||||||||||
Rest of the world (b) | 23,857 | — | 74,036 | (2,133 | ) | 95,760 | 5.2 | % | |||||||||||||||
Sub-total, non United States | 222,632 | 1,827 | 367,239 | (24,913 | ) | 566,785 | 30.6 | % | |||||||||||||||
Worldwide including United States (a) | 166,550 | 7,137 | 50,737 | (3,440 | ) | 220,984 | 11.9 | % | |||||||||||||||
Other location non-specific (c) | 316,052 | — | 356,748 | (24,159 | ) | 648,641 | 35 | % | |||||||||||||||
Total | $ | 1,052,726 | $ | 21,607 | $ | 837,536 | $ | (57,276 | ) | $ | 1,854,593 | 100 | % | ||||||||||
(a) | Represents risks in two or more geographic zones. | ||||||||||||||||||||||
(b) | Represents risks in one geographic zone. | ||||||||||||||||||||||
(c) | The Other location non-specific category refers to business for which an analysis of exposure by geographic zone is not applicable such as marine and aerospace risks and can span multiple geographic areas and are not fixed locations in some instances. |
Subsequent_events
Subsequent events | 9 Months Ended | |
Sep. 30, 2013 | ||
Subsequent Events [Abstract] | ' | |
Subsequent events | ' | |
Subsequent events | ||
(a) | Quarterly Dividend | |
On October 31, 2013, the Company announced a quarterly cash dividend of $0.30 per each common share and $0.30 per common share equivalent for which each outstanding warrant is exercisable, payable on December 31, 2013 to holders of record on December 13, 2013. | ||
(b) Sale of Subsidiary | ||
During October, the Company completed the sale of its wholly owned subsidiary, Flagstone Alliance Insurance and Reinsurance. | ||
(c) Share Repurchase Authorization | ||
On October 31, 2013, the Board of Directors of the Company approved an increase in the Company's common share repurchase authorization to $500,000. This amount is in addition to the $1,567,380 of common shares repurchased by the Company through October 31, 2013 under its previously authorized share repurchase programs. The Company expects the repurchases to be made from time to time in the open market or in privately negotiated transactions. The timing, form and amount of the share repurchases under the program will depend on a variety of factors, including market conditions, the Company's capital position relative to internal and rating agency targets, legal requirements and other factors. The repurchase program may be modified, extended or terminated by the Board at any time. |
Significant_accounting_policie
Significant accounting policies (Policies) | 9 Months Ended |
Sep. 30, 2013 | |
Accounting Policies [Abstract] | ' |
Basis of preparation | ' |
These unaudited consolidated financial statements include Validus Holdings, Ltd. and its subsidiaries (together, the "Company") and have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 in Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In addition, the year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. This Quarterly Report should be read in conjunction with the financial statements included in the Company's Annual Report on Form 10-K/A for the year ended December 31, 2012, as filed with the U.S. Securities and Exchange Commission (the "SEC"). | |
In the opinion of management, these unaudited consolidated financial statements reflect all adjustments (including normal recurring adjustments) considered necessary for a fair presentation of the Company's financial position and results of operations as at the end of and for the periods presented. Certain amounts in prior periods have been reclassified to conform to current period presentation. All intercompany accounts and transactions have been eliminated. | |
Use of estimates | ' |
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The significant estimates reflected in the Company's consolidated financial statements include the reserve for losses and loss expenses, premium estimates for business written on a line slip or proportional basis, reinsurance premiums ceded and reinsurance recoverable balances including the provision for unrecoverable reinsurance recoverable balances and investment valuation. Actual results could differ materially from those estimates. | |
Reserves for losses and loss expenses | ' |
Reserves for losses and loss expenses are based in part upon the estimation of case reserves reported from brokers, insureds and ceding companies. The Company also uses statistical and actuarial methods to estimate ultimate expected losses and loss expenses. The period of time from the occurrence of a loss to the reporting of a loss to the Company and to the settlement of the Company's liability may be several months or years. During this period, additional facts and trends may be revealed. As these factors become apparent, reserves will be adjusted, sometimes requiring an increase or decrease in the overall reserves of the Company, and at other times requiring a reallocation of incurred but not reported reserves to specific case reserves. These estimates are reviewed and adjusted regularly, and such adjustments, if any, are reflected in earnings in the period in which they become known. While management believes that it has made a reasonable estimate of ultimate losses, there can be no assurances that ultimate losses and loss expenses will not exceed this estimate. | |
Reinsurance | ' |
The Company enters into reinsurance and retrocession agreements in order to mitigate its accumulation of loss, reduce its liability on individual risks, enable it to underwrite policies with higher limits and increase its aggregate capacity. The cession of insurance and reinsurance does not legally discharge the Company from its primary liability for the full amount of the policies, and the Company is required to pay the loss and bear collection risk if the reinsurer fails to meet its obligations under the reinsurance or retrocession agreement. Amounts recoverable from reinsurers are estimated in a manner consistent with the underlying liabilities. | |
To estimate the provision for uncollectible reinsurance recoverable, the reinsurance recoverable is first allocated to applicable reinsurers. This determination is based on a process rather than an estimate, although an element of judgment is applied. As part of this process, ceded IBNR is allocated by reinsurer. The Company uses a default analysis to estimate uncollectible reinsurance. The primary components of the default analysis are reinsurance recoverable balances by reinsurer and default factors used to determine the portion of a reinsurer's balance deemed to be uncollectible. Default factors require considerable judgment and are determined using the current rating, or rating equivalent, of each reinsurer as well as other key considerations and assumptions. |
Investments_Tables
Investments (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Investments [Abstract] | ' | |||||||||||||||
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | |||||||||||||||
The amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments at September 30, 2013 were as follows: | ||||||||||||||||
Amortized Cost or Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | |||||||||||||
U.S. government and government agency | $ | 1,319,499 | $ | 4,313 | $ | (3,329 | ) | $ | 1,320,483 | |||||||
Non-U.S. government and government agency | 401,149 | 4,028 | (1,180 | ) | 403,997 | |||||||||||
U.S. states, municipalities and political subdivisions | 43,912 | 440 | (423 | ) | 43,929 | |||||||||||
Agency residential mortgage-backed securities | 313,177 | 8,384 | (1,360 | ) | 320,201 | |||||||||||
Non-agency residential mortgage-backed securities | 24,029 | 164 | (1,062 | ) | 23,131 | |||||||||||
U.S. corporate | 1,363,418 | 10,616 | (6,889 | ) | 1,367,145 | |||||||||||
Non-U.S. corporate | 686,656 | 5,658 | (3,264 | ) | 689,050 | |||||||||||
Bank loans | 732,922 | 5,421 | (1,885 | ) | 736,458 | |||||||||||
Catastrophe bonds | 56,504 | 2,358 | — | 58,862 | ||||||||||||
Asset-backed securities | 474,598 | 1,279 | (868 | ) | 475,009 | |||||||||||
Total fixed maturities | 5,415,864 | 42,661 | (20,260 | ) | 5,438,265 | |||||||||||
Total short-term investments | 761,631 | 12 | (1 | ) | 761,642 | |||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | 3,274 | 97 | (921 | ) | 2,450 | |||||||||||
Private equity investments | 12,493 | 2,259 | (79 | ) | 14,673 | |||||||||||
Hedge funds (a) | 584,519 | 46,087 | (97,261 | ) | 533,345 | |||||||||||
Mutual funds | 6,199 | 2,805 | — | 9,004 | ||||||||||||
Total other investments | 606,485 | 51,248 | (98,261 | ) | 559,472 | |||||||||||
Total | $ | 6,783,980 | $ | 93,921 | $ | (118,522 | ) | $ | 6,759,379 | |||||||
Noncontrolling interest (a) | $ | (527,850 | ) | $ | (40,887 | ) | $ | 87,535 | $ | (481,202 | ) | |||||
Total investments excluding noncontrolling interest | $ | 6,256,130 | $ | 53,034 | $ | (30,987 | ) | $ | 6,278,177 | |||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. | |||||||||||||||
The amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments at December 31, 2012 were as follows: | ||||||||||||||||
Amortized Cost or Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | |||||||||||||
U.S. government and government agency | $ | 1,091,357 | $ | 7,957 | $ | (84 | ) | $ | 1,099,230 | |||||||
Non-U.S. government and government agency | 295,602 | 6,904 | (227 | ) | 302,279 | |||||||||||
U.S. states, municipalities and political subdivisions | 41,286 | 800 | (23 | ) | 42,063 | |||||||||||
Agency residential mortgage-backed securities | 375,368 | 13,708 | (202 | ) | 388,874 | |||||||||||
Non-agency residential mortgage-backed securities | 106,536 | 1,266 | (1,346 | ) | 106,456 | |||||||||||
U.S. corporate | 1,189,173 | 21,681 | (681 | ) | 1,210,173 | |||||||||||
Non-U.S. corporate | 582,115 | 11,373 | (223 | ) | 593,265 | |||||||||||
Bank loans | 663,217 | 10,593 | (427 | ) | 673,383 | |||||||||||
Catastrophe bonds | 56,757 | 481 | (291 | ) | 56,947 | |||||||||||
Asset-backed securities | 607,103 | 5,767 | (206 | ) | 612,664 | |||||||||||
Total fixed maturities | 5,008,514 | 80,530 | (3,710 | ) | 5,085,334 | |||||||||||
Total short-term investments | 1,112,929 | 1,349 | (28 | ) | 1,114,250 | |||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | 4,677 | 299 | (219 | ) | 4,757 | |||||||||||
Private equity investments | 12,857 | 94 | — | 12,951 | ||||||||||||
Hedge funds (a) | 559,335 | 21,814 | (42,623 | ) | 538,526 | |||||||||||
Mutual funds | 6,199 | 2,015 | — | 8,214 | ||||||||||||
Total other investments | 583,068 | 24,222 | (42,842 | ) | 564,448 | |||||||||||
Total | $ | 6,704,511 | $ | 106,101 | $ | (46,580 | ) | $ | 6,764,032 | |||||||
Noncontrolling interest (a) | (450,000 | ) | (19,427 | ) | 36,690 | (432,737 | ) | |||||||||
Total investments excluding noncontrolling interest | $ | 6,254,511 | $ | 86,674 | $ | (9,890 | ) | $ | 6,331,295 | |||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. | |||||||||||||||
Investment ratings on fixed maturities | ' | |||||||||||||||
September 30, 2013 | December 31, 2012 | |||||||||||||||
Estimated Fair Value | % of Total | Estimated Fair Value | % of Total | |||||||||||||
AAA | $ | 776,896 | 14.3 | % | $ | 1,062,794 | 20.9 | % | ||||||||
AA | 2,256,592 | 41.5 | % | 1,862,322 | 36.6 | % | ||||||||||
A | 1,196,037 | 22 | % | 1,049,969 | 20.6 | % | ||||||||||
BBB | 423,228 | 7.8 | % | 374,447 | 7.4 | % | ||||||||||
Investment grade | 4,652,753 | 85.6 | % | 4,349,532 | 85.5 | % | ||||||||||
BB | 356,205 | 6.5 | % | 373,907 | 7.4 | % | ||||||||||
B | 397,888 | 7.3 | % | 330,416 | 6.5 | % | ||||||||||
CCC | 4,754 | 0.1 | % | 4,483 | 0.1 | % | ||||||||||
CC | 2,821 | 0.1 | % | 3,259 | 0.1 | % | ||||||||||
D/NR | 23,844 | 0.4 | % | 23,737 | 0.4 | % | ||||||||||
Non-Investment grade | 785,512 | 14.4 | % | 735,802 | 14.5 | % | ||||||||||
Total Fixed Maturities | $ | 5,438,265 | 100 | % | $ | 5,085,334 | 100 | % | ||||||||
Fixed maturities investments by contractual maturity | ' | |||||||||||||||
September 30, 2013 | December 31, 2012 | |||||||||||||||
Amortized Cost | Estimated Fair Value | Amortized Cost | Estimated Fair Value | |||||||||||||
Due in one year or less | $ | 745,812 | $ | 750,992 | $ | 526,529 | $ | 530,499 | ||||||||
Due after one year through five years | 3,492,605 | 3,504,812 | 2,971,118 | 3,018,544 | ||||||||||||
Due after five years through ten years | 362,563 | 361,011 | 418,377 | 424,304 | ||||||||||||
Due after ten years | 3,080 | 3,109 | 3,483 | 3,993 | ||||||||||||
4,604,060 | 4,619,924 | 3,919,507 | 3,977,340 | |||||||||||||
Asset-backed and mortgage-backed securities | 811,804 | 818,341 | 1,089,007 | 1,107,994 | ||||||||||||
Total Fixed Maturities | $ | 5,415,864 | $ | 5,438,265 | $ | 5,008,514 | $ | 5,085,334 | ||||||||
Net investment income | ' | |||||||||||||||
Net investment income was derived from the following sources: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Fixed maturities and short-term investments | $ | 20,936 | $ | 25,703 | $ | 74,618 | $ | 79,450 | ||||||||
Cash and cash equivalents | 1,079 | 1,770 | 3,241 | 5,536 | ||||||||||||
Securities lending income | 3 | 3 | 3 | 9 | ||||||||||||
Total gross investment income | 22,018 | 27,476 | 77,862 | 84,995 | ||||||||||||
Investment expenses | (2,009 | ) | (1,987 | ) | (5,994 | ) | (5,861 | ) | ||||||||
Net investment income | $ | 20,009 | $ | 25,489 | $ | 71,868 | $ | 79,134 | ||||||||
Analysis of net realized gains and change in unrealized (losses) gains on investments | ' | |||||||||||||||
The following represents an analysis of net realized gains (losses) and the change in net unrealized (losses) on investments: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Fixed maturities, short-term and other investments and cash equivalents | ||||||||||||||||
Gross realized gains | $ | 7,706 | $ | 10,187 | $ | 25,578 | $ | 29,610 | ||||||||
Gross realized (losses) | (14,026 | ) | (1,124 | ) | (26,768 | ) | (6,861 | ) | ||||||||
Net realized (losses) gains on investments | (6,320 | ) | 9,063 | (1,190 | ) | 22,749 | ||||||||||
Net unrealized gains on securities lending | — | 223 | — | 260 | ||||||||||||
Change in net unrealized gains (losses) on investments | 69,967 | 86,122 | (78,618 | ) | 53,182 | |||||||||||
Net change in unrealized gains (losses) on investments | $ | 69,967 | $ | 86,345 | $ | (78,618 | ) | $ | 53,442 | |||||||
Total net realized (losses) gains and change in net unrealized gains (losses) on investments | $ | 63,647 | $ | 95,408 | $ | (79,808 | ) | $ | 76,191 | |||||||
Noncontrolling interest (a) | (42,578 | ) | (55,806 | ) | 25,767 | (10,924 | ) | |||||||||
Total net realized gains and change in net unrealized (losses) on investments excluding noncontrolling interest | $ | 21,069 | $ | 39,602 | $ | (54,041 | ) | $ | 65,267 | |||||||
(a) | Includes change in net unrealized (gains) losses on investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. | |||||||||||||||
Investments pledged as collateral under credit facilities | ' | |||||||||||||||
The following tables outline investments pledged as collateral under the Company's credit facilities. For further details of the credit facilities, please refer to Note 12: “Debt and financing arrangements.” | ||||||||||||||||
September 30, 2013 | ||||||||||||||||
Description | Commitment | Issued and Outstanding | Investments pledged as collateral | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | $ | 400,000 | $ | — | $ | — | ||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 371,990 | 491,761 | |||||||||||||
$200,000 secured bi-lateral letter of credit facility | 200,000 | 77,626 | 129,768 | |||||||||||||
Talbot FAL Facility | 25,000 | 25,000 | 36,996 | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 258 | — | |||||||||||||
IPC bi-lateral facility | 40,000 | 26,019 | 98,260 | |||||||||||||
$375,000 Flagstone bi-lateral facility | 375,000 | 297,996 | 453,241 | |||||||||||||
$ | 1,575,000 | $ | 798,889 | $ | 1,210,026 | |||||||||||
31-Dec-12 | ||||||||||||||||
Description | Commitment | Issued and Outstanding | Investments pledged as collateral | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | $ | 400,000 | $ | — | $ | — | ||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 376,570 | 517,210 | |||||||||||||
$500,000 secured bi-lateral letter of credit facility | 500,000 | 92,402 | 125,991 | |||||||||||||
Talbot FAL Facility | 25,000 | 25,000 | 41,372 | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 219 | — | |||||||||||||
IPC bi-lateral facility | 80,000 | 40,613 | 98,593 | |||||||||||||
$550,000 Flagstone bi-lateral facility | 550,000 | 381,019 | 416,414 | |||||||||||||
$ | 2,090,000 | $ | 915,823 | $ | 1,199,580 | |||||||||||
Fair_value_measurements_Tables
Fair value measurements (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||
Fair value hierarchy - allocation of investments | ' | |||||||||||||||
At September 30, 2013, the Company’s investments were allocated between Levels 1, 2 and 3 as follows: | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
U.S. government and government agency | $ | — | $ | 1,320,483 | $ | — | $ | 1,320,483 | ||||||||
Non-U.S. government and government agency | — | 403,997 | — | 403,997 | ||||||||||||
States, municipalities, political subdivision | — | 43,929 | — | 43,929 | ||||||||||||
Agency residential mortgage-backed securities | — | 320,201 | — | 320,201 | ||||||||||||
Non-agency residential mortgage-backed securities | — | 23,131 | — | 23,131 | ||||||||||||
U.S. corporate | — | 1,367,145 | — | 1,367,145 | ||||||||||||
Non-U.S. corporate | — | 689,050 | — | 689,050 | ||||||||||||
Bank loans | — | 736,458 | — | 736,458 | ||||||||||||
Catastrophe bonds | — | 58,862 | — | 58,862 | ||||||||||||
Asset-backed securities | — | 475,009 | — | 475,009 | ||||||||||||
Total fixed maturities | — | 5,438,265 | — | 5,438,265 | ||||||||||||
Short-term investments | 755,747 | 5,895 | — | 761,642 | ||||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | — | — | 2,450 | 2,450 | ||||||||||||
Private equity investments | — | — | 14,673 | 14,673 | ||||||||||||
Hedge funds (a) | — | — | 533,345 | 533,345 | ||||||||||||
Mutual funds | — | 9,004 | — | 9,004 | ||||||||||||
Total other investments | — | 9,004 | 550,468 | 559,472 | ||||||||||||
Total | $ | 755,747 | $ | 5,453,164 | $ | 550,468 | $ | 6,759,379 | ||||||||
Noncontrolling interest (a) | (15,730 | ) | — | (465,472 | ) | (481,202 | ) | |||||||||
Total investments excluding noncontrolling interest | $ | 740,017 | $ | 5,453,164 | $ | 84,996 | $ | 6,278,177 | ||||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. | |||||||||||||||
At December 31, 2012, the Company’s investments were allocated between Levels 1, 2 and 3 as follows: | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
U.S. government and government agency | $ | — | $ | 1,099,230 | $ | — | $ | 1,099,230 | ||||||||
Non-U.S. government and government agency | — | 302,279 | — | 302,279 | ||||||||||||
States, municipalities, political subdivision | — | 42,063 | — | 42,063 | ||||||||||||
Agency residential mortgage-backed securities | — | 388,874 | — | 388,874 | ||||||||||||
Non-agency residential mortgage-backed securities | — | 106,456 | — | 106,456 | ||||||||||||
U.S. corporate | — | 1,210,173 | — | 1,210,173 | ||||||||||||
Non-U.S. corporate | — | 593,265 | — | 593,265 | ||||||||||||
Bank loans | — | 673,383 | — | 673,383 | ||||||||||||
Catastrophe bonds | — | 56,947 | — | 56,947 | ||||||||||||
Asset-backed securities | — | 612,664 | — | 612,664 | ||||||||||||
Total fixed maturities | — | 5,085,334 | — | 5,085,334 | ||||||||||||
Short-term investments | 1,063,175 | 51,075 | — | 1,114,250 | ||||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | — | — | 4,757 | 4,757 | ||||||||||||
Private equity investments | — | — | 12,951 | 12,951 | ||||||||||||
Hedge funds (a) | — | — | 538,526 | 538,526 | ||||||||||||
Mutual funds | — | 8,214 | — | 8,214 | ||||||||||||
Total other investments | — | 8,214 | 556,234 | 564,448 | ||||||||||||
Total | $ | 1,063,175 | $ | 5,144,623 | $ | 556,234 | $ | 6,764,032 | ||||||||
Noncontrolling interest (a) | — | — | (432,737 | ) | (432,737 | ) | ||||||||||
Total investments excluding noncontrolling interest | $ | 1,063,175 | $ | 5,144,623 | $ | 123,497 | $ | 6,331,295 | ||||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. | |||||||||||||||
Reconciliation of beginning and ending balances for all Level 3 investments measured at fair value on recurring basis | ' | |||||||||||||||
The following tables present a reconciliation of the beginning and ending balances for all investments measured at fair value on a recurring basis using Level 3 inputs during the three and nine months ended September 30, 2013 and 2012: | ||||||||||||||||
Three Months Ended September 30, 2013 | Three Months Ended September 30, 2012 | |||||||||||||||
Total Fair Market Value | Total Fair Market Value | |||||||||||||||
Level 3 investments - Beginning of period | $ | 505,158 | $ | 454,793 | ||||||||||||
Purchases | 33,154 | — | ||||||||||||||
Sales | (35,264 | ) | (218 | ) | ||||||||||||
Net realized gains | 4,503 | 13 | ||||||||||||||
Net unrealized gains | 42,917 | 61,746 | ||||||||||||||
Transfers | — | 921 | ||||||||||||||
Level 3 investments - End of period | $ | 550,468 | $ | 517,255 | ||||||||||||
Noncontrolling interest (a) | (465,472 | ) | (460,924 | ) | ||||||||||||
Level 3 investments excluding noncontrolling interest | $ | 84,996 | $ | 56,331 | ||||||||||||
Nine Months Ended September 30, 2013 | Nine Months Ended September 30, 2012 | |||||||||||||||
Total Fair Market Value | Total Fair Market Value | |||||||||||||||
Level 3 investments - Beginning of period | $ | 556,234 | $ | 8,880 | ||||||||||||
Purchases | 98,669 | 500,000 | ||||||||||||||
Sales | (80,095 | ) | (1,115 | ) | ||||||||||||
Net realized gains | 4,843 | 61 | ||||||||||||||
Net unrealized (losses) gains | (29,183 | ) | 11,762 | |||||||||||||
Transfers | — | (2,333 | ) | |||||||||||||
Level 3 investments - End of period | $ | 550,468 | $ | 517,255 | ||||||||||||
Noncontrolling interest (a) | (465,472 | ) | (460,924 | ) | ||||||||||||
Level 3 investments excluding noncontrolling interest | $ | 84,996 | $ | 56,331 | ||||||||||||
(a) | Includes Level 3 investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. | |||||||||||||||
Investments_in_affiliates_Tabl
Investments in affiliates (Tables) | 9 Months Ended | |||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||
Equity Method Investments and Joint Ventures [Abstract] | ' | |||||||||||||||||||
Reconciliation of the beginning and ending non-consolidated affiliate balance | ' | |||||||||||||||||||
The following table presents a reconciliation of the beginning and ending investment in the Company's investment affiliate balance for the three and nine months ended September 30, 2013 and 2012: | ||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||
Investment affiliate, beginning of period | $ | 25,352 | $ | 6,317 | $ | 15,218 | $ | 3,253 | ||||||||||||
Capital contributions | 6,185 | 430 | 13,089 | 5,328 | ||||||||||||||||
Net unrealized (loss) on investments (a) | — | — | — | (1,436 | ) | |||||||||||||||
Income (loss) from investment affiliate | 1,044 | (160 | ) | 4,274 | (558 | ) | ||||||||||||||
Investment affiliate, end of period | $ | 32,581 | $ | 6,587 | $ | 32,581 | $ | 6,587 | ||||||||||||
(a) | Until March 31, 2012, this investment was included in " Other investments" as a level 3 investment in the fair value hierarchy, hence the change in fair value was included in net unrealized (losses) gains on investments. | |||||||||||||||||||
The following table presents a reconciliation of the beginning and ending investment in operating affiliates balances for the three and nine months ended September 30, 2013 and 2012: | ||||||||||||||||||||
Three Months Ended September 30, 2013 | ||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | AlphaCat 2013 | AlphaCat ILS funds | Total | ||||||||||||||||
As at June 30, 2013 | $ | 11,054 | $ | 5,204 | $ | 48,536 | $ | 20,326 | $ | 85,120 | ||||||||||
Return of investment | (2,800 | ) | (4,550 | ) | — | — | (7,350 | ) | ||||||||||||
(Loss) income from operating affiliates | (270 | ) | (7 | ) | 585 | 1,155 | 1,463 | |||||||||||||
As at September 30, 2013 | $ | 7,984 | $ | 647 | $ | 49,121 | $ | 21,481 | $ | 79,233 | ||||||||||
Three Months Ended September 30, 2012 | ||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | Total | ||||||||||||||||||
As at June 30, 2012 | $ | 59,238 | $ | 27,252 | $ | 86,490 | ||||||||||||||
Income from operating affiliates | 4,079 | 2,156 | 6,235 | |||||||||||||||||
As at September 30, 2012 | $ | 63,317 | $ | 29,408 | $ | 92,725 | ||||||||||||||
Nine Months Ended September 30, 2013 | ||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | AlphaCat 2013 | AlphaCat ILS funds | Total | ||||||||||||||||
As at December 31, 2012 | $ | 62,792 | $ | 29,319 | $ | 45,000 | $ | 20,000 | $ | 157,111 | ||||||||||
Return of investment | (54,914 | ) | (31,743 | ) | — | — | (86,657 | ) | ||||||||||||
Income from operating affiliates | 106 | 3,071 | 4,121 | 1,481 | 8,779 | |||||||||||||||
As at September 30, 2013 | $ | 7,984 | $ | 647 | $ | 49,121 | $ | 21,481 | $ | 79,233 | ||||||||||
Nine Months Ended September 30, 2012 | ||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | Total | ||||||||||||||||||
As at December 31, 2011 | $ | 53,031 | $ | — | $ | 53,031 | ||||||||||||||
Purchase of shares | — | 26,500 | 26,500 | |||||||||||||||||
Income from operating affiliates | 10,286 | 2,908 | 13,194 | |||||||||||||||||
As at September 30, 2012 | $ | 63,317 | $ | 29,408 | $ | 92,725 | ||||||||||||||
Schedule of equity method investments | ' | |||||||||||||||||||
The following table presents the Company's investments in operating affiliates as at September 30, 2013: | ||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||
Investment at cost | Voting ownership % | Equity ownership % | Carrying value | |||||||||||||||||
AlphaCat Re 2011 | $ | 8,254 | 43.7 | % | 22.3 | % | $ | 7,984 | ||||||||||||
AlphaCat Re 2012 | 652 | 49 | % | 37.9 | % | 647 | ||||||||||||||
AlphaCat 2013 | 45,000 | 40.9 | % | 19.7 | % | 49,121 | ||||||||||||||
AlphaCat ILS Funds | 20,000 | — | % | 9.1 | % | 21,481 | ||||||||||||||
Total | $ | 73,906 | $ | 79,233 | ||||||||||||||||
The following table presents the Company's investments in operating affiliates as at December 31, 2012: | ||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||
Investment at cost | Voting ownership % | Equity ownership % | Carrying value | |||||||||||||||||
AlphaCat Re 2011 | $ | 41,389 | 43.7 | % | 22.3 | % | $ | 62,792 | ||||||||||||
AlphaCat Re 2012 | 26,500 | 49 | % | 37.9 | % | 29,319 | ||||||||||||||
AlphaCat 2013 | 45,000 | 40.9 | % | 19.7 | % | 45,000 | ||||||||||||||
AlphaCat ILS Fund | $ | 20,000 | — | % | 11.8 | % | $ | 20,000 | ||||||||||||
Total | $ | 132,889 | $ | 157,111 | ||||||||||||||||
The following table presents the Company's investment in the Partnership as at September 30, 2013: | ||||||||||||||||||||
Investment in investment affiliate | ||||||||||||||||||||
Investment at cost | Voting ownership % | Equity Ownership | Carrying Value | |||||||||||||||||
Aquiline Financial Services Fund II L.P | $ | 30,707 | — | % | 6.59 | % | $ | 32,581 | ||||||||||||
Noncontrolling_interest_Tables
Noncontrolling interest (Tables) | 9 Months Ended | |||||||||||
Sep. 30, 2013 | ||||||||||||
Noncontrolling Interest [Abstract] | ' | |||||||||||
Noncontrolling interest | ' | |||||||||||
The following table presents a reconciliation of the beginning and ending balances of noncontrolling interest for the three and nine months ended September 30, 2013 and 2012: | ||||||||||||
Three Months Ended September 30, 2013 | ||||||||||||
PaCRe | AlphaCat ILS funds | Total | ||||||||||
As at June 30, 2013 | $ | 427,755 | $ | 70,690 | $ | 498,445 | ||||||
Purchase of shares by noncontrolling interest | — | 13,000 | 13,000 | |||||||||
Net income attributable to noncontrolling interest | 44,178 | 1,516 | 45,694 | |||||||||
As at September 30, 2013 | $ | 471,933 | $ | 85,206 | $ | 557,139 | ||||||
Three Months Ended September 30, 2012 | ||||||||||||
PaCRe | Total | |||||||||||
As at June 30, 2012 | $ | 404,740 | $ | 404,740 | ||||||||
Net income attributable to noncontrolling interest | 56,746 | 56,746 | ||||||||||
As at September 30, 2012 | $ | 461,486 | $ | 461,486 | ||||||||
Nine Months Ended September 30, 2013 | ||||||||||||
PaCRe | AlphaCat ILS funds | Total | ||||||||||
As at December 31, 2012 | $ | 434,280 | $ | — | $ | 434,280 | ||||||
Purchase of shares by noncontrolling interest | 58,500 | 82,190 | 140,690 | |||||||||
Net (loss) income attributable to noncontrolling interest | (20,847 | ) | 3,016 | (17,831 | ) | |||||||
As at September 30, 2013 | $ | 471,933 | $ | 85,206 | $ | 557,139 | ||||||
Nine Months Ended September 30, 2012 | ||||||||||||
PaCRe | Total | |||||||||||
As at December 31, 2011 | $ | — | $ | — | ||||||||
Purchase of shares by noncontrolling interest | 450,100 | 450,100 | ||||||||||
Net income attributable to noncontrolling interest | 11,386 | 11,386 | ||||||||||
As at September 30, 2012 | $ | 461,486 | $ | 461,486 | ||||||||
Derivative_instruments_used_in
Derivative instruments used in hedging activities (Tables) | 9 Months Ended | ||||||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ||||||||||||||||||||||||
Location and fair value amount of derivative instruments reported on the balance sheet | ' | ||||||||||||||||||||||||
The following table summarizes information on the location and amount of the fair value of derivatives not designated as hedging instruments on the consolidated balance sheet at September 30, 2013 and December 31, 2012: | |||||||||||||||||||||||||
At September 30, 2013 | At December 31, 2012 | ||||||||||||||||||||||||
Derivatives not designated as hedging instruments: | Net notional exposure | Asset Derivative at Fair Value (a) | Liability Derivative at Fair Value (a) | Net notional exposure | Asset Derivative at Fair Value (a) | Liability Derivative at Fair Value (a) | |||||||||||||||||||
Currency swaps | $ | — | $ | — | $ | — | $ | 17,153 | $ | — | $ | 772 | |||||||||||||
Foreign currency forward contracts | $ | — | $ | — | $ | — | $ | 310,541 | $ | — | $ | 394 | |||||||||||||
(a) | Asset and liability derivatives are classified within other assets and accounts payable and accrued expenses respectively on the Consolidated Balance Sheets. | ||||||||||||||||||||||||
The following table summarizes information on the location and amount of the fair value of derivatives designated as hedging instruments on the consolidated balance sheets at September 30, 2013 and December 31, 2012: | |||||||||||||||||||||||||
At September 30, 2013 | At December 31, 2012 | ||||||||||||||||||||||||
Derivatives designated as hedging instruments: | Net notional exposure | Asset Derivative at Fair Value (a) | Liability Derivative at Fair Value (a) | Net notional exposure | Asset Derivative at Fair Value (a) | Liability Derivative at Fair Value (a) | |||||||||||||||||||
Foreign currency forward contracts | $ | 168,722 | $ | 4,977 | $ | 1,115 | $ | 35,976 | $ | — | $ | 223 | |||||||||||||
Interest rate swap contracts | $ | 552,263 | $ | — | 873 | $ | 289,800 | $ | — | $ | 220 | ||||||||||||||
Location and amount of gains and losses related to derivative instruments reported on in the income statement | ' | ||||||||||||||||||||||||
The following table provides the total impact on earnings relating to the derivative instruments formally designated as fair value hedges along with the impact of the related hedged items for the three and nine months ended September 30, 2013 and 2012: | |||||||||||||||||||||||||
Foreign currency forward contracts | Three Months Ended September 30, 2013 | Three Months Ended September 30, 2012 | Nine Months Ended September 30, 2013 | Nine Months Ended September 30, 2012 | |||||||||||||||||||||
Amount of gain (loss) recognized in income on derivative | $ | 3,116 | $ | 1,749 | $ | 2,670 | $ | 130 | |||||||||||||||||
Amount of gain (loss) on hedged item recognized in income attributable to risk being hedged | $ | (3,116 | ) | $ | (1,749 | ) | $ | (2,670 | ) | $ | (130 | ) | |||||||||||||
Amount of gain (loss) recognized in income on derivative (ineffective portion) | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||
The gain (loss) is recognized in income within foreign exchange gains (losses). | |||||||||||||||||||||||||
The following table provides the total impact on other comprehensive income and earnings relating to the derivative instruments formally designated as cash flow hedges along with the impact of the related hedged items for the three and nine months ended September 30, 2013: | |||||||||||||||||||||||||
Interest rate swap contracts | Three Months Ended September 30, 2013 | Three Months Ended September 30, 2012 | Nine Months Ended September 30, 2013 | Nine Months Ended September 30, 2012 | |||||||||||||||||||||
Amount of effective portion recognized in other comprehensive income | $ | 3,268 | $ | 195 | $ | 7,838 | $ | 195 | |||||||||||||||||
Amount of effective portion subsequently reclassified to earnings | $ | (3,268 | ) | $ | (195 | ) | $ | (7,838 | ) | $ | (195 | ) | |||||||||||||
Amount of ineffective portion excluded from effectiveness testing | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||
The above balances relate to interest paid and have been classified as finance expenses in the consolidated statements of comprehensive income. There was no interest rate swap contract activity for the three and nine months ended September 30, 2012 |
Reserve_for_losses_and_loss_ex1
Reserve for losses and loss expenses (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | ' | |||||||||||||||
Reserve for losses and loss expenses | ' | |||||||||||||||
The following table represents an analysis of paid and unpaid losses and loss expenses incurred and a reconciliation of the beginning and ending unpaid losses and loss expenses for the three and nine months ended September 30, 2013 and 2012: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Reserve for losses and loss expenses, beginning of period | $ | 3,283,450 | $ | 2,591,299 | $ | 3,517,573 | $ | 2,631,143 | ||||||||
Losses and loss expenses recoverable | (418,693 | ) | (371,484 | ) | (439,967 | ) | (372,485 | ) | ||||||||
Net reserves for losses and loss expenses, beginning of period | 2,864,757 | 2,219,815 | 3,077,606 | 2,258,658 | ||||||||||||
Net reserves acquired | — | — | 948 | — | ||||||||||||
Increase (decrease) in net losses and loss expenses incurred in respect of losses occurring in: | ||||||||||||||||
Current year | 243,015 | 205,219 | 759,617 | 658,884 | ||||||||||||
Prior years | (65,050 | ) | (49,764 | ) | (171,837 | ) | (117,748 | ) | ||||||||
Total incurred losses and loss expenses | 177,965 | 155,455 | 587,780 | 541,136 | ||||||||||||
Total net paid losses | (274,868 | ) | (144,628 | ) | (847,192 | ) | (569,380 | ) | ||||||||
Foreign exchange | 34,363 | 14,710 | (16,925 | ) | 14,938 | |||||||||||
Net reserve for losses and loss expenses, end of period | 2,802,217 | 2,245,352 | 2,802,217 | 2,245,352 | ||||||||||||
Losses and loss expenses recoverable | 421,518 | 317,252 | 421,518 | 317,252 | ||||||||||||
Reserve for losses and loss expenses, end of period | $ | 3,223,735 | $ | 2,562,604 | $ | 3,223,735 | $ | 2,562,604 | ||||||||
Reinsurance_Tables
Reinsurance (Tables) | 9 Months Ended | |||||||||||||
Sep. 30, 2013 | ||||||||||||||
Reinsurance Disclosures [Abstract] | ' | |||||||||||||
Reinsurance recoverables by reinsurer | ' | |||||||||||||
Reinsurance recoverables by reinsurer are as follows: | ||||||||||||||
September 30, 2013 | December 31, 2012 | |||||||||||||
Reinsurance Recoverable | % of Total | Reinsurance Recoverable | % of Total | |||||||||||
Top 10 reinsurers | $ | 340,988 | 75.5 | % | $ | 360,234 | 74.1 | % | ||||||
Other reinsurers’ balances > $1 million | 102,714 | 22.7 | % | 115,262 | 23.7 | % | ||||||||
Other reinsurers’ balances < $1 million | 7,890 | 1.8 | % | 10,906 | 2.2 | % | ||||||||
Total | $ | 451,592 | 100 | % | $ | 486,402 | 100 | % | ||||||
September 30, 2013 | ||||||||||||||
Top 10 Reinsurers | Rating | Reinsurance Recoverable | % of Total | |||||||||||
Lloyd's Syndicates | A+ | $ | 74,586 | 21.9 | % | |||||||||
Everest Re | A+ | 52,372 | 15.3 | % | ||||||||||
National Indemnity | AA+ | 50,984 | 14.9 | % | ||||||||||
Hannover Re | AA- | 45,975 | 13.5 | % | ||||||||||
Fully Collateralized | NR | 34,293 | 10.1 | % | ||||||||||
Swiss Re | AA- | 20,728 | 6.1 | % | ||||||||||
Third Point Reinsurance Ltd | A- | 20,049 | 5.9 | % | ||||||||||
Transatlantic Re | A+ | 15,887 | 4.7 | % | ||||||||||
XL Re | A | 14,062 | 4.1 | % | ||||||||||
Munich Re | AA- | 12,052 | 3.5 | % | ||||||||||
Total | $ | 340,988 | 100 | % | ||||||||||
December 31, 2012 | ||||||||||||||
Top 10 Reinsurers | Rating | Reinsurance Recoverable | % of Total | |||||||||||
Lloyd’s Syndicates | A+ | $ | 71,469 | 19.9 | % | |||||||||
National Indemnity | AA+ | 59,941 | 16.6 | % | ||||||||||
Everest Re | A+ | 51,340 | 14.3 | % | ||||||||||
Fully Collateralized | NR | 47,445 | 13.2 | % | ||||||||||
Hannover Re | AA- | 40,552 | 11.3 | % | ||||||||||
Munich Re | AA- | 20,954 | 5.8 | % | ||||||||||
Transatlantic Re | A+ | 20,320 | 5.6 | % | ||||||||||
Swiss Re | AA- | 16,992 | 4.7 | % | ||||||||||
Allianz | AA- | 16,367 | 4.5 | % | ||||||||||
XL Re | A | 14,854 | 4.1 | % | ||||||||||
Total | $ | 360,234 | 100 | % | ||||||||||
NR: Not rated |
Share_capital_Tables
Share capital (Tables) | 9 Months Ended | ||
Sep. 30, 2013 | |||
Stockholders' Equity Note [Abstract] | ' | ||
Summary of common shares issued and outstanding | ' | ||
The following table is a summary of the common shares issued and outstanding: | |||
Common Shares | |||
Common shares issued, December 31, 2012 | 152,698,191 | ||
Restricted share awards vested, net of shares withheld | 768,889 | ||
Restricted share units vested, net of shares withheld | 14,381 | ||
Options exercised | 277,615 | ||
Warrants exercised | 591,480 | ||
Direct issuance of common stock | 928 | ||
Performance share awards vested, net of shares withheld | 31,897 | ||
Deferred share units vested, net of shares withheld | 2,935 | ||
Common shares issued, September 30, 2013 | 154,386,316 | ||
Shares repurchased, September 30, 2013 | (54,488,320 | ) | |
Common shares outstanding, September 30, 2013 | 99,897,996 | ||
Common Shares | |||
Common shares issued, December 31, 2011 | 134,503,065 | ||
Restricted share awards vested, net of shares withheld | 1,545,024 | ||
Restricted share units vested, net of shares withheld | 15,173 | ||
Options exercised | 439,065 | ||
Warrants exercised | 130,121 | ||
Common shares issued, September 30, 2012 | 136,632,448 | ||
Shares repurchased, September 30, 2012 | (43,138,057 | ) | |
Common shares outstanding, September 30, 2012 | 93,494,391 | ||
Stock_plans_Tables
Stock plans (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||||||
Options, activity during the period | ' | |||||||||||||||
Activity with respect to options for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Options | Weighted Average Grant Date Fair Value | Weighted Average Grant Date Exercise Price | ||||||||||||||
Options outstanding, December 31, 2012 | 1,823,947 | $ | 6.52 | $ | 20.69 | |||||||||||
Options regranted (modified) | 1,833,414 | 6.76 | 19.02 | |||||||||||||
Options exercised | (277,615 | ) | 5.24 | 23.58 | ||||||||||||
Options cancelled (modified) | (1,733,139 | ) | 6.76 | 20.12 | ||||||||||||
Options outstanding, September 30, 2013 | 1,646,607 | $ | 6.75 | $ | 18.94 | |||||||||||
Options exercisable, September 30, 2013 | 1,646,607 | $ | 6.75 | $ | 18.94 | |||||||||||
Activity with respect to options for the nine months ended September 30, 2012 was as follows: | ||||||||||||||||
Options | Weighted Average Grant Date Fair Value | Weighted Average Grant Date Exercise Price | ||||||||||||||
Options outstanding, December 31, 2011 | 2,263,012 | $ | 6.69 | $ | 20.12 | |||||||||||
Options exercised | (439,065 | ) | 7.44 | 17.73 | ||||||||||||
Options outstanding, September 30, 2012 | 1,823,947 | $ | 6.52 | $ | 20.69 | |||||||||||
Options exercisable, September 30, 2012 | 1,823,947 | $ | 6.52 | $ | 20.69 | |||||||||||
Restricted shares awards, activity during the period | ' | |||||||||||||||
Activity with respect to unvested restricted share awards for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Restricted Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share awards outstanding, December 31, 2012 | 2,170,547 | $ | 29.24 | |||||||||||||
Restricted share awards granted | 1,580,117 | 36.06 | ||||||||||||||
Restricted share awards vested | (930,296 | ) | 28.08 | |||||||||||||
Restricted share awards forfeited | (110,912 | ) | 28.34 | |||||||||||||
Restricted share awards outstanding, September 30, 2013 | 2,709,456 | $ | 33.65 | |||||||||||||
Activity with respect to unvested restricted share awards for the nine months ended September 30, 2012 was as follows: | ||||||||||||||||
Restricted Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share awards outstanding, December 31, 2011 | 3,003,547 | $ | 25.77 | |||||||||||||
Restricted share awards granted | 901,506 | 31.38 | ||||||||||||||
Restricted share awards vested | (1,678,905 | ) | 24.36 | |||||||||||||
Restricted share awards forfeited | (30,801 | ) | 28.1 | |||||||||||||
Restricted share awards outstanding, September 30, 2012 | 2,195,347 | $ | 29.12 | |||||||||||||
Restricted share units, activity during the period | ' | |||||||||||||||
Activity with respect to unvested restricted share units for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Restricted Share Units | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share units outstanding, December 31, 2012 | 47,238 | $ | 29.61 | |||||||||||||
Restricted share units granted | 36,635 | 36.11 | ||||||||||||||
Restricted share units vested | (21,814 | ) | 28.17 | |||||||||||||
Restricted share units issued in lieu of cash dividends | 3,924 | 30.29 | ||||||||||||||
Restricted share units outstanding, September 30, 2013 | 65,983 | $ | 33.74 | |||||||||||||
Activity with respect to unvested restricted share units for the nine months ended September 30, 2012 was as follows: | ||||||||||||||||
Restricted Share Units | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share units outstanding, December 31, 2011 | 53,312 | $ | 27.6 | |||||||||||||
Restricted share units granted | 16,633 | 31.77 | ||||||||||||||
Restricted share units vested | (22,818 | ) | 26.49 | |||||||||||||
Restricted share units issued in lieu of cash dividends | 1,162 | 28.36 | ||||||||||||||
Restricted share units forfeited | (1,393 | ) | 28.57 | |||||||||||||
Restricted share units outstanding, September 30, 2012 | 46,896 | $ | 29.61 | |||||||||||||
Performance share awards, activity during the period | ' | |||||||||||||||
Activity with respect to unvested performance share awards for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Performance Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Performance share awards outstanding, December 31, 2012 | 220,845 | $ | 31.81 | |||||||||||||
Performance share awards granted | 38,386 | 36.11 | ||||||||||||||
Performance share awards vested | (39,094 | ) | 28.7 | |||||||||||||
Performance share awards forfeited | (18,701 | ) | 31.05 | |||||||||||||
Performance share awards conversion adjustment | (99,616 | ) | $ | 33.05 | ||||||||||||
Performance share awards outstanding, September 30, 2013 | 101,820 | $ | 33.56 | |||||||||||||
Activity with respect to unvested performance share awards for the nine months ended September 30, 2012 was as follows: | ||||||||||||||||
Performance Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Performance share awards outstanding, December 31, 2011 | 279,019 | $ | 30.77 | |||||||||||||
Performance share awards granted | 41,128 | 31.38 | ||||||||||||||
Performance share awards forfeited | (99,302 | ) | 28.7 | |||||||||||||
Performance share awards outstanding, September 30, 2012 | 220,845 | $ | 31.81 | |||||||||||||
Total share compensation expenses | ' | |||||||||||||||
The breakdown of share compensation expenses by award type was as follows: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Options | $ | — | $ | — | $ | — | $ | 142 | ||||||||
Restricted share awards | 10,041 | 6,626 | 20,035 | 18,742 | ||||||||||||
Restricted share units | 168 | 132 | 419 | 363 | ||||||||||||
Performance share awards | 318 | 587 | (971 | ) | 336 | |||||||||||
Total | $ | 10,527 | $ | 7,345 | $ | 19,483 | $ | 19,583 | ||||||||
Debt_and_financing_arrangement1
Debt and financing arrangements (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Debt Disclosure [Abstract] | ' | |||||||||||||||
Schedule of financing structure | ' | |||||||||||||||
The financing structure at September 30, 2013 was: | ||||||||||||||||
Commitment | Outstanding (a) | Drawn | ||||||||||||||
2006 Junior Subordinated Deferrable Debentures | $ | 150,000 | $ | 150,000 | $ | 150,000 | ||||||||||
2007 Junior Subordinated Deferrable Debentures | 200,000 | 139,800 | 139,800 | |||||||||||||
2010 Senior Notes due 2040 | 250,000 | 250,000 | 247,171 | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | 400,000 | — | — | |||||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 371,990 | — | |||||||||||||
$200,000 bi-lateral secured letter of credit facility | 200,000 | 77,626 | — | |||||||||||||
Talbot FAL Facility (b) | 25,000 | 25,000 | — | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 258 | — | |||||||||||||
IPC bi-lateral facility | 40,000 | 26,019 | — | |||||||||||||
$375,000 Flagstone bi-lateral facility | 375,000 | 297,996 | — | |||||||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | 137,577 | 137,577 | 137,577 | |||||||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 113,750 | 113,750 | 113,750 | |||||||||||||
Total | $ | 2,426,327 | $ | 1,590,016 | $ | 788,298 | ||||||||||
The financing structure at December 31, 2012 was: | ||||||||||||||||
Commitment | Outstanding (a) | Drawn | ||||||||||||||
2006 Junior Subordinated Deferrable Debentures | $ | 150,000 | $ | 150,000 | $ | 150,000 | ||||||||||
2007 Junior Subordinated Deferrable Debentures | 200,000 | 139,800 | 139,800 | |||||||||||||
2010 Senior Notes due 2040 | 250,000 | 250,000 | 247,090 | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | 400,000 | — | — | |||||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 376,570 | — | |||||||||||||
$500,000 secured letter of credit facility | 500,000 | 92,402 | — | |||||||||||||
Talbot FAL Facility (b) | 25,000 | 25,000 | — | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 219 | — | |||||||||||||
IPC bi-lateral facility | 80,000 | 40,613 | — | |||||||||||||
$550,000 Flagstone bi-lateral facility | 550,000 | 381,019 | — | |||||||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | 137,159 | 137,159 | 137,159 | |||||||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 113,750 | 113,750 | 113,750 | |||||||||||||
Total | $ | 2,940,909 | $ | 1,706,532 | $ | 787,799 | ||||||||||
(a) | Indicates utilization of commitment amount, not drawn borrowings. | |||||||||||||||
(b) | Talbot operates in the Lloyd’s market ("Lloyds") through a corporate member, Talbot 2002 Underwriting Capital Ltd (“T02”), which is the sole participant in Syndicate 1183. Lloyd’s sets T02’s required capital annually based on Syndicate 1183’s business plan, rating environment, reserving environment together with input arising from Lloyd’s discussions with, inter alia, regulatory and rating agencies. Such capital, called Funds at Lloyd’s (“FAL”), comprises: cash, investments and undrawn letters of credit provided by various banks. | |||||||||||||||
Components of finance expenses | ' | |||||||||||||||
Finance expenses consist of interest on our junior subordinated deferrable debentures, senior notes, variable funding notes, the amortization of debt offering costs, fees relating to our credit facilities, bank charges and the costs of FAL as follows: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
2006 Junior Subordinated Deferrable Debentures | $ | 2,235 | $ | 1,628 | $ | 6,633 | $ | 4,729 | ||||||||
2007 Junior Subordinated Deferrable Debentures | 1,848 | 1,211 | 5,492 | 7,072 | ||||||||||||
2010 Senior Notes due 2040 | 5,597 | 5,597 | 16,792 | 16,792 | ||||||||||||
Variable Funding Notes (a) | 11,893 | — | 44,562 | — | ||||||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | 2,285 | — | 5,988 | — | ||||||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 1,807 | — | 4,426 | — | ||||||||||||
Credit facilities | 1,248 | 948 | 5,001 | 10,530 | ||||||||||||
Bank charges | 187 | (52 | ) | 419 | 131 | |||||||||||
Talbot FAL Facility | 32 | 30 | 95 | 93 | ||||||||||||
Total | $ | 27,132 | $ | 9,362 | $ | 89,408 | $ | 39,347 | ||||||||
(a) | Includes variable funding note expense and other AlphaCat related fees. Refer to Note 13: "Variable funding notes" for further details. | |||||||||||||||
Future expected payments of principal | ' | |||||||||||||||
Future expected payments of principal on the 2006 and 2007 Junior Subordinated Deferrable Debentures and Flagstone 2006 and 2007 Junior Subordinated Deferrable Debentures are as follows: | ||||||||||||||||
2013 | $ | — | ||||||||||||||
2014 | — | |||||||||||||||
2015 | — | |||||||||||||||
2016 | — | |||||||||||||||
2017 and thereafter | 540,709 | |||||||||||||||
Total minimum future payments | $ | 540,709 | ||||||||||||||
Future expected payments of principal on the 2010 Senior Notes are as follows: | ||||||||||||||||
2013 | $ | — | ||||||||||||||
2014 | — | |||||||||||||||
2015 | — | |||||||||||||||
2016 | — | |||||||||||||||
2017 and thereafter | 250,000 | |||||||||||||||
Total minimum future payments | $ | 250,000 | ||||||||||||||
Variable_funding_notes_Tables
Variable funding notes (Tables) | 9 Months Ended | |||
Sep. 30, 2013 | ||||
Variable Funding Notes Disclosure [Abstract] | ' | |||
Summary of variable funding notes | ' | |||
The following table presents a summary of the VFNs on the balance sheet as at September 30, 2013: | ||||
September 30, | ||||
2013 | ||||
AlphaCat 2013 | $ | 214,639 | ||
AlphaCat ILS funds | 223,331 | |||
Total | $ | 437,970 | ||
Accumulated_Other_Comprehensiv1
Accumulated Other Comprehensive Income (Loss) (Tables) | 9 Months Ended | |||
Sep. 30, 2013 | ||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | |||
Schedule of changes in accumulated other comprehensive income | ' | |||
The changes in accumulated other comprehensive income ("AOCI"), by component for the three and nine months ended September 30, 2013 are as follows: | ||||
Three Months Ended | ||||
30-Sep-13 | ||||
Foreign currency translation adjustments | ||||
Beginning Balance - June 30, 2013 | (8,262 | ) | ||
Amounts reclassified to retained earnings | — | |||
Current period foreign currency translation adjustments | 4,390 | |||
Ending balance - September 30, 2013 | (3,872 | ) | ||
Nine Months Ended | ||||
30-Sep-13 | ||||
Foreign currency translation adjustments | ||||
Beginning Balance - December 31, 2012 | (2,953 | ) | ||
Amounts reclassified to retained earnings | 4,290 | |||
Current period foreign currency translation adjustments | (5,209 | ) | ||
Ending balance - September 30, 2013 | (3,872 | ) |
Earnings_per_share_Tables
Earnings per share (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Earnings Per Share [Abstract] | ' | |||||||||||||||
Computation of basic and diluted earnings per share | ' | |||||||||||||||
The following table sets forth the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2013 and 2012: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Basic earnings per share | ||||||||||||||||
Net income | $ | 229,063 | $ | 264,044 | $ | 419,503 | $ | 510,540 | ||||||||
Loss attributable to noncontrolling interest | (45,694 | ) | (56,746 | ) | 17,831 | (11,386 | ) | |||||||||
Net income available to Validus | 183,369 | 207,298 | 437,334 | 499,154 | ||||||||||||
Less: Dividends and distributions declared on outstanding warrants | (1,552 | ) | (1,663 | ) | (17,662 | ) | (5,121 | ) | ||||||||
Net income available to common shareholders | $ | 181,817 | $ | 205,635 | $ | 419,672 | $ | 494,033 | ||||||||
Weighted average number of common shares outstanding | 99,834,563 | 93,368,775 | 103,451,396 | 97,016,034 | ||||||||||||
Basic earnings per share available to common shareholders | $ | 1.82 | $ | 2.2 | $ | 4.06 | $ | 5.09 | ||||||||
Diluted earnings per share | ||||||||||||||||
Net income | $ | 229,063 | $ | 264,044 | $ | 419,503 | $ | 510,540 | ||||||||
(Income) loss attributable to noncontrolling interest | (45,694 | ) | (56,746 | ) | 17,831 | (11,386 | ) | |||||||||
Net income available to Validus | 183,369 | 207,298 | 437,334 | 499,154 | ||||||||||||
Less: Dividends and distributions declared on outstanding warrants | — | — | (17,662 | ) | — | |||||||||||
Net income available to common shareholders | $ | 183,369 | $ | 207,298 | $ | 419,672 | $ | 499,154 | ||||||||
Weighted average number of common shares outstanding | 99,834,563 | 93,368,775 | 103,451,396 | 97,016,034 | ||||||||||||
Share equivalents: | ||||||||||||||||
Warrants | 2,606,669 | 3,248,788 | — | 3,116,298 | ||||||||||||
Stock options | 782,158 | 716,693 | 1,090,298 | 777,245 | ||||||||||||
Unvested restricted shares | 390,376 | 902,234 | 723,219 | 1,423,938 | ||||||||||||
Weighted average number of diluted common shares outstanding | 103,613,766 | 98,236,490 | 105,264,913 | 102,333,515 | ||||||||||||
Diluted earnings per share available to common shareholders | $ | 1.77 | $ | 2.11 | $ | 3.99 | $ | 4.88 | ||||||||
Segment_information_Tables
Segment information (Tables) | 9 Months Ended | ||||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||||||||||||
Summary of results of operating segments and corporate | ' | ||||||||||||||||||||||
The following tables summarize the results of our operating segments and "Corporate": | |||||||||||||||||||||||
Three Months Ended September 30, 2013 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 130,925 | $ | 3,481 | $ | 246,468 | $ | (24,114 | ) | $ | 356,760 | ||||||||||||
Reinsurance premiums ceded | (13,006 | ) | (525 | ) | (49,998 | ) | 24,114 | (39,415 | ) | ||||||||||||||
Net premiums written | 117,919 | 2,956 | 196,470 | — | 317,345 | ||||||||||||||||||
Change in unearned premiums | 157,873 | 34,210 | 21,860 | — | 213,943 | ||||||||||||||||||
Net premiums earned | 275,792 | 37,166 | 218,330 | — | 531,288 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 62,250 | 15,615 | 100,100 | — | 177,965 | ||||||||||||||||||
Policy acquisition costs | 47,662 | 3,787 | 44,899 | (1,448 | ) | 94,900 | |||||||||||||||||
General and administrative expenses | 19,785 | 5,728 | 37,402 | 18,174 | 81,089 | ||||||||||||||||||
Share compensation expenses | 2,479 | 152 | 2,992 | 4,904 | 10,527 | ||||||||||||||||||
Total underwriting deductions | 132,176 | 25,282 | 185,393 | 21,630 | 364,481 | ||||||||||||||||||
Underwriting income (loss) | $ | 143,616 | $ | 11,884 | $ | 32,937 | $ | (21,630 | ) | $ | 166,807 | ||||||||||||
Net investment income | 15,628 | 967 | 4,395 | (981 | ) | 20,009 | |||||||||||||||||
Other (loss) income | (1,892 | ) | 3,791 | 73 | (4,778 | ) | (2,806 | ) | |||||||||||||||
Finance expenses | (3,640 | ) | (11,895 | ) | (107 | ) | (11,490 | ) | (27,132 | ) | |||||||||||||
Operating income (loss) before taxes and income from operating affiliates | 153,712 | 4,747 | 37,298 | (38,879 | ) | 156,878 | |||||||||||||||||
Tax benefit (expense) | 143 | — | (513 | ) | 365 | (5 | ) | ||||||||||||||||
Income from operating affiliates | — | 1,463 | — | — | 1,463 | ||||||||||||||||||
Net operating income (loss) | $ | 153,855 | $ | 6,210 | $ | 36,785 | $ | (38,514 | ) | $ | 158,336 | ||||||||||||
Net realized (losses) gains on investments | (10,137 | ) | 4,084 | (267 | ) | — | (6,320 | ) | |||||||||||||||
Net unrealized gains on investments | 23,144 | 44,145 | 2,678 | — | 69,967 | ||||||||||||||||||
Income from investment affiliate | 1,044 | — | — | — | 1,044 | ||||||||||||||||||
Foreign exchange gains (losses) | 2,168 | 388 | 4,238 | (758 | ) | 6,036 | |||||||||||||||||
Net income (loss) | $ | 170,074 | $ | 54,827 | $ | 43,434 | $ | (39,272 | ) | $ | 229,063 | ||||||||||||
Net loss attributable to noncontrolling interest | — | (45,694 | ) | — | — | (45,694 | ) | ||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 170,074 | $ | 9,133 | $ | 43,434 | $ | (39,272 | ) | $ | 183,369 | ||||||||||||
Selected ratios: | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 90.1 | % | 84.9 | % | 79.7 | % | 89 | % | |||||||||||||||
Losses and loss expenses (a) | 22.6 | % | 42 | % | 45.8 | % | 33.5 | % | |||||||||||||||
Policy acquisition costs (a) | 17.3 | % | 10.2 | % | 20.6 | % | 17.9 | % | |||||||||||||||
General and administrative expenses (a) (b) | 8.1 | % | 15.8 | % | 18.5 | % | 17.2 | % | |||||||||||||||
Expense ratio (a) | 25.4 | % | 26 | % | 39.1 | % | 35.1 | % | |||||||||||||||
Combined ratio (a) | 48 | % | 68 | % | 84.9 | % | 68.6 | % | |||||||||||||||
Total assets | $ | 5,854,354 | $ | 1,446,941 | $ | 2,892,477 | $ | 123,596 | $ | 10,317,368 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
Three Months Ended September 30, 2012 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 145,010 | $ | 2,934 | $ | 260,755 | $ | (18,484 | ) | $ | 390,215 | ||||||||||||
Reinsurance premiums ceded | (10,426 | ) | — | (53,801 | ) | 18,484 | (45,743 | ) | |||||||||||||||
Net premiums written | 134,584 | 2,934 | 206,954 | — | 344,472 | ||||||||||||||||||
Change in unearned premiums | 107,728 | 2,591 | 20,313 | — | 130,632 | ||||||||||||||||||
Net premiums earned | 242,312 | 5,525 | 227,267 | — | 475,104 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 66,890 | — | 88,565 | — | 155,455 | ||||||||||||||||||
Policy acquisition costs | 37,785 | 547 | 61,640 | (1,349 | ) | 98,623 | |||||||||||||||||
General and administrative expenses | 16,938 | 2,087 | 36,605 | 14,917 | 70,547 | ||||||||||||||||||
Share compensation expenses | 2,076 | 84 | 2,200 | 2,985 | 7,345 | ||||||||||||||||||
Total underwriting deductions | 123,689 | 2,718 | 189,010 | 16,553 | 331,970 | ||||||||||||||||||
Underwriting income (loss) | $ | 118,623 | $ | 2,807 | $ | 38,257 | $ | (16,553 | ) | $ | 143,134 | ||||||||||||
Net investment income | 19,644 | 1,193 | 5,260 | (608 | ) | 25,489 | |||||||||||||||||
Other income | 1,543 | 7,674 | 680 | (2,573 | ) | 7,324 | |||||||||||||||||
Finance expenses | (789 | ) | (56 | ) | (73 | ) | (8,444 | ) | (9,362 | ) | |||||||||||||
Operating income (loss) before taxes and income from operating affiliates | 139,021 | 11,618 | 44,124 | (28,178 | ) | 166,585 | |||||||||||||||||
Tax expense | (2 | ) | — | (11 | ) | (1,330 | ) | (1,343 | ) | ||||||||||||||
Income from operating affiliates | — | 6,235 | — | — | 6,235 | ||||||||||||||||||
Net operating income (loss) | $ | 139,019 | $ | 17,853 | $ | 44,113 | $ | (29,508 | ) | $ | 171,477 | ||||||||||||
Net realized gains on investments | 6,643 | 300 | 2,120 | — | 9,063 | ||||||||||||||||||
Net unrealized on investments | 19,232 | 62,432 | 4,681 | — | 86,345 | ||||||||||||||||||
(Loss) from investment affiliate | (160 | ) | — | — | — | (160 | ) | ||||||||||||||||
Foreign exchange gains (losses) | 8 | 30 | 1,146 | (81 | ) | 1,103 | |||||||||||||||||
Transaction expenses (c) | — | — | — | (3,784 | ) | (3,784 | ) | ||||||||||||||||
Net income (loss) | $ | 164,742 | $ | 80,615 | $ | 52,060 | $ | (33,373 | ) | $ | 264,044 | ||||||||||||
Net loss attributable to noncontrolling interest | — | (56,746 | ) | — | — | (56,746 | ) | ||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 164,742 | $ | 23,869 | $ | 52,060 | $ | (33,373 | ) | $ | 207,298 | ||||||||||||
Selected ratios: | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 92.8 | % | 100 | % | 79.4 | % | 88.3 | % | |||||||||||||||
Losses and loss expenses (a) | 27.6 | % | 0 | % | 39 | % | 32.7 | % | |||||||||||||||
Policy acquisition costs (a) | 15.6 | % | 9.9 | % | 27.1 | % | 20.8 | % | |||||||||||||||
General and administrative expenses (a) (b) | 7.8 | % | 39.3 | % | 17.1 | % | 16.4 | % | |||||||||||||||
Expense ratio (a) | 23.4 | % | 49.2 | % | 44.2 | % | 37.2 | % | |||||||||||||||
Combined ratio (a) | 51 | % | 49.2 | % | 83.2 | % | 69.9 | % | |||||||||||||||
Total assets | $ | 4,729,344 | $ | 768,612 | $ | 2,931,174 | $ | 34,690 | $ | 8,463,820 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
(c) | The transaction expenses relate to costs incurred in connection with the acquisition of Flagstone Reinsurance Holdings, S.A. | ||||||||||||||||||||||
Nine Months Ended September 30, 2013 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 1,232,272 | $ | 146,757 | $ | 855,516 | $ | (70,712 | ) | $ | 2,163,833 | ||||||||||||
Reinsurance premiums ceded | (226,292 | ) | (525 | ) | (191,922 | ) | 70,712 | (348,027 | ) | ||||||||||||||
Net premiums written | 1,005,980 | 146,232 | 663,594 | — | 1,815,806 | ||||||||||||||||||
Change in unearned premiums | (122,303 | ) | (46,459 | ) | (37,237 | ) | — | (205,999 | ) | ||||||||||||||
Net premiums earned | 883,677 | 99,773 | 626,357 | — | 1,609,807 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 319,298 | 16,928 | 251,554 | — | 587,780 | ||||||||||||||||||
Policy acquisition costs | 142,195 | 10,011 | 127,092 | (3,635 | ) | 275,663 | |||||||||||||||||
General and administrative expenses | 69,649 | 13,757 | 100,506 | 48,423 | 232,335 | ||||||||||||||||||
Share compensation expenses | 5,421 | 314 | 6,754 | 6,994 | 19,483 | ||||||||||||||||||
Total underwriting deductions | 536,563 | 41,010 | 485,906 | 51,782 | 1,115,261 | ||||||||||||||||||
Underwriting income (loss) | $ | 347,114 | $ | 58,763 | $ | 140,451 | $ | (51,782 | ) | $ | 494,546 | ||||||||||||
Net investment income | 61,770 | 2,821 | 13,496 | (6,219 | ) | 71,868 | |||||||||||||||||
Other income (loss) | 11,237 | 17,439 | 564 | (24,943 | ) | 4,297 | |||||||||||||||||
Finance expenses | (12,133 | ) | (46,429 | ) | (256 | ) | (30,590 | ) | (89,408 | ) | |||||||||||||
Operating income (loss) before taxes and income from operating affiliates | 407,988 | 32,594 | 154,255 | (113,534 | ) | 481,303 | |||||||||||||||||
Tax benefit (expense) | 1,755 | — | (1,184 | ) | (351 | ) | 220 | ||||||||||||||||
Income from operating affiliates | — | 8,779 | — | — | 8,779 | ||||||||||||||||||
Net operating income (loss) | $ | 409,743 | $ | 41,373 | $ | 153,071 | $ | (113,885 | ) | $ | 490,302 | ||||||||||||
Net realized (losses) gains on investments | (5,790 | ) | 4,084 | 516 | — | (1,190 | ) | ||||||||||||||||
Net unrealized (losses) on investments | (36,883 | ) | (31,029 | ) | (10,706 | ) | — | (78,618 | ) | ||||||||||||||
Income from investment affiliate | 4,274 | — | — | — | 4,274 | ||||||||||||||||||
Foreign exchange gains (losses) | 7,448 | (663 | ) | (1,877 | ) | (173 | ) | 4,735 | |||||||||||||||
Net income (loss) | $ | 378,792 | $ | 13,765 | $ | 141,004 | $ | (114,058 | ) | $ | 419,503 | ||||||||||||
Net loss attributable to noncontrolling interest | — | 17,831 | — | — | 17,831 | ||||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 378,792 | $ | 31,596 | $ | 141,004 | $ | (114,058 | ) | $ | 437,334 | ||||||||||||
Selected ratios: | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 81.6 | % | 99.6 | % | 77.6 | % | 83.9 | % | |||||||||||||||
Losses and loss expenses (a) | 36.1 | % | 17 | % | 40.2 | % | 36.5 | % | |||||||||||||||
Policy acquisition costs (a) | 16.1 | % | 10 | % | 20.3 | % | 17.2 | % | |||||||||||||||
General and administrative expenses (a) (b) | 8.5 | % | 14.1 | % | 17.1 | % | 15.6 | % | |||||||||||||||
Expense ratio (a) | 24.6 | % | 24.1 | % | 37.4 | % | 32.8 | % | |||||||||||||||
Combined ratio (a) | 60.7 | % | 41.1 | % | 77.6 | % | 69.3 | % | |||||||||||||||
Total assets | $ | 5,854,354 | $ | 1,446,941 | $ | 2,892,477 | $ | 123,596 | $ | 10,317,368 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
Nine Months Ended September 30, 2012 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 1,052,726 | $ | 21,607 | $ | 837,536 | $ | (57,276 | ) | $ | 1,854,593 | ||||||||||||
Reinsurance premiums ceded | (137,504 | ) | — | (191,619 | ) | 57,276 | (271,847 | ) | |||||||||||||||
Net premiums written | 915,222 | 21,607 | 645,917 | — | 1,582,746 | ||||||||||||||||||
Change in unearned premiums | (177,215 | ) | (9,832 | ) | (21,769 | ) | — | (208,816 | ) | ||||||||||||||
Net premiums earned | 738,007 | 11,775 | 624,148 | — | 1,373,930 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 244,286 | — | 296,850 | — | 541,136 | ||||||||||||||||||
Policy acquisition costs | 113,659 | 1,185 | 142,181 | (4,141 | ) | 252,884 | |||||||||||||||||
General and administrative expenses | 48,332 | 5,521 | 100,910 | 43,794 | 198,557 | ||||||||||||||||||
Share compensation expenses | 5,914 | 195 | 5,347 | 8,127 | 19,583 | ||||||||||||||||||
Total underwriting deductions | 412,191 | 6,901 | 545,288 | 47,780 | 1,012,160 | ||||||||||||||||||
Underwriting income (loss) | $ | 325,816 | $ | 4,874 | $ | 78,860 | $ | (47,780 | ) | $ | 361,770 | ||||||||||||
Net investment income | 64,915 | 2,672 | 16,475 | (4,928 | ) | 79,134 | |||||||||||||||||
Other income | 4,229 | 22,237 | 2,033 | (6,290 | ) | 22,209 | |||||||||||||||||
Finance expenses | (6,628 | ) | (495 | ) | (224 | ) | (32,000 | ) | (39,347 | ) | |||||||||||||
Operating income (loss) before taxes and income from operating affiliates | 388,332 | 29,288 | 97,144 | (90,998 | ) | 423,766 | |||||||||||||||||
Tax (expense) benefit | (11 | ) | — | (562 | ) | (1,313 | ) | (1,886 | ) | ||||||||||||||
Income from operating affiliates | — | 13,194 | — | — | 13,194 | ||||||||||||||||||
Net operating income (loss) | $ | 388,321 | $ | 42,482 | $ | 96,582 | $ | (92,311 | ) | $ | 435,074 | ||||||||||||
Net realized gains on investments | 17,708 | 216 | 4,825 | — | 22,749 | ||||||||||||||||||
Net unrealized gains on investments | 35,400 | 12,316 | 5,726 | — | 53,442 | ||||||||||||||||||
(Loss) from investment affiliate | (558 | ) | — | — | — | (558 | ) | ||||||||||||||||
Foreign exchange gains (losses) | 2,461 | 47 | 1,334 | (225 | ) | 3,617 | |||||||||||||||||
Transaction expenses (c) | — | — | — | (3,784 | ) | (3,784 | ) | ||||||||||||||||
Net income (loss) | $ | 443,332 | $ | 55,061 | $ | 108,467 | $ | (96,320 | ) | $ | 510,540 | ||||||||||||
Net loss attributable to noncontrolling interest | — | (11,386 | ) | — | — | (11,386 | ) | ||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 443,332 | $ | 43,675 | $ | 108,467 | $ | (96,320 | ) | $ | 499,154 | ||||||||||||
Selected ratios: | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 86.9 | % | 100 | % | 77.1 | % | 85.3 | % | |||||||||||||||
Losses and loss expenses (a) | 33.1 | % | 0 | % | 47.6 | % | 39.4 | % | |||||||||||||||
Policy acquisition costs (a) | 15.4 | % | 10.1 | % | 22.8 | % | 18.4 | % | |||||||||||||||
General and administrative expenses (a) (b) | 7.4 | % | 48.5 | % | 17 | % | 15.9 | % | |||||||||||||||
Expense ratio (a) | 22.8 | % | 58.6 | % | 39.8 | % | 34.3 | % | |||||||||||||||
Combined ratio (a) | 55.9 | % | 58.6 | % | 87.4 | % | 73.7 | % | |||||||||||||||
Total assets | $ | 4,729,344 | $ | 768,612 | $ | 2,931,174 | $ | 34,690 | $ | 8,463,820 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
(c) | The transaction expenses relate to costs incurred in connection with the acquisition of Flagstone Reinsurance Holdings, S.A. | ||||||||||||||||||||||
Gross premiums written allocated to the territory of coverage exposure | ' | ||||||||||||||||||||||
The following tables set forth the gross premiums written allocated to the territory of coverage exposure for the periods indicated: | |||||||||||||||||||||||
Three Months Ended September 30, 2013 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 39,618 | $ | 2,546 | $ | 21,573 | $ | (2,105 | ) | $ | 61,632 | 17.3 | % | ||||||||||
Worldwide excluding United States (a) | 16,973 | — | 34,751 | (4,138 | ) | 47,586 | 13.3 | % | |||||||||||||||
Australia and New Zealand | (9,482 | ) | 33 | 2,905 | (236 | ) | (6,780 | ) | (1.9 | )% | |||||||||||||
Europe | 4,252 | 377 | 9,778 | (986 | ) | 13,421 | 3.8 | % | |||||||||||||||
Latin America and Caribbean | 5,902 | — | 38,084 | (3,353 | ) | 40,633 | 11.4 | % | |||||||||||||||
Japan | (2,637 | ) | — | 1,066 | (117 | ) | (1,688 | ) | (0.5 | )% | |||||||||||||
Canada | 1,469 | 500 | 2,749 | (740 | ) | 3,978 | 1.1 | % | |||||||||||||||
Rest of the world (b) | 5,641 | — | 22,167 | (1,830 | ) | 25,978 | 7.3 | % | |||||||||||||||
Sub-total, non United States | 22,118 | 910 | 111,500 | (11,400 | ) | 123,128 | 34.5 | % | |||||||||||||||
Worldwide including United States (a) | 29,611 | 25 | 18,246 | (1,665 | ) | 46,217 | 13 | % | |||||||||||||||
Other location non-specific (c) | 39,578 | — | 95,149 | (8,944 | ) | 125,783 | 35.3 | % | |||||||||||||||
Total | $ | 130,925 | $ | 3,481 | $ | 246,468 | $ | (24,114 | ) | $ | 356,760 | 100 | % | ||||||||||
Three Months Ended September 30, 2012 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 53,138 | $ | 2,211 | $ | 21,004 | $ | (1,482 | ) | $ | 74,871 | 19.2 | % | ||||||||||
Worldwide excluding United States (a) | 7,085 | — | 28,113 | (2,029 | ) | 33,169 | 8.5 | % | |||||||||||||||
Australia and New Zealand | 4,887 | 217 | 5,356 | (369 | ) | 10,091 | 2.6 | % | |||||||||||||||
Europe | 10,251 | 512 | 10,426 | (748 | ) | 20,441 | 5.2 | % | |||||||||||||||
Latin America and Caribbean | 3,299 | — | 36,735 | (2,621 | ) | 37,413 | 9.6 | % | |||||||||||||||
Japan | 781 | — | 1,916 | (136 | ) | 2,561 | 0.7 | % | |||||||||||||||
Canada | 260 | — | 3,696 | (258 | ) | 3,698 | 0.9 | % | |||||||||||||||
Rest of the world (b) | 6,303 | — | 30,572 | (2,133 | ) | 34,742 | 8.9 | % | |||||||||||||||
Sub-total, non United States | 32,866 | 729 | 116,814 | (8,294 | ) | 142,115 | 36.4 | % | |||||||||||||||
Worldwide including United States (a) | 17,375 | (6 | ) | 17,571 | (1,238 | ) | 33,702 | 8.6 | % | ||||||||||||||
Other location non-specific (c) | 41,631 | — | 105,366 | (7,470 | ) | 139,527 | 35.8 | % | |||||||||||||||
Total | $ | 145,010 | $ | 2,934 | $ | 260,755 | $ | (18,484 | ) | $ | 390,215 | 100 | % | ||||||||||
(a) | Represents risks in two or more geographic zones. | ||||||||||||||||||||||
(b) | Represents risks in one geographic zone. | ||||||||||||||||||||||
(c) | The Other location non-specific category refers to business for which an analysis of exposure by geographic zone is not applicable such as marine and aerospace risks and can span multiple geographic areas and are not fixed locations in some instances. | ||||||||||||||||||||||
Nine Months Ended September 30, 2013 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 470,745 | $ | 50,935 | $ | 77,630 | $ | (10,599 | ) | $ | 588,711 | 27.2 | % | ||||||||||
Worldwide excluding United States (a) | 69,482 | 14,801 | 109,562 | (9,065 | ) | 184,780 | 8.4 | % | |||||||||||||||
Australia and New Zealand | 21,116 | 2,216 | 7,930 | (467 | ) | 30,795 | 1.4 | % | |||||||||||||||
Europe | 64,986 | 2,514 | 41,523 | (3,892 | ) | 105,131 | 4.9 | % | |||||||||||||||
Latin America and Caribbean | 5,885 | — | 124,120 | (7,312 | ) | 122,693 | 5.7 | % | |||||||||||||||
Japan | 41,939 | 653 | 5,258 | (963 | ) | 46,887 | 2.2 | % | |||||||||||||||
Canada | 4,503 | 818 | 8,790 | (1,336 | ) | 12,775 | 0.6 | % | |||||||||||||||
Rest of the world (b) | 29,211 | — | 62,803 | (3,700 | ) | 88,314 | 4.1 | % | |||||||||||||||
Sub-total, non United States | 237,122 | 21,002 | 359,986 | (26,735 | ) | 591,375 | 27.3 | % | |||||||||||||||
Worldwide including United States (a) | 180,621 | 74,820 | 63,998 | (10,214 | ) | 309,225 | 14.3 | % | |||||||||||||||
Other location non-specific (c) | 343,784 | — | 353,902 | (23,164 | ) | 674,522 | 31.2 | % | |||||||||||||||
Total | $ | 1,232,272 | $ | 146,757 | $ | 855,516 | $ | (70,712 | ) | $ | 2,163,833 | 100 | % | ||||||||||
Nine Months Ended September 30, 2012 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 347,492 | $ | 12,643 | $ | 62,812 | $ | (4,764 | ) | $ | 418,183 | 22.5 | % | ||||||||||
Worldwide excluding United States (a) | 51,289 | 278 | 115,836 | (10,681 | ) | 156,722 | 8.5 | % | |||||||||||||||
Australia and New Zealand | 37,474 | 217 | 9,798 | (721 | ) | 46,768 | 2.5 | % | |||||||||||||||
Europe | 67,206 | 1,332 | 39,871 | (2,703 | ) | 105,706 | 5.7 | % | |||||||||||||||
Latin America and Caribbean | 8,456 | — | 112,329 | (7,634 | ) | 113,151 | 6.1 | % | |||||||||||||||
Japan | 31,597 | — | 6,003 | (407 | ) | 37,193 | 2 | % | |||||||||||||||
Canada | 2,753 | — | 9,366 | (634 | ) | 11,485 | 0.6 | % | |||||||||||||||
Rest of the world (b) | 23,857 | — | 74,036 | (2,133 | ) | 95,760 | 5.2 | % | |||||||||||||||
Sub-total, non United States | 222,632 | 1,827 | 367,239 | (24,913 | ) | 566,785 | 30.6 | % | |||||||||||||||
Worldwide including United States (a) | 166,550 | 7,137 | 50,737 | (3,440 | ) | 220,984 | 11.9 | % | |||||||||||||||
Other location non-specific (c) | 316,052 | — | 356,748 | (24,159 | ) | 648,641 | 35 | % | |||||||||||||||
Total | $ | 1,052,726 | $ | 21,607 | $ | 837,536 | $ | (57,276 | ) | $ | 1,854,593 | 100 | % | ||||||||||
(a) | Represents risks in two or more geographic zones. | ||||||||||||||||||||||
(b) | Represents risks in one geographic zone. | ||||||||||||||||||||||
(c) | The Other location non-specific category refers to business for which an analysis of exposure by geographic zone is not applicable such as marine and aerospace risks and can span multiple geographic areas and are not fixed locations in some instances. |
Basis_of_preparation_and_conso1
Basis of preparation and consolidation Basis of preparation and consolidation (Details) (Flagstone Reinsurance Holdings Sa [Member], USD $) | 0 Months Ended |
Nov. 30, 2012 | |
Flagstone Reinsurance Holdings Sa [Member] | ' |
Business Acquisition [Line Items] | ' |
Exchange ratio (in shares) | 0.1935 |
Per share price paid by Company to acquire FSR common shares | $2 |
Investments_Gross_unrealized_g
Investments (Gross unrealized gains and losses on fixed maturities) (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 | |
In Thousands, unless otherwise specified | |||
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Fixed maturities, at amortized cost | $5,415,864 | $5,008,514 | |
Short-term investments, at amortized cost | 761,631 | 1,112,929 | |
Other investments, at cost | 606,485 | 583,068 | |
Amortized cost | 6,783,980 | 6,704,511 | |
Noncontrolling interest, cost or amortized cost | -527,850 | -450,000 | [1] |
Total investments excluding non-controlling interest, cost or amortized cost | 6,256,130 | 6,254,511 | |
Fixed maturities, gross unrealized gains | 42,661 | 80,530 | |
Short term investments, gross unrealized gains | 12 | 1,349 | |
Other investments, gross unrealized gains | 51,248 | 24,222 | |
Gross unrealized gains | 93,921 | 106,101 | |
Noncontrolling interest share of unrealized gains other investments | -40,887 | -19,427 | [1] |
Total investments excluding non-controlling interest, unrealized gains | 53,034 | 86,674 | |
Fixed maturities, gross unrealized losses | -20,260 | -3,710 | |
Short term investments, gross unrealized losses | -1 | -28 | |
Other investments, gross unrealized losses | -98,261 | -42,842 | |
Gross unrealized losses | -118,522 | -46,580 | |
Noncontrolling interest share of unrealized losses | 87,535 | 36,690 | [1] |
Total investments excluding non-controlling interest, unrealized losses | -30,987 | -9,890 | |
Total fixed maturities | 5,438,265 | 5,085,334 | |
Short-term investments | 761,642 | 1,114,250 | |
Other investments | 559,472 | 564,448 | |
Total | 6,759,379 | 6,764,032 | |
Noncontrolling interest | -481,202 | -432,737 | [1] |
Total investments excluding noncontrolling interest | 6,278,177 | 6,331,295 | |
U.S. government and government agency | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Fixed maturities, at amortized cost | 1,319,499 | 1,091,357 | |
Fixed maturities, gross unrealized gains | 4,313 | 7,957 | |
Fixed maturities, gross unrealized losses | -3,329 | -84 | |
Total fixed maturities | 1,320,483 | 1,099,230 | |
Non-U.S. government and government agency | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Fixed maturities, at amortized cost | 401,149 | 295,602 | |
Fixed maturities, gross unrealized gains | 4,028 | 6,904 | |
Fixed maturities, gross unrealized losses | -1,180 | -227 | |
Total fixed maturities | 403,997 | 302,279 | |
U.S. states, municipalities and political subdivisions | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Fixed maturities, at amortized cost | 43,912 | 41,286 | |
Fixed maturities, gross unrealized gains | 440 | 800 | |
Fixed maturities, gross unrealized losses | -423 | -23 | |
Total fixed maturities | 43,929 | 42,063 | |
Agency residential mortgage-backed securities | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Fixed maturities, at amortized cost | 313,177 | 375,368 | |
Fixed maturities, gross unrealized gains | 8,384 | 13,708 | |
Fixed maturities, gross unrealized losses | -1,360 | -202 | |
Total fixed maturities | 320,201 | 388,874 | |
Non-agency residential mortgage-backed securities | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Fixed maturities, at amortized cost | 24,029 | 106,536 | |
Fixed maturities, gross unrealized gains | 164 | 1,266 | |
Fixed maturities, gross unrealized losses | -1,062 | -1,346 | |
Total fixed maturities | 23,131 | 106,456 | |
U.S. corporate | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Fixed maturities, at amortized cost | 1,363,418 | 1,189,173 | |
Fixed maturities, gross unrealized gains | 10,616 | 21,681 | |
Fixed maturities, gross unrealized losses | -6,889 | -681 | |
Total fixed maturities | 1,367,145 | 1,210,173 | |
Non-U.S. corporate | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Fixed maturities, at amortized cost | 686,656 | 582,115 | |
Fixed maturities, gross unrealized gains | 5,658 | 11,373 | |
Fixed maturities, gross unrealized losses | -3,264 | -223 | |
Total fixed maturities | 689,050 | 593,265 | |
Bank loans | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Fixed maturities, at amortized cost | 732,922 | 663,217 | |
Fixed maturities, gross unrealized gains | 5,421 | 10,593 | |
Fixed maturities, gross unrealized losses | -1,885 | -427 | |
Total fixed maturities | 736,458 | 673,383 | |
Catastrophe bonds | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Fixed maturities, at amortized cost | 56,504 | 56,757 | |
Fixed maturities, gross unrealized gains | 2,358 | 481 | |
Fixed maturities, gross unrealized losses | 0 | -291 | |
Total fixed maturities | 58,862 | 56,947 | |
Asset-backed securities | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Fixed maturities, at amortized cost | 474,598 | 607,103 | |
Fixed maturities, gross unrealized gains | 1,279 | 5,767 | |
Fixed maturities, gross unrealized losses | -868 | -206 | |
Total fixed maturities | 475,009 | 612,664 | |
Fund of hedge funds | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Other investments, at cost | 3,274 | 4,677 | |
Other investments, gross unrealized gains | 97 | 299 | |
Other investments, gross unrealized losses | -921 | -219 | |
Other investments | 2,450 | 4,757 | |
Private equity investments | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Other investments, at cost | 12,493 | 12,857 | |
Other investments, gross unrealized gains | 2,259 | 94 | |
Other investments, gross unrealized losses | -79 | 0 | |
Other investments | 14,673 | 12,951 | |
Hedge funds | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Other investments, at cost | 584,519 | 559,335 | [1] |
Other investments, gross unrealized gains | 46,087 | 21,814 | [1] |
Other investments, gross unrealized losses | -97,261 | -42,623 | [1] |
Other investments | 533,345 | 538,526 | [1] |
Mutual funds | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Other investments, at cost | 6,199 | 6,199 | |
Other investments, gross unrealized gains | 2,805 | 2,015 | |
Other investments, gross unrealized losses | 0 | 0 | |
Other investments | $9,004 | $8,214 | |
PaCRe funds | ' | ' | |
Amortized cost, gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | |
Noncontrolling Interest, Ownership Percentage by Parent | 10.00% | 10.00% | |
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 90.00% | 90.00% | |
[1] | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. |
Investments_Fixed_maturities_b
Investments (Fixed maturities by investment rating) (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Fixed Maturities | ' | ' |
Estimated fair value | $5,438,265 | $5,085,334 |
Percentage of total | 100.00% | 100.00% |
Investment Grade | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 4,652,753 | 4,349,532 |
Percentage of total | 85.60% | 85.50% |
AAA | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 776,896 | 1,062,794 |
Percentage of total | 14.30% | 20.90% |
AA | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 2,256,592 | 1,862,322 |
Percentage of total | 41.50% | 36.60% |
A | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 1,196,037 | 1,049,969 |
Percentage of total | 22.00% | 20.60% |
BBB | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 423,228 | 374,447 |
Percentage of total | 7.80% | 7.40% |
Non Investment Grade | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 785,512 | 735,802 |
Percentage of total | 14.40% | 14.50% |
BB | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 356,205 | 373,907 |
Percentage of total | 6.50% | 7.40% |
B | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 397,888 | 330,416 |
Percentage of total | 7.30% | 6.50% |
CCC | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 4,754 | 4,483 |
Percentage of total | 0.10% | 0.10% |
CC | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 2,821 | 3,259 |
Percentage of total | 0.10% | 0.10% |
D/NR | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | $23,844 | $23,737 |
Percentage of total | 0.40% | 0.40% |
Investments_Maturity_profile_o
Investments (Maturity profile of fixed maturity investments) (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Maturity profile | ' | ' |
Amortized cost | $5,415,864 | $5,008,514 |
Estimated fair value | 5,438,265 | 5,085,334 |
Fixed maturities trading securities allocated to contractual maturity | ' | ' |
Maturity profile | ' | ' |
Amortized cost | 4,604,060 | 3,919,507 |
Estimated fair value | 4,619,924 | 3,977,340 |
Due in one year or less | Fixed maturities trading securities allocated to contractual maturity | ' | ' |
Maturity profile | ' | ' |
Amortized cost | 745,812 | 526,529 |
Estimated fair value | 750,992 | 530,499 |
Due after one year through five years | Fixed maturities trading securities allocated to contractual maturity | ' | ' |
Maturity profile | ' | ' |
Amortized cost | 3,492,605 | 2,971,118 |
Estimated fair value | 3,504,812 | 3,018,544 |
Due after five years through ten years | Fixed maturities trading securities allocated to contractual maturity | ' | ' |
Maturity profile | ' | ' |
Amortized cost | 362,563 | 418,377 |
Estimated fair value | 361,011 | 424,304 |
Due after ten years | Fixed maturities trading securities allocated to contractual maturity | ' | ' |
Maturity profile | ' | ' |
Amortized cost | 3,080 | 3,483 |
Estimated fair value | 3,109 | 3,993 |
Asset backed and mortgaged backed securities | No single maturity date | ' | ' |
Maturity profile | ' | ' |
Amortized cost | 811,804 | 1,089,007 |
Estimated fair value | $818,341 | $1,107,994 |
Investments_Components_of_net_
Investments (Components of net investment income) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Net investment income | ' | ' | ' | ' |
Total gross investment income | $22,018 | $27,476 | $77,862 | $84,995 |
Investment expenses | -2,009 | -1,987 | -5,994 | -5,861 |
Net investment income | 20,009 | 25,489 | 71,868 | 79,134 |
Fixed maturities and short term investments | ' | ' | ' | ' |
Net investment income | ' | ' | ' | ' |
Total gross investment income | 20,936 | 25,703 | 74,618 | 79,450 |
Cash and cash equivalents | ' | ' | ' | ' |
Net investment income | ' | ' | ' | ' |
Total gross investment income | 1,079 | 1,770 | 3,241 | 5,536 |
Securities lending income | ' | ' | ' | ' |
Net investment income | ' | ' | ' | ' |
Total gross investment income | $3 | $3 | $3 | $9 |
Investments_Realized_and_unrea
Investments (Realized and unrealized gains) (Details) (USD $) | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | ||||||||||||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | ||||
PaCRe funds | PaCRe funds | Securities lending | Securities lending | Securities lending | Securities lending | Investments excluding securities lending | Investments excluding securities lending | Investments excluding securities lending | Investments excluding securities lending | |||||||||
Schedule of Trading Securities and Other Trading Assets [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Noncontrolling Interest, Ownership Percentage by Parent | ' | ' | ' | ' | 10.00% | 10.00% | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Fixed maturities, short-term and other investments and cash equivalents | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Gross realized gains | $7,706 | $10,187 | $25,578 | $29,610 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Gross realized (losses) | -14,026 | -1,124 | -26,768 | -6,861 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Net realized gains on investments | -6,320 | 9,063 | -1,190 | 22,749 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Change in net unrealized gains (losses) on investments | 69,967 | 86,345 | -78,618 | 53,442 | ' | ' | 0 | 223 | 0 | 260 | 69,967 | 86,122 | -78,618 | 53,182 | ||||
Total net realized gains and change in net unrealized gains (losses) on investments | 63,647 | 95,408 | -79,808 | 76,191 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Noncontrolling interest | -42,578 | [1] | -55,806 | [1] | 25,767 | [1] | -10,924 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total net realized gains and change in net unrealized gains (losses) on investments excluding noncontrolling interest | $21,069 | $39,602 | ($54,041) | $65,267 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | ' | ' | ' | ' | 90.00% | 90.00% | ' | ' | ' | ' | ' | ' | ' | ' | ||||
[1] | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. |
Investments_Investments_pledge
Investments (Investments pledged as collateral) (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 | ||
In Thousands, unless otherwise specified | ||||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' | ||
Credit facility, commitment | $1,575,000 | $2,090,000 | ||
Letters of credit issued and outstanding | 798,889 | 915,823 | ||
Investments pledged as collateral | 1,210,026 | 1,199,580 | ||
$400,000 syndicated unsecured letter of credit facility | ' | ' | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' | ||
Credit facility, commitment | 400,000 | 400,000 | ||
Letters of credit issued and outstanding | 0 | 0 | ||
Investments pledged as collateral | 0 | 0 | ||
$525,000 syndicated secured letter of credit facility | ' | ' | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' | ||
Credit facility, commitment | 525,000 | 525,000 | ||
Letters of credit issued and outstanding | 371,990 | 376,570 | ||
Investments pledged as collateral | 491,761 | 517,210 | ||
Bi-lateral secured facility | ' | ' | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' | ||
Credit facility, commitment | 200,000 | 500,000 | ||
Letters of credit issued and outstanding | 77,626 | 92,402 | ||
Investments pledged as collateral | 129,768 | 125,991 | ||
Talbot FAL Facility | ' | ' | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' | ||
Credit facility, commitment | 25,000 | [1] | 25,000 | [1] |
Letters of credit issued and outstanding | 25,000 | 25,000 | ||
Investments pledged as collateral | 36,996 | 41,372 | ||
PaCRe Senior secured letter of credit facility | ' | ' | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' | ||
Credit facility, commitment | 10,000 | 10,000 | ||
Letters of credit issued and outstanding | 258 | 219 | ||
Investments pledged as collateral | 0 | 0 | ||
IPC Bi Lateral Facility | ' | ' | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' | ||
Credit facility, commitment | 40,000 | [2] | 80,000 | [2] |
Letters of credit issued and outstanding | 26,019 | 40,613 | ||
Investments pledged as collateral | 98,260 | 98,593 | ||
Flagstone BiLateral Facility | ' | ' | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' | ||
Credit facility, commitment | 375,000 | 550,000 | ||
Letters of credit issued and outstanding | 297,996 | 381,019 | ||
Investments pledged as collateral | $453,241 | $416,414 | ||
[1] | Talbot operates in the Lloyd’s market ("Lloyds") through a corporate member, Talbot 2002 Underwriting Capital Ltd (“T02â€), which is the sole participant in Syndicate 1183. Lloyd’s sets T02’s required capital annually based on Syndicate 1183’s business plan, rating environment, reserving environment together with input arising from Lloyd’s discussions with, inter alia, regulatory and rating agencies. Such capital, called Funds at Lloyd’s (“FALâ€), comprises: cash, investments and undrawn letters of credit provided by various banks. | |||
[2] | Indicates utilization of commitment amount, not drawn borrowings. |
Fair_value_measurements_Fair_v
Fair value measurements (Fair value hierarchy) (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 | ||
In Thousands, unless otherwise specified | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | $5,438,265 | $5,085,334 | ||
Short-term investments, at fair value | 761,642 | 1,114,250 | ||
Other investments, at fair value | 559,472 | 564,448 | ||
Total | 6,759,379 | 6,764,032 | ||
Noncontrolling interest | -481,202 | -432,737 | [1] | |
Total investments excluding noncontrolling interest | 6,278,177 | 6,331,295 | ||
U.S. government and government agency | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 1,320,483 | 1,099,230 | ||
Non-US government and government agency | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 403,997 | 302,279 | ||
States, municipalities, political subdivision | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 43,929 | 42,063 | ||
Agency residential mortgage-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 320,201 | 388,874 | ||
Non-Agency residential mortgage-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 23,131 | 106,456 | ||
U.S. corporate | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 1,367,145 | 1,210,173 | ||
Non-U.S. corporate | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 689,050 | 593,265 | ||
Bank loans | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 736,458 | 673,383 | ||
Catastrophe bonds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 58,862 | 56,947 | ||
Asset-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 475,009 | 612,664 | ||
Fund of hedge funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 2,450 | 4,757 | ||
Private equity investments | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 14,673 | 12,951 | ||
Hedge funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 533,345 | 538,526 | [1] | |
Mutual funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 9,004 | 8,214 | ||
PaCRe funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Noncontrolling Interest, Ownership Percentage by Parent | 10.00% | 10.00% | ||
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 90.00% | 90.00% | ||
Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 5,438,265 | 5,085,334 | ||
Short-term investments, at fair value | 761,642 | 1,114,250 | ||
Other investments, at fair value | 559,472 | 564,448 | ||
Total | 6,759,379 | 6,764,032 | ||
Noncontrolling interest | -481,202 | [1] | -432,737 | [1] |
Total investments excluding noncontrolling interest | 6,278,177 | 6,331,295 | ||
Fair Value, Measurements, Recurring [Member] | U.S. government and government agency | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 1,320,483 | 1,099,230 | ||
Fair Value, Measurements, Recurring [Member] | Non-US government and government agency | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 403,997 | 302,279 | ||
Fair Value, Measurements, Recurring [Member] | States, municipalities, political subdivision | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 43,929 | 42,063 | ||
Fair Value, Measurements, Recurring [Member] | Agency residential mortgage-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 320,201 | 388,874 | ||
Fair Value, Measurements, Recurring [Member] | Non-Agency residential mortgage-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 23,131 | 106,456 | ||
Fair Value, Measurements, Recurring [Member] | U.S. corporate | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 1,367,145 | 1,210,173 | ||
Fair Value, Measurements, Recurring [Member] | Non-U.S. corporate | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 689,050 | 593,265 | ||
Fair Value, Measurements, Recurring [Member] | Bank loans | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 736,458 | 673,383 | ||
Fair Value, Measurements, Recurring [Member] | Catastrophe bonds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 58,862 | 56,947 | ||
Fair Value, Measurements, Recurring [Member] | Asset-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 475,009 | 612,664 | ||
Fair Value, Measurements, Recurring [Member] | Fund of hedge funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 2,450 | 4,757 | ||
Fair Value, Measurements, Recurring [Member] | Private equity investments | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 14,673 | 12,951 | ||
Fair Value, Measurements, Recurring [Member] | Hedge funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 533,345 | [1] | 538,526 | [1] |
Fair Value, Measurements, Recurring [Member] | Mutual funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 9,004 | 8,214 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Short-term investments, at fair value | 755,747 | 1,063,175 | ||
Other investments, at fair value | 0 | 0 | ||
Total | 755,747 | 1,063,175 | ||
Noncontrolling interest | -15,730 | [1] | 0 | [1] |
Total investments excluding noncontrolling interest | 740,017 | 1,063,175 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | U.S. government and government agency | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | Non-US government and government agency | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | States, municipalities, political subdivision | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | Agency residential mortgage-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | Non-Agency residential mortgage-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | U.S. corporate | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | Non-U.S. corporate | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | Bank loans | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | Catastrophe bonds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | Asset-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | Fund of hedge funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | Private equity investments | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 1 | Hedge funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 0 | [1] | 0 | [1] |
Fair Value, Measurements, Recurring [Member] | Level 1 | Mutual funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 5,438,265 | 5,085,334 | ||
Short-term investments, at fair value | 5,895 | 51,075 | ||
Other investments, at fair value | 9,004 | 8,214 | ||
Total | 5,453,164 | 5,144,623 | ||
Noncontrolling interest | 0 | [1] | 0 | [1] |
Total investments excluding noncontrolling interest | 5,453,164 | 5,144,623 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | U.S. government and government agency | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 1,320,483 | 1,099,230 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | Non-US government and government agency | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 403,997 | 302,279 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | States, municipalities, political subdivision | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 43,929 | 42,063 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | Agency residential mortgage-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 320,201 | 388,874 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | Non-Agency residential mortgage-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 23,131 | 106,456 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | U.S. corporate | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 1,367,145 | 1,210,173 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | Non-U.S. corporate | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 689,050 | 593,265 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | Bank loans | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 736,458 | 673,383 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | Catastrophe bonds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 58,862 | 56,947 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | Asset-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 475,009 | 612,664 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | Fund of hedge funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | Private equity investments | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 2 | Hedge funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 0 | [1] | 0 | [1] |
Fair Value, Measurements, Recurring [Member] | Level 2 | Mutual funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 9,004 | 8,214 | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Short-term investments, at fair value | 0 | 0 | ||
Other investments, at fair value | 550,468 | 556,234 | ||
Total | 550,468 | 556,234 | ||
Noncontrolling interest | -465,472 | [1] | -432,737 | [1] |
Total investments excluding noncontrolling interest | 84,996 | 123,497 | ||
Percentage Of Fair Value Assets Measured On Recurring Basis | 1.40% | 2.00% | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | U.S. government and government agency | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | Non-US government and government agency | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | States, municipalities, political subdivision | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | Agency residential mortgage-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | Non-Agency residential mortgage-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | U.S. corporate | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | Non-U.S. corporate | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | Bank loans | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | Catastrophe bonds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | Asset-backed securities | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Fixed maturities, at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | Fund of hedge funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 2,450 | 4,757 | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | Private equity investments | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 14,673 | 12,951 | ||
Fair Value, Measurements, Recurring [Member] | Level 3 | Hedge funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | 533,345 | [1] | 538,526 | [1] |
Fair Value, Measurements, Recurring [Member] | Level 3 | Mutual funds | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Other investments, at fair value | $0 | $0 | ||
[1] | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. |
Fair_value_measurements_Level_
Fair value measurements (Level 3 rollforward) (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Dec. 31, 2012 | |||||||||
In Thousands, unless otherwise specified | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Level 3 | Level 3 | Level 3 | Level 3 | Level 3 | Level 3 | PaCRe funds | PaCRe funds | |||||||||||
Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | ||||||||||||||||
Other Investments | Other Investments | Other Investments | Other Investments | ||||||||||||||||||
Reconciliation of beginning and ending balances for all investments measured at fair value on recurring basis | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Noncontrolling Interest, Ownership Percentage by Parent | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10.00% | 10.00% | |||||||||
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 90.00% | 90.00% | |||||||||
Level 3 investments - beginning of period | ' | ' | ' | ' | ' | ' | $505,158 | $454,793 | $556,234 | $8,880 | ' | ' | |||||||||
Purchases | ' | ' | ' | ' | ' | ' | 33,154 | 0 | 98,669 | 500,000 | ' | ' | |||||||||
Sales | ' | ' | ' | ' | ' | ' | -35,264 | -218 | -80,095 | -1,115 | ' | ' | |||||||||
Realized gains | ' | ' | ' | ' | ' | ' | 4,503 | 13 | 4,843 | 61 | ' | ' | |||||||||
Unrealized losses | ' | ' | ' | ' | ' | ' | 42,917 | 61,746 | -29,183 | 11,762 | ' | ' | |||||||||
Transfers | ' | ' | ' | ' | ' | ' | 0 | 921 | 0 | -2,333 | ' | ' | |||||||||
Level 3 investments - end of period | ' | ' | ' | ' | ' | ' | 550,468 | 517,255 | 550,468 | 517,255 | ' | ' | |||||||||
Noncontrolling interest | -481,202 | -432,737 | [1] | -481,202 | [1] | -432,737 | [1] | -465,472 | [1] | -432,737 | [1] | -465,472 | [1] | -460,924 | [1] | -465,472 | [1] | -460,924 | [1] | ' | ' |
Investments excluding noncontrolling interest level three rollforward | ' | ' | ' | ' | ' | ' | $84,996 | $56,331 | $84,996 | $56,331 | ' | ' | |||||||||
[1] | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. |
Fair_value_measurements_Narrat
Fair value measurements (Narrative) (Details) (USD $) | 9 Months Ended | |||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Dec. 31, 2012 | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | $559,472 | $564,448 | ||
Mutual Funds [Member] | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 9,004 | 8,214 | ||
Other Investments Number Of Funds | 2 | ' | ||
Hedge funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 533,345 | 538,526 | [1] | |
Fund of hedge funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 2,450 | 4,757 | ||
Investment Time Lag Reporting | '1 month | ' | ||
Investments Assumed In Flagstone Acquisition [Member] | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Investment Time Lag Reporting | '1 month | ' | ||
Other Investments Number Of Funds | 2 | ' | ||
PaCRe funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Investment Time Lag Reporting | '1 month | ' | ||
Other Investments Number Of Funds | 4 | ' | ||
Private equity investments | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 14,673 | 12,951 | ||
Other Investments Number Of Funds | 3 | ' | ||
Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 559,472 | 564,448 | ||
Fair Value, Measurements, Recurring [Member] | Mutual Funds [Member] | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 9,004 | 8,214 | ||
Fair Value, Measurements, Recurring [Member] | Hedge funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 533,345 | [1] | 538,526 | [1] |
Fair Value, Measurements, Recurring [Member] | Fund of hedge funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 2,450 | 4,757 | ||
Fair Value, Measurements, Recurring [Member] | Private equity investments | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | $14,673 | $12,951 | ||
[1] | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors. |
Investments_in_affiliates_Oper
Investments in affiliates (Operating affiliates rollforward) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Activity in non-consolidated affiliate balances for the period: | ' | ' | ' | ' |
Balance, beginning of period | $85,120 | $86,490 | $157,111 | $53,031 |
Return of investment | -7,350 | ' | -86,657 | ' |
Purchase of shares | ' | ' | ' | 26,500 |
Income from operating affiliates | 1,463 | 6,235 | 8,779 | 13,194 |
Balance, end of period | 79,233 | 92,725 | 79,233 | 92,725 |
AlphaCat Re 2011 Ltd | ' | ' | ' | ' |
Activity in non-consolidated affiliate balances for the period: | ' | ' | ' | ' |
Balance, beginning of period | 11,054 | 59,238 | 62,792 | 53,031 |
Return of investment | -2,800 | ' | -54,914 | ' |
Purchase of shares | ' | ' | ' | 0 |
Income from operating affiliates | -270 | 4,079 | 106 | 10,286 |
Balance, end of period | 7,984 | 63,317 | 7,984 | 63,317 |
AlphaCat Re 2012 Ltd | ' | ' | ' | ' |
Activity in non-consolidated affiliate balances for the period: | ' | ' | ' | ' |
Balance, beginning of period | 5,204 | 27,252 | 29,319 | 0 |
Return of investment | -4,550 | ' | -31,743 | ' |
Purchase of shares | ' | ' | ' | 26,500 |
Income from operating affiliates | -7 | 2,156 | 3,071 | 2,908 |
Balance, end of period | 647 | 29,408 | 647 | 29,408 |
AlphaCat 2013 Ltd | ' | ' | ' | ' |
Activity in non-consolidated affiliate balances for the period: | ' | ' | ' | ' |
Balance, beginning of period | 48,536 | ' | 45,000 | ' |
Return of investment | 0 | ' | 0 | ' |
Income from operating affiliates | 585 | ' | 4,121 | ' |
Balance, end of period | 49,121 | ' | 49,121 | ' |
AlphaCat ILS Funds | ' | ' | ' | ' |
Activity in non-consolidated affiliate balances for the period: | ' | ' | ' | ' |
Balance, beginning of period | 20,326 | ' | 20,000 | ' |
Return of investment | 0 | ' | 0 | ' |
Income from operating affiliates | 1,155 | ' | 1,481 | ' |
Balance, end of period | $21,481 | ' | $21,481 | ' |
Investments_in_affiliates_Oper1
Investments in affiliates (Operating affiliates - other details) (Details) (USD $) | Sep. 30, 2013 | Jun. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Dec. 31, 2011 |
In Thousands, unless otherwise specified | ||||||
Investment: | ' | ' | ' | ' | ' | ' |
Investment at cost | $73,906 | ' | $132,889 | ' | ' | ' |
Carrying value | 79,233 | 85,120 | 157,111 | 92,725 | 86,490 | 53,031 |
AlphaCat Re 2011 Ltd | ' | ' | ' | ' | ' | ' |
Investment: | ' | ' | ' | ' | ' | ' |
Investment at cost | 8,254 | ' | 41,389 | ' | ' | ' |
Voting ownership % | 43.70% | ' | 43.70% | ' | ' | ' |
Equity ownership % | 22.30% | ' | 22.30% | ' | ' | ' |
Carrying value | 7,984 | 11,054 | 62,792 | 63,317 | 59,238 | 53,031 |
AlphaCat Re 2012 Ltd | ' | ' | ' | ' | ' | ' |
Investment: | ' | ' | ' | ' | ' | ' |
Investment at cost | 652 | ' | 26,500 | ' | ' | ' |
Voting ownership % | 49.00% | ' | 49.00% | ' | ' | ' |
Equity ownership % | 37.90% | ' | 37.90% | ' | ' | ' |
Carrying value | 647 | 5,204 | 29,319 | 29,408 | 27,252 | 0 |
AlphaCat 2013 Ltd | ' | ' | ' | ' | ' | ' |
Investment: | ' | ' | ' | ' | ' | ' |
Investment at cost | 45,000 | ' | 45,000 | ' | ' | ' |
Voting ownership % | 40.90% | ' | 40.90% | ' | ' | ' |
Equity ownership % | 19.70% | ' | 19.70% | ' | ' | ' |
Carrying value | 49,121 | 48,536 | 45,000 | ' | ' | ' |
AlphaCat ILS Funds | ' | ' | ' | ' | ' | ' |
Investment: | ' | ' | ' | ' | ' | ' |
Investment at cost | 20,000 | ' | 20,000 | ' | ' | ' |
Voting ownership % | 0.00% | ' | 0.00% | ' | ' | ' |
Equity ownership % | 9.10% | ' | 11.80% | ' | ' | ' |
Carrying value | $21,481 | $20,326 | $20,000 | ' | ' | ' |
Investments_in_affiliates_Inve
Investments in affiliates (Investment affiliate) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | ||||
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ||||
Income (loss) from investment affiliate | $1,044 | ($160) | $4,274 | ($558) | ||||
Aquiline Financial Services Fund LP | ' | ' | ' | ' | ||||
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ||||
Investment in limited partnership (Aquiline Financial Services Fund II L.P.), beginning of period | 25,352 | 6,317 | 15,218 | 3,253 | ||||
Capital contributions | 6,185 | 430 | 13,089 | 5,328 | ||||
Net unrealized (loss) on investments | 0 | [1] | 0 | [1] | 0 | [1] | -1,436 | [1] |
Income (loss) from investment affiliate | 1,044 | -160 | 4,274 | -558 | ||||
Investment in limited partnership (Aquiline Financial Services Fund II L.P.), end of period | 32,581 | 6,587 | 32,581 | 6,587 | ||||
Investment in Aquiline - other details | ' | ' | ' | ' | ||||
Investment at cost | 30,707 | ' | 30,707 | ' | ||||
Equity ownership % | 6.59% | ' | 6.59% | ' | ||||
Carrying value | $32,581 | $6,587 | $32,581 | $6,587 | ||||
[1] | (a)Until March 31, 2012, this investment was included in " Other investments" as a level 3 investment in the fair value hierarchy, hence the change in fair value was included in net unrealized (losses) gains on investments. |
Investments_in_affiliates_Text
Investments in affiliates (Text) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Jun. 30, 2013 | Dec. 31, 2012 | Jun. 30, 2012 | Dec. 31, 2011 |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' |
Income from operating affiliates | $1,463 | $6,235 | $8,779 | $13,194 | ' | ' | ' | ' |
Carrying value | 79,233 | 92,725 | 79,233 | 92,725 | 85,120 | 157,111 | 86,490 | 53,031 |
AlphaCat Re 2011 Ltd | ' | ' | ' | ' | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' |
Equity Method Investment Voting Percentage | 43.70% | ' | 43.70% | ' | ' | 43.70% | ' | ' |
Ownership percentage required for consolidation | ' | ' | 50.00% | ' | ' | ' | ' | ' |
Equity ownership % | 22.30% | ' | 22.30% | ' | ' | 22.30% | ' | ' |
Income from operating affiliates | -270 | 4,079 | 106 | 10,286 | ' | ' | ' | ' |
Carrying value | 7,984 | 63,317 | 7,984 | 63,317 | 11,054 | 62,792 | 59,238 | 53,031 |
AlphaCat Re 2012 Ltd | ' | ' | ' | ' | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' |
Equity Method Investment Voting Percentage | 49.00% | ' | 49.00% | ' | ' | 49.00% | ' | ' |
Equity ownership % | 37.90% | ' | 37.90% | ' | ' | 37.90% | ' | ' |
Income from operating affiliates | -7 | 2,156 | 3,071 | 2,908 | ' | ' | ' | ' |
Carrying value | 647 | 29,408 | 647 | 29,408 | 5,204 | 29,319 | 27,252 | 0 |
AlphaCat 2013 Ltd | ' | ' | ' | ' | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' |
Equity Method Investment Voting Percentage | 40.90% | ' | 40.90% | ' | ' | 40.90% | ' | ' |
Equity ownership % | 19.70% | ' | 19.70% | ' | ' | 19.70% | ' | ' |
Income from operating affiliates | 585 | ' | 4,121 | ' | ' | ' | ' | ' |
Carrying value | 49,121 | ' | 49,121 | ' | 48,536 | 45,000 | ' | ' |
Investment in ILS Funds | ' | ' | ' | ' | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' |
Other Investments Number Of Funds | 3 | ' | 3 | ' | ' | ' | ' | ' |
Third party subscriptions | ' | ' | ' | ' | ' | 219,400 | ' | ' |
AlphaCat ILS Funds | ' | ' | ' | ' | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' |
Additional Third Party Subscriptions | 13,000 | ' | 82,190 | ' | ' | ' | ' | ' |
Equity Method Investment Voting Percentage | 0.00% | ' | 0.00% | ' | ' | 0.00% | ' | ' |
Equity ownership % | 9.10% | ' | 9.10% | ' | ' | 11.80% | ' | ' |
Income from operating affiliates | 1,155 | ' | 1,481 | ' | ' | ' | ' | ' |
Carrying value | 21,481 | ' | 21,481 | ' | 20,326 | 20,000 | ' | ' |
Aquiline Financial Services Fund LP | ' | ' | ' | ' | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' |
Equity Method Investment Voting Percentage | 0.00% | ' | 0.00% | ' | ' | ' | ' | ' |
Equity ownership % | 6.59% | ' | 6.59% | ' | ' | ' | ' | ' |
Investment Time Lag Reporting | ' | ' | '3 months | ' | ' | ' | ' | ' |
Percentage of Assignor's interest assumed | ' | ' | 100.00% | ' | ' | ' | ' | ' |
Total capital commitment | ' | ' | $50,000 | ' | ' | ' | ' | ' |
Variable interest entity, not primary beneficiary | Investment in ILS Funds | ' | ' | ' | ' | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' |
Other Investments Number Of Funds | 2 | ' | 2 | ' | ' | ' | ' | ' |
Noncontrolling_interest_Detail
Noncontrolling interest (Details) (USD $) | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | |||||||||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 |
PaCRe, Ltd | PaCRe, Ltd | PaCRe, Ltd | PaCRe, Ltd | AlphaCat ILS Funds | AlphaCat ILS Funds | Investment in ILS Funds | Investment in ILS Funds | PaCRe funds | PaCRe funds | Variable interest entity, not primary beneficiary | |||||
funds | funds | Investment in ILS Funds | |||||||||||||
funds | |||||||||||||||
Noncontrolling Interest [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Additional capital contributions from Validus Re to PaCRe | ' | ' | ' | ' | $6,500 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Noncontrolling Interest, Ownership Percentage by Parent | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10.00% | 10.00% | ' |
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 90.00% | 90.00% | ' |
Third party subscriptions | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 219,400 | ' | ' | ' |
Other Investments Number Of Funds | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3 | ' | 4 | ' | 2 |
Activity in net income attributable to noncontrolling interest | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Balance - Beginning of Period | 498,445 | 404,740 | 434,280 | 0 | 427,755 | 404,740 | 434,280 | 0 | 70,690 | 0 | ' | ' | ' | ' | ' |
Purchase of shares by noncontrolling interest | 13,000 | ' | 140,690 | 450,100 | 0 | ' | 58,500 | 450,100 | 13,000 | 82,190 | ' | ' | ' | ' | ' |
Net (income) loss attributable to noncontrolling interest | 45,694 | 56,746 | -17,831 | 11,386 | 44,178 | 56,746 | -20,847 | 11,386 | 1,516 | 3,016 | ' | ' | ' | ' | ' |
Balance - End of Period | $557,139 | $461,486 | $557,139 | $461,486 | $471,933 | $461,486 | $471,933 | $461,486 | $85,206 | $85,206 | ' | ' | ' | ' | ' |
Derivative_instruments_Derivat
Derivative instruments Derivative instruments not designated as hedging instruments (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Currency swap | Not Designated as Hedging Instrument [Member] | ' | ' |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ' | ' |
Derivative, Notional Amount | $0 | $17,153 |
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | ' | ' |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ' | ' |
Derivative, Notional Amount | 0 | 310,541 |
Accounts Payable and Accrued Liabilities [Member] | Currency swap | Not Designated as Hedging Instrument [Member] | ' | ' |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 0 | 772 |
Accounts Payable and Accrued Liabilities [Member] | Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | ' | ' |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 0 | 394 |
Other Assets [Member] | Currency swap | Not Designated as Hedging Instrument [Member] | ' | ' |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 0 | ' |
Other Assets [Member] | Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | ' | ' |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ' | ' |
Derivative Asset, Fair Value, Gross Asset | $0 | ' |
Junior Subordinated Deferrable Debentures [Member] | Interest rate swap contracts | ' | ' |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ' | ' |
Number of derivative instruments held | 2 | ' |
Flagstone Junior Subordinated Deferrable Debentures [Member] | Interest rate swap contracts | ' | ' |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ' | ' |
Number of derivative instruments held | 3 | ' |
Flagstone Junior Subordinated Deferrable Debentures [Member] | Cross Currency Interest Rate Contract [Member] | ' | ' |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ' | ' |
Number of derivative instruments held | 1 | ' |
Derivative_instruments_used_in1
Derivative instruments used in hedging activities (Amount and balance sheet location) (Details) (Designated as hedging instruments, USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Foreign exchange contracts | ' | ' |
Summary of amount of derivatives designated as hedging instruments | ' | ' |
Notional amount | $168,722 | $35,976 |
Foreign exchange contracts | Other assets | ' | ' |
Summary of amount of derivatives designated as hedging instruments | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 4,977 | 0 |
Foreign exchange contracts | Accounts Payable and Accrued Liabilities [Member] | ' | ' |
Summary of amount of derivatives designated as hedging instruments | ' | ' |
Fair value, derivative liabilities | 1,115 | 223 |
Interest rate swap contracts | ' | ' |
Summary of amount of derivatives designated as hedging instruments | ' | ' |
Notional amount | 552,263 | 289,800 |
Interest rate swap contracts | Other assets | ' | ' |
Summary of amount of derivatives designated as hedging instruments | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 0 | 0 |
Interest rate swap contracts | Accounts Payable and Accrued Liabilities [Member] | ' | ' |
Summary of amount of derivatives designated as hedging instruments | ' | ' |
Fair value, derivative liabilities | $873 | $220 |
Derivative_instruments_used_in2
Derivative instruments used in hedging activities (Amount included in statement of operations) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Fair Value Hedging [Member] | Foreign Exchange Contract [Member] | Foreign Currency Gain (Loss) [Member] | ' | ' | ' | ' |
Derivatives designated as fair value hedges and related hedged item | ' | ' | ' | ' |
Amount of gain (loss) recognized in income on derivative | $3,116 | $1,749 | $2,670 | $130 |
Amount of gain (loss) on hedged item recognized in income attributable to risk being hedged | -3,116 | -1,749 | -2,670 | -130 |
Amount of gain (loss) recognized in income on derivative (ineffective portion) | 0 | 0 | 0 | 0 |
Cash flow hedge | Interest rate swap contracts | ' | ' | ' | ' |
Derivative instruments designated as a cash flow hedge | ' | ' | ' | ' |
Amount of ineffective portion excluded from effectiveness testing | 0 | 0 | 0 | 0 |
Cash flow hedge | Interest rate swap contracts | Other comprehensive income | ' | ' | ' | ' |
Derivative instruments designated as a cash flow hedge | ' | ' | ' | ' |
Amount of effective portion recognized in other comprehensive income | 3,268 | 195 | 7,838 | 195 |
Cash flow hedge | Interest rate swap contracts | Finance expenses | ' | ' | ' | ' |
Derivative instruments designated as a cash flow hedge | ' | ' | ' | ' |
Amount of effective portion subsequently reclassified to earnings | ($3,268) | ($195) | ($7,838) | ($195) |
Reserve_for_losses_and_loss_ex2
Reserve for losses and loss expenses (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Reserve for paid losses and unpaid loss expenses | ' | ' | ' | ' |
Reserve for losses and loss expenses, beginning of period | $3,283,450 | $2,591,299 | $3,517,573 | $2,631,143 |
Losses and loss expenses recoverable, beginning of period | -418,693 | -371,484 | -439,967 | -372,485 |
Net reserves for losses and loss expenses, beginning of period | 2,864,757 | 2,219,815 | 3,077,606 | 2,258,658 |
Net reserves acquired | ' | ' | 948 | 0 |
Increase (decrease) in net losses and loss expenses incurred in respect of losses occurring in: | ' | ' | ' | ' |
Current year | 243,015 | 205,219 | 759,617 | 658,884 |
Prior years | -65,050 | -49,764 | -171,837 | -117,748 |
Total incurred losses and loss expenses | 177,965 | 155,455 | 587,780 | 541,136 |
Total net paid losses | -274,868 | -144,628 | -847,192 | -569,380 |
Foreign exchange | 34,363 | 14,710 | -16,925 | 14,938 |
Net reserve for losses and loss expenses, end of period | 2,802,217 | 2,245,352 | 2,802,217 | 2,245,352 |
Losses and loss expenses recoverable, end of period | 421,518 | 317,252 | 421,518 | 317,252 |
Reserve for losses and loss expenses, end of period | $3,223,735 | $2,562,604 | $3,223,735 | $2,562,604 |
Reinsurance_Details
Reinsurance (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | $451,592 | $486,402 |
Percentage of reinsurance recoverables | 100.00% | 100.00% |
Reinsurance (Textuals) [Abstract] | ' | ' |
Incurred but not reported recoverable | 211,864 | 185,255 |
Provision for uncollectible reinsurance relating to losses recoverable | 6,209 | 6,602 |
A- or better | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Percentage of reinsurance recoverables | 97.70% | 97.90% |
Fully Collateralized Reinsurers | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 34,293 | 47,445 |
Top 10 reinsurers | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 340,988 | 360,234 |
Percentage of reinsurance recoverables | 75.50% | 74.10% |
Percentage of top 10 reinsurers reinsurance recoverables | 100.00% | 100.00% |
Top 10 reinsurers | Lloyd's Syndicates | A plus | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 74,586 | 71,469 |
Percentage of top 10 reinsurers reinsurance recoverables | 21.90% | 19.90% |
Top 10 reinsurers | National Indemnity | AA plus | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 50,984 | 59,941 |
Percentage of top 10 reinsurers reinsurance recoverables | 14.90% | 16.60% |
Top 10 reinsurers | Everest Re | A plus | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 52,372 | 51,340 |
Percentage of top 10 reinsurers reinsurance recoverables | 15.30% | 14.30% |
Top 10 reinsurers | Hannover Re | AA- | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 45,975 | 40,552 |
Percentage of top 10 reinsurers reinsurance recoverables | 13.50% | 11.30% |
Top 10 reinsurers | Fully Collateralized Reinsurers | NR | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 34,293 | 47,445 |
Percentage of top 10 reinsurers reinsurance recoverables | 10.10% | 13.20% |
Top 10 reinsurers | Transatlantic Re | A plus | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 15,887 | 20,320 |
Percentage of top 10 reinsurers reinsurance recoverables | 4.70% | 5.60% |
Top 10 reinsurers | Swiss Re | AA- | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 20,728 | 16,992 |
Percentage of top 10 reinsurers reinsurance recoverables | 6.10% | 4.70% |
Top 10 reinsurers | XL Re | A | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 14,062 | 14,854 |
Percentage of top 10 reinsurers reinsurance recoverables | 4.10% | 4.10% |
Top 10 reinsurers | Third Point Re [Member] | A- | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 20,049 | ' |
Percentage of top 10 reinsurers reinsurance recoverables | 5.90% | ' |
Top 10 reinsurers | Munich Re | AA- | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 12,052 | 20,954 |
Percentage of top 10 reinsurers reinsurance recoverables | 3.50% | 5.80% |
Top 10 reinsurers | Allianz | AA- | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | ' | 16,367 |
Percentage of top 10 reinsurers reinsurance recoverables | ' | 4.50% |
Other reinsurers' balances greater than $1 million | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 102,714 | 115,262 |
Percentage of reinsurance recoverables | 22.70% | 23.70% |
Other reinsurers' balances less than $1 million | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | $7,890 | $10,906 |
Percentage of reinsurance recoverables | 1.80% | 2.20% |
Share_capital_Details
Share capital (Details) (USD $) | 0 Months Ended | 3 Months Ended | 9 Months Ended | 0 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | ||||||||||||||||||||||
In Thousands, except Share data, unless otherwise specified | Feb. 06, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 | Nov. 30, 2012 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Mar. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Mar. 31, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2012 | Dec. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 |
Flagstone Reinsurance Holdings Sa [Member] | Common shares | Common shares | Common shares | Common shares | Common shares | Common shares | Common shares | Common share equivalents | Common share equivalents | Common share equivalents | Common share equivalents | Performance shares | Warrants | Warrants | Warrants | Warrants | Deferred share units | Restricted share awards | Restricted share awards | Restricted share units | Restricted share units | Employee director | |||||||||||
Special dividend declared | Special dividend declared | Deferred share units | |||||||||||||||||||||||||||||||
Schedule of Common Stock Issued and Outstanding [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of warrants exercised during period | ' | ' | ' | ' | ' | ' | ' | 1,114,416 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 163,772 | 264,127 | 264,127 | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Shares, Conversion of Convertible Securities | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 83,287 | ' | ' | 130,121 | 591,480 | 130,121 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Outstanding | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5,296,056 | ' | ' | 6,410,472 | ' | ' | ' | ' | ' | ' |
Summary of common shares issued and outstanding | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common shares issued, beginning balance | ' | ' | ' | 152,698,191 | ' | ' | 134,503,065 | 152,698,191 | 134,503,065 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vested, net of shares withheld | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 31,897 | ' | ' | ' | ' | ' | 768,889 | 1,545,024 | 14,381 | 15,173 | ' |
Options exercised (in shares) | ' | ' | ' | ' | ' | ' | ' | 277,615 | 439,065 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Direct issuance of common stock | ' | ' | ' | ' | ' | ' | ' | 928 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Deferred share units vested, net of shares withheld | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,935 | ' | ' | ' | ' | 2,935 |
Common shares issued, ending balance | ' | 154,386,316 | ' | ' | 136,632,448 | ' | ' | 154,386,316 | 136,632,448 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Shares repurchased, ending balance | ' | -54,488,320 | ' | ' | -43,138,057 | ' | ' | -54,488,320 | -43,138,057 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common shares outstanding, ending balance | ' | 99,897,996 | ' | ' | 93,494,391 | ' | ' | 99,897,996 | 93,494,391 | 107,921,259 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share repurchases | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Repurchase Program, Authorized Amount | $500,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share repurchase program, cumulative shares repurchased | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 52,849,445 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Shares repurchased, cumulative | 1,206,845 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,564,029 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Remaining share repurchase authorization amount | ' | ' | ' | ' | ' | ' | ' | $142,816 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Treasury Stock, Shares, Acquired | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,638,875 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share Capital (Texts) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common shares, shares authorized | ' | 571,428,571 | ' | ' | ' | ' | ' | 571,428,571 | ' | 571,428,571 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common shares, par value | ' | $0.18 | ' | ' | ' | ' | ' | $0.18 | ' | $0.18 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common stock voting rights | ' | ' | ' | ' | ' | ' | ' | 'one vote per share | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Restriction on percentage of voting power | ' | ' | ' | ' | ' | ' | ' | 9.09% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued Net Of Shares Withheld | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 14,202,664 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Business Acquisition, Cost of Acquired Entity, Equity Interests Withheld For Income Taxes | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 87,725 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Treasury Stock, Shares, Acquired | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,638,875 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Closing Price Per Share Of Companys Stock | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $34.87 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Business Combination Acquired Warrants | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 121,942 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Warrant strike price | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 62.02 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Deferred share units, adjustment factor | ' | ' | ' | ' | ' | ' | ' | 100.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total outstanding deferred share units | ' | 0 | ' | ' | ' | ' | ' | 0 | ' | 5,001 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vested (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 39,094 | ' | ' | ' | ' | ' | 930,296 | 1,678,905 | 21,814 | 22,818 | 5,039 |
Date of dividend declaration | ' | 30-Jul-13 | 1-May-13 | 6-Feb-13 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash dividends declared per share | ' | $0.30 | ' | ' | $0.25 | $0.25 | $0.25 | $2.90 | $0.75 | ' | ' | $0.30 | $0.30 | $0.30 | ' | ' | ' | $2 | $0.30 | $0.30 | $0.30 | $2 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock_plans_Options_activity_D
Stock plans (Options activity) (Details) (USD $) | 9 Months Ended | |
Sep. 30, 2013 | Sep. 30, 2012 | |
Options activities: | ' | ' |
Options outstanding, beginning balance (in shares) | 1,823,947 | 2,263,012 |
Options regranted (modified) (in shares) | 1,833,414 | ' |
Options exercised (in shares) | -277,615 | -439,065 |
Options cancelled (modified) (in shares) | -1,733,139 | ' |
Options outstanding, ending balance (in shares) | 1,646,607 | 1,823,947 |
Options exercisable (in shares) | 1,646,607 | 1,823,947 |
Weighted Average Grant Date Fair Value | ' | ' |
Weighted average grant date fair value, beginning balance (in dollars per share) | $6.52 | $6.69 |
Weighted average grant date fair value, options regranted (modified) (in dollars per share) | $6.76 | ' |
Weighted average grant date fair value, options exercised (in dollars per share) | $5.24 | $7.44 |
Weighted average grant date fair value, options cancelled (modified) (in dollars per share) | $6.76 | ' |
Weighted average grant date fair value, ending balance (in dollars per share) | $6.75 | $6.52 |
Weighted average grant date fair value, options exercisable (in dollars per share) | $6.75 | $6.52 |
Weighted Average Grant Date Exercise Price | ' | ' |
Weighted average grant date exercise price, beginning balance (in dollars per share) | $20.69 | $20.12 |
Weighted average grant date exercise price, options regranted (repriced) (in dollars per share) | $19.02 | ' |
Weighted average grant date exercise price, options exercised (in dollars per share) | $23.58 | $17.73 |
Weighted average grant date exercise price, options cancelled (repriced) (in dollars per share) | $20.12 | ' |
Weighted average grant date exercise price, ending balance (in dollars per share) | $18.94 | $20.69 |
Weighted average grant date exercise price, options exercisable (in dollars per share) | $18.94 | $20.69 |
Stock_plans_Other_awards_activ
Stock plans (Other awards activity) (Details) (USD $) | 9 Months Ended | |
Sep. 30, 2013 | Sep. 30, 2012 | |
Restricted share awards | ' | ' |
Activities | ' | ' |
Beginning balance (in shares) | 2,170,547 | 3,003,547 |
Granted (in shares) | 1,580,117 | 901,506 |
Vested (in shares) | -930,296 | -1,678,905 |
Forfeited (in shares) | -110,912 | -30,801 |
Ending balance (in shares) | 2,709,456 | 2,195,347 |
Weighted average grant date fair value | ' | ' |
Weighted average grant date fair value, beginning balance (in dollars per share) | $29.24 | $25.77 |
Weighted average grant date fair value, granted (in dollars per share) | $36.06 | $31.38 |
Weighted average grant date fair value, vested (in dollars per share) | $28.08 | $24.36 |
Weighted average grant date fair value, forfeited (in dollars per share) | $28.34 | $28.10 |
Weighted average grant date fair value, ending balance (in dollars per share) | $33.65 | $29.12 |
Restricted share units | ' | ' |
Activities | ' | ' |
Beginning balance (in shares) | 47,238 | 53,312 |
Granted (in shares) | 36,635 | 16,633 |
Vested (in shares) | -21,814 | -22,818 |
Issued in lieu of cash dividends (in shares) | 3,924 | 1,162 |
Forfeited (in shares) | ' | -1,393 |
Ending balance (in shares) | 65,983 | 46,896 |
Weighted average grant date fair value | ' | ' |
Weighted average grant date fair value, beginning balance (in dollars per share) | $29.61 | $27.60 |
Weighted average grant date fair value, granted (in dollars per share) | $36.11 | $31.77 |
Weighted average grant date fair value, vested (in dollars per share) | $28.17 | $26.49 |
Weighted average grant date fair value, issued in lieu of cash dividends (in dollars per share) | $30.29 | $28.36 |
Weighted average grant date fair value, forfeited (in dollars per share) | ' | $28.57 |
Weighted average grant date fair value, ending balance (in dollars per share) | $33.74 | $29.61 |
Performance shares | ' | ' |
Activities | ' | ' |
Beginning balance (in shares) | 220,845 | 279,019 |
Granted (in shares) | 38,386 | 41,128 |
Vested (in shares) | -39,094 | ' |
Forfeited (in shares) | -18,701 | -99,302 |
Conversion adjustment (in shares) | -99,616 | ' |
Ending balance (in shares) | 101,820 | 220,845 |
Weighted average grant date fair value | ' | ' |
Weighted average grant date fair value, beginning balance (in dollars per share) | $31.81 | $30.77 |
Weighted average grant date fair value, granted (in dollars per share) | $36.11 | $31.38 |
Weighted average grant date fair value, vested (in dollars per share) | $28.70 | ' |
Weighted average grant date fair value, forfeited (in dollars per share) | $31.05 | $28.70 |
Weighted average grant date fair value, conversion adjustment (in dollars per share) | $33.05 | ' |
Weighted average grant date fair value, ending balance (in dollars per share) | $33.56 | $31.81 |
Stock_plans_Components_of_shar
Stock plans (Components of share compensation expenses) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Total share compensation expenses | ' | ' | ' | ' |
Share compensation expenses | $10,527 | $7,345 | $19,483 | $19,583 |
Options | ' | ' | ' | ' |
Total share compensation expenses | ' | ' | ' | ' |
Share compensation expenses | 0 | 0 | 0 | 142 |
Restricted share awards | ' | ' | ' | ' |
Total share compensation expenses | ' | ' | ' | ' |
Share compensation expenses | 10,041 | 6,626 | 20,035 | 18,742 |
Restricted share units | ' | ' | ' | ' |
Total share compensation expenses | ' | ' | ' | ' |
Share compensation expenses | 168 | 132 | 419 | 363 |
Performance shares | ' | ' | ' | ' |
Total share compensation expenses | ' | ' | ' | ' |
Share compensation expenses | $318 | $587 | ($971) | $336 |
Stock_plans_Text_Details
Stock plans (Text) (Details) (USD $) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 |
Stock plans (other details) | ' | ' | ' | ' | ' |
Number of shares reserved for issuance under the LTIP and STIP | 13,126,896 | ' | 13,126,896 | ' | ' |
Remaining number of shares reserved for issuance | 1,783,462 | ' | 1,783,462 | ' | ' |
Share compensation expenses | $10,527 | $7,345 | $19,483 | $19,583 | ' |
Options | ' | ' | ' | ' | ' |
Stock plans (other details) | ' | ' | ' | ' | ' |
Life of options | ' | ' | '10 years | ' | ' |
Share compensation expenses | 0 | 0 | 0 | 142 | ' |
Weighted average period of recognizing share based compensation expenses | ' | ' | '0 years | ' | '0 years |
Restricted share awards | ' | ' | ' | ' | ' |
Stock plans (other details) | ' | ' | ' | ' | ' |
Share compensation expenses | 10,041 | 6,626 | 20,035 | 18,742 | ' |
Unrecognized share compensation expenses | 76,084 | ' | 76,084 | ' | 43,952 |
Weighted average period of recognizing share based compensation expenses | ' | ' | '3 years 4 months 24 days | ' | '2 years 7 months 6 days |
Restricted share units | ' | ' | ' | ' | ' |
Stock plans (other details) | ' | ' | ' | ' | ' |
Share compensation expenses | 168 | 132 | 419 | 363 | ' |
Unrecognized share compensation expenses | 1,839 | ' | 1,839 | ' | 978 |
Weighted average period of recognizing share based compensation expenses | ' | ' | '3 years 6 months 0 days | ' | '2 years 7 months 6 days |
Performance shares | ' | ' | ' | ' | ' |
Stock plans (other details) | ' | ' | ' | ' | ' |
Share compensation expenses | 318 | 587 | -971 | 336 | ' |
Unrecognized share compensation expenses | $1,893 | ' | $1,893 | ' | 3,328 |
Weighted average period of recognizing share based compensation expenses | ' | ' | '2 years 2 months 12 days | ' | '1 year 8 months 12 days |
Performance share awards performance period | ' | ' | '3 years | ' | ' |
Debt_and_financing_arrangement2
Debt and financing arrangements (Schedule of finance structure) (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 | ||
In Thousands, unless otherwise specified | ||||
Debt Instrument [Line Items] | ' | ' | ||
Credit facility, commitment | $1,575,000 | $2,090,000 | ||
Long-term debt, drawn | 788,298 | 787,799 | ||
Debt Instrument And Line Of Credit Facility Amount Committed | 2,426,327 | 2,940,909 | ||
Debt Instrument And Line Of Credit Facility Amount Outstanding | 1,590,016 | [1] | 1,706,532 | [1] |
Flagstone BiLateral Facility | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ||
Credit facility, commitment | 375,000 | 550,000 | ||
Guarantor Obligations, Maximum Exposure, Undiscounted | 297,996 | [1] | 381,019 | [1] |
Ipc Bi Lateral Facility [Member] | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ||
Credit facility, commitment | 40,000 | [1] | 80,000 | [1] |
Guarantor Obligations, Maximum Exposure, Undiscounted | 26,019 | [1] | 40,613 | [1] |
PaCRe Senior secured letter of credit facility | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ||
Credit facility, commitment | 10,000 | 10,000 | ||
Guarantor Obligations, Maximum Exposure, Undiscounted | 258 | [1] | 219 | [1] |
Talbot Fal Facility [Member] | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ||
Credit facility, commitment | 25,000 | [2] | 25,000 | [2] |
Guarantor Obligations, Maximum Exposure, Undiscounted | 25,000 | [1],[2] | 25,000 | [1],[2] |
Secured Bi-Lateral Facility [Member] | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ||
Credit facility, commitment | 200,000 | 500,000 | ||
Guarantor Obligations, Maximum Exposure, Undiscounted | 77,626 | [1] | 92,402 | [1] |
Four Year Secured Credit Facility [Member] | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ||
Credit facility, commitment | 525,000 | 525,000 | ||
Guarantor Obligations, Maximum Exposure, Undiscounted | 371,990 | [1] | 376,570 | [1] |
Four Year Unsecured Credit Facility [Member] | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ||
Credit facility, commitment | 400,000 | 400,000 | ||
Guarantor Obligations, Maximum Exposure, Undiscounted | 0 | [1] | 0 | [1] |
Senior Notes Two Thousand Ten Due Two Thousand Forty [Member] | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ||
Debt instrument, outstanding | 250,000 | [1] | 250,000 | [1] |
Long-term debt, drawn | 247,171 | 247,090 | ||
Debt Instrument, Face Amount | 250,000 | 250,000 | ||
Flagstone 2006 Junior Subordinated Deferrable Interest Notes | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ||
Debt instrument, outstanding | 137,577 | [1] | 137,159 | [1] |
Long-term debt, drawn | 137,577 | 137,159 | ||
Debt Instrument, Face Amount | 137,577 | 137,159 | ||
Flagstone 2007 Junior Subordinated Deferrable Interest Notes | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ||
Debt instrument, outstanding | 113,750 | [1] | 113,750 | [1] |
Long-term debt, drawn | 113,750 | 113,750 | ||
Debt Instrument, Face Amount | 113,750 | 113,750 | ||
Junior Subordinated Deferrable Debentures Two Thousand Seven [Member] | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ||
Debt instrument, outstanding | 139,800 | [1] | 139,800 | [1] |
Long-term debt, drawn | 139,800 | 139,800 | ||
Debt Instrument, Face Amount | 200,000 | 200,000 | ||
Junior Subordinated Deferrable Debentures Two Thousand Six [Member] | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ||
Debt instrument, outstanding | 150,000 | [1] | 150,000 | [1] |
Long-term debt, drawn | 150,000 | 150,000 | ||
Debt Instrument, Face Amount | $150,000 | $150,000 | ||
[1] | Indicates utilization of commitment amount, not drawn borrowings. | |||
[2] | Talbot operates in the Lloyd’s market ("Lloyds") through a corporate member, Talbot 2002 Underwriting Capital Ltd (“T02â€), which is the sole participant in Syndicate 1183. Lloyd’s sets T02’s required capital annually based on Syndicate 1183’s business plan, rating environment, reserving environment together with input arising from Lloyd’s discussions with, inter alia, regulatory and rating agencies. Such capital, called Funds at Lloyd’s (“FALâ€), comprises: cash, investments and undrawn letters of credit provided by various banks. |
Recovered_Sheet1
Debt and financing Arrangements (Components of finance expenses) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | ||
Debt Instrument [Line Items] | ' | ' | ' | ' | ||
Financing Interest Expense | $27,132 | $9,362 | $89,408 | $39,347 | ||
AlphaCat Variable Funding Notes [Member] | ' | ' | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ' | ' | ||
Financing Interest Expense | 11,893 | [1] | 0 | 44,562 | [1] | 0 |
Credit Facilities [Member] | ' | ' | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ' | ' | ||
Financing Interest Expense | 1,248 | 948 | 5,001 | 10,530 | ||
Bank charges [Member] | ' | ' | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ' | ' | ||
Financing Interest Expense | 187 | -52 | 419 | 131 | ||
Talbot Fal Facility [Member] | ' | ' | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ' | ' | ||
Financing Interest Expense | 32 | 30 | 95 | 93 | ||
Junior Subordinated Deferrable Debentures Two Thousand Six [Member] | ' | ' | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ' | ' | ||
Financing Interest Expense | 2,235 | 1,628 | 6,633 | 4,729 | ||
Junior Subordinated Deferrable Debentures Two Thousand Seven [Member] | ' | ' | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ' | ' | ||
Financing Interest Expense | 1,848 | 1,211 | 5,492 | 7,072 | ||
Senior Notes Two Thousand Ten Due Two Thousand Forty [Member] | ' | ' | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ' | ' | ||
Financing Interest Expense | 5,597 | 5,597 | 16,792 | 16,792 | ||
Flagstone 2006 Junior Subordinated Deferrable Interest Notes | ' | ' | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ' | ' | ||
Financing Interest Expense | 2,285 | 0 | 5,988 | 0 | ||
Flagstone 2007 Junior Subordinated Deferrable Interest Notes | ' | ' | ' | ' | ||
Debt Instrument [Line Items] | ' | ' | ' | ' | ||
Financing Interest Expense | $1,807 | $0 | $4,426 | $0 | ||
[1] | Includes variable funding note expense and other AlphaCat related fees. Refer to Note 13: "Variable funding notes" for further details. |
Recovered_Sheet2
Debt and financing Arrangements (Future payments of principal) (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Future expected payments of principal | ' | ' |
Total minimum future payments | $541,127 | $540,709 |
2010 Senior Notes Due 2040 | ' | ' |
Future expected payments of principal | ' | ' |
2013 | 0 | ' |
2014 | 0 | ' |
2015 | 0 | ' |
2016 | 0 | ' |
2017 and thereafter | 250,000 | ' |
Total minimum future payments | 250,000 | ' |
Junior subordinated deferrable debentures | ' | ' |
Future expected payments of principal | ' | ' |
2013 | 0 | ' |
2014 | 0 | ' |
2015 | 0 | ' |
2016 | 0 | ' |
2017 and thereafter | 540,709 | ' |
Total minimum future payments | $540,709 | ' |
Recovered_Sheet3
Debt and financing Arrangements (Text) (Details) (USD $) | 9 Months Ended | |||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Dec. 31, 2012 | ||
Senior Notes and Junior Debentures | ' | ' | ||
Long-term debt, drawn | $788,298 | $787,799 | ||
Credit Facilities | ' | ' | ||
Credit facility, commitment | 1,575,000 | 2,090,000 | ||
Credit Facilities | ' | ' | ||
Credit Facilities | ' | ' | ||
Minimum level of consolidated net worth | 2,600,000 | ' | ||
Percent of consolidated net income quarterly increase under covenant | 50.00% | ' | ||
Percent of any net proceeds from issuance of common shares | 50.00% | ' | ||
Ratio consolidated total debt to net worth under covenant | '0.35:1.00 | ' | ||
Four-year syndicated unsecured credit facility | ' | ' | ||
Credit Facilities | ' | ' | ||
Credit facility, commitment | 400,000 | 400,000 | ||
Letter of credit facility period | '4 years | ' | ||
Letter of credit facility amount issued and outstanding | 0 | [1] | 0 | [1] |
Line of credit facility initiation date | 9-Mar-12 | ' | ||
Description of interest rate basis | 'The borrowings bear interest, at the option of the Company, at the base rate (the higher of the prime rate announced by JPMorgan Chase Bank, the federal funds effective rate plus 0.50%, and the adjusted LIBOR rate plus 1.0%) or the adjusted LIBOR rate applicable to such loans, plus an applicable rate. | ' | ||
Four-year syndicated secured credit facility | ' | ' | ||
Credit Facilities | ' | ' | ||
Credit facility, commitment | 525,000 | 525,000 | ||
Letter of credit facility period | '4 years | ' | ||
Aggregate commitments, maximum | 700,000 | ' | ||
Letter of credit facility amount issued and outstanding | 371,990 | [1] | 376,570 | [1] |
Line of credit facility initiation date | 9-Mar-12 | ' | ||
Description of interest rate basis | 'The borrowings bear interest at the base rate (the higher of the prime rate announced by JPMorgan Chase Bank, NA, the federal funds effective rate plus 0,50%, and the adjusted LIBOR rate plus 1.0%). | ' | ||
Four-year syndicated secured credit facility | Maximum | ' | ' | ||
Credit Facilities | ' | ' | ||
Basis spread on variable rate | 0.01 | ' | ||
Four-year syndicated secured credit facility | Minimum | ' | ' | ||
Credit Facilities | ' | ' | ||
Basis spread on variable rate | 0.005 | ' | ||
Syndicated unsecured letter of credit facility | ' | ' | ||
Credit Facilities | ' | ' | ||
Credit facility, commitment | 400,000 | 400,000 | ||
Aggregate commitments, maximum | 500,000 | ' | ||
Syndicated unsecured letter of credit facility | Maximum | ' | ' | ||
Credit Facilities | ' | ' | ||
Basis spread on variable rate | 0.01 | ' | ||
Syndicated unsecured letter of credit facility | Minimum | ' | ' | ||
Credit Facilities | ' | ' | ||
Basis spread on variable rate | 0.005 | ' | ||
Bilateral unsecured letter of credit facility | Terminated Credit Facilities [Member] | ' | ' | ||
Credit Facilities | ' | ' | ||
Credit facility, commitment | 60,000 | ' | ||
Letter of credit facility period | '3 years | ' | ||
Three year unsecured letter of credit facility | Terminated Credit Facilities [Member] | ' | ' | ||
Credit Facilities | ' | ' | ||
Credit facility, commitment | 340,000 | ' | ||
Letter of credit facility period | '3 years | ' | ||
Five year secured letter of credit facility | ' | ' | ||
Credit Facilities | ' | ' | ||
Credit facility, commitment | 525,000 | 525,000 | ||
Five year secured letter of credit facility | Terminated Credit Facilities [Member] | ' | ' | ||
Credit Facilities | ' | ' | ||
Credit facility, commitment | 500,000 | ' | ||
Letter of credit facility period | '5 years | ' | ||
Talbot FAL Facility | ' | ' | ||
Credit Facilities | ' | ' | ||
Credit facility, commitment | 25,000 | [2] | 25,000 | [2] |
Letter of credit facility amount issued and outstanding | 25,000 | [1],[2] | 25,000 | [1],[2] |
Letter of credit facility, original commitment amount | 100,000 | ' | ||
Line of credit facility initiation date | 29-Nov-07 | ' | ||
Minimum level of consolidated net worth | 2,589,615 | ' | ||
Percent of consolidated net income quarterly increase under covenant | 50.00% | ' | ||
Percent of any net proceeds from issuance of common shares | 50.00% | ' | ||
Ratio consolidated total debt to net worth under covenant | '0.35:1.00 | ' | ||
IPC Bi Lateral Facility | ' | ' | ||
Credit Facilities | ' | ' | ||
Credit facility, commitment | 40,000 | [1] | 80,000 | [1] |
Letter of credit facility amount issued and outstanding | 26,019 | [1] | 40,613 | [1] |
Bi-lateral secured facility | ' | ' | ||
Credit Facilities | ' | ' | ||
Credit facility, commitment | 200,000 | 500,000 | ||
Letter of credit facility amount issued and outstanding | 77,626 | [1] | 92,402 | [1] |
Line of credit facility initiation date | 10-Aug-09 | ' | ||
PaCRe Senior secured letter of credit facility | ' | ' | ||
Credit Facilities | ' | ' | ||
Credit facility, commitment | 10,000 | 10,000 | ||
Letter of credit facility period | '364 days | ' | ||
Letter of credit facility amount issued and outstanding | 258 | [1] | 219 | [1] |
Line of credit facility initiation date | 11-May-12 | ' | ||
Flagstone BiLateral Facility | ' | ' | ||
Credit Facilities | ' | ' | ||
Credit facility, commitment | 375,000 | 550,000 | ||
Letter of credit facility amount issued and outstanding | 297,996 | [1] | 381,019 | [1] |
2006 Junior Subordinated Deferrable Debentures | ' | ' | ||
Senior Notes and Junior Debentures | ' | ' | ||
Debt instrument issuance date | 15-Jun-06 | ' | ||
Debt instrument maturity date | 15-Jun-36 | ' | ||
Frequency of required payments | 'quarterly | ' | ||
Debt issuance cost | 3,750 | ' | ||
Length of optional redemption period | '5 years | ' | ||
Debt instrument, outstanding | 150,000 | [1] | 150,000 | [1] |
Debt instrument, commitment | 150,000 | 150,000 | ||
Long-term debt, drawn | 150,000 | 150,000 | ||
Start of optional redemption period | 15-Jun-11 | ' | ||
Gross proceeds on issuance of junior subordinated deferrable debentures | 150,000 | ' | ||
2007 Junior Subordinated Deferrable Debentures | ' | ' | ||
Senior Notes and Junior Debentures | ' | ' | ||
Debt instrument issuance date | 21-Jun-07 | ' | ||
Debt instrument maturity date | 15-Jun-37 | ' | ||
Frequency of required payments | 'quarterly | ' | ||
Debt issuance cost | 2,000 | ' | ||
Length of optional redemption period | '5 years | ' | ||
Debt instrument, outstanding | 139,800 | [1] | 139,800 | [1] |
Debt instrument, commitment | 200,000 | 200,000 | ||
Long-term debt, drawn | 139,800 | 139,800 | ||
Start of optional redemption period | 15-Jun-12 | ' | ||
Gross proceeds on issuance of junior subordinated deferrable debentures | 200,000 | ' | ||
2010 Senior Notes Due 2040 | ' | ' | ||
Senior Notes and Junior Debentures | ' | ' | ||
Debt instrument maturity date | 26-Jan-40 | ' | ||
Interest rate | 8.88% | ' | ||
Frequency of required payments | 'semi-annually | ' | ||
Net proceeds on issuance of senior notes | 243,967 | ' | ||
Debt issuance cost | 2,808 | ' | ||
Debt instrument, outstanding | 250,000 | [1] | 250,000 | [1] |
Debt instrument, commitment | 250,000 | 250,000 | ||
Long-term debt, drawn | 247,171 | 247,090 | ||
Flagstone 2006 Junior Subordinated Deferrable Interest Notes | ' | ' | ||
Senior Notes and Junior Debentures | ' | ' | ||
Debt instrument maturity date | 15-Sep-36 | ' | ||
Frequency of required payments | 'quarterly | ' | ||
Description of variable rate basis | 'three-month LIBOR | ' | ||
Basis spread on variable rate | 3.54% | ' | ||
Debt instrument, outstanding | 137,577 | [1] | 137,159 | [1] |
Debt instrument, commitment | 137,577 | 137,159 | ||
Long-term debt, drawn | 137,577 | 137,159 | ||
Start of optional redemption period | 15-Sep-11 | ' | ||
Flagstone 2007 Junior Subordinated Deferrable Interest Notes | ' | ' | ||
Senior Notes and Junior Debentures | ' | ' | ||
Debt instrument, outstanding | 113,750 | [1] | 113,750 | [1] |
Debt instrument, commitment | 113,750 | 113,750 | ||
Long-term debt, drawn | 113,750 | 113,750 | ||
Senior Notes Two Thousand Ten Due Two Thousand Forty [Member] | ' | ' | ||
Senior Notes and Junior Debentures | ' | ' | ||
Debt instrument issuance date | 21-Jan-10 | ' | ||
Date of first required payment | 26-Jul-10 | ' | ||
Jun 15 2006 - Jun 15 2011 | 2006 Junior Subordinated Deferrable Debentures | ' | ' | ||
Senior Notes and Junior Debentures | ' | ' | ||
Interest rate | 9.07% | ' | ||
Jun 21 2007 - Jun 15 2012 | 2007 Junior Subordinated Deferrable Debentures | ' | ' | ||
Senior Notes and Junior Debentures | ' | ' | ||
Interest rate | 8.48% | ' | ||
Jun 15 2011 - Jun 15 2036 | 2006 Junior Subordinated Deferrable Debentures | ' | ' | ||
Senior Notes and Junior Debentures | ' | ' | ||
Description of variable rate basis | 'three-month LIBOR | ' | ||
Basis spread on variable rate | 3.55% | ' | ||
Jun 15 2012 - Jun 15 2037 | 2007 Junior Subordinated Deferrable Debentures | ' | ' | ||
Senior Notes and Junior Debentures | ' | ' | ||
Description of variable rate basis | 'three-month LIBOR | ' | ||
Basis spread on variable rate | 2.95% | ' | ||
Flagstone 2007 Due July 30 2037 | Flagstone 2007 Junior Subordinated Deferrable Interest Notes | ' | ' | ||
Senior Notes and Junior Debentures | ' | ' | ||
Frequency of required payments | 'quarterly | ' | ||
Description of variable rate basis | 'three-month LIBOR | ' | ||
Basis spread on variable rate | 3.00% | ' | ||
Debt instrument, commitment | 88,750 | ' | ||
Debt Instrument, September 15, 2037 Maturity Date | 30-Jul-37 | ' | ||
Start of optional redemption period | 30-Jul-12 | ' | ||
Flagstone 2007 Debt Due September 15 2037 | Flagstone 2007 Junior Subordinated Deferrable Interest Notes | ' | ' | ||
Senior Notes and Junior Debentures | ' | ' | ||
Frequency of required payments | 'quarterly | ' | ||
Description of variable rate basis | 'three-month LIBOR | ' | ||
Basis spread on variable rate | 3.10% | ' | ||
Debt instrument, commitment | $25,000 | ' | ||
Start of optional redemption period | 15-Sep-12 | ' | ||
Debt Instrument, July 30, 2037 Maturity Date | 15-Sep-37 | ' | ||
[1] | Indicates utilization of commitment amount, not drawn borrowings. | |||
[2] | Talbot operates in the Lloyd’s market ("Lloyds") through a corporate member, Talbot 2002 Underwriting Capital Ltd (“T02â€), which is the sole participant in Syndicate 1183. Lloyd’s sets T02’s required capital annually based on Syndicate 1183’s business plan, rating environment, reserving environment together with input arising from Lloyd’s discussions with, inter alia, regulatory and rating agencies. Such capital, called Funds at Lloyd’s (“FALâ€), comprises: cash, investments and undrawn letters of credit provided by various banks. |
Variable_funding_notes_Details
Variable funding notes (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets and Liabilities, Net [Abstract] | ' | ' |
Variable funding notes | $437,970 | $0 |
Variable interest entity, not primary beneficiary | ' | ' |
Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets and Liabilities, Net [Abstract] | ' | ' |
Variable funding notes | 437,970 | ' |
Variable interest entity, not primary beneficiary | AlphaCat 2013 Ltd | ' | ' |
Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets and Liabilities, Net [Abstract] | ' | ' |
Variable funding notes | 214,639 | ' |
Variable interest entity, not primary beneficiary | AlphaCat ILS Funds | ' | ' |
Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets and Liabilities, Net [Abstract] | ' | ' |
Variable funding notes | $223,331 | ' |
Accumulated_Other_Comprehensiv2
Accumulated Other Comprehensive Income (Loss) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ' | ' | ' | ' |
Balance, beginning of period | ' | ' | ($2,953) | ' |
Foreign currency translation adjustments | 4,390 | 1,400 | -5,209 | 2,036 |
Balance, end of period | -3,872 | ' | -3,872 | ' |
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Translation Adjustment [Member] | ' | ' | ' | ' |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ' | ' | ' | ' |
Balance, beginning of period | -8,262 | ' | -2,953 | ' |
Amounts reclassified from/to accumulated other comprehensive income | 0 | ' | 4,290 | ' |
Foreign currency translation adjustments | 4,390 | ' | -5,209 | ' |
Balance, end of period | ($3,872) | ' | ($3,872) | ' |
Commitments_and_contingencies_
Commitments and contingencies (Investment portfolio) (Details) (Concentrations of credit risk) | 9 Months Ended |
Sep. 30, 2013 | |
Investment portfolio excluding government and agency securities | ' |
Concentrations Of Credit Risk [Abstract] | ' |
Maximum aggregate exposure to single issuer, allowed | 3.00% |
Aggregate exposure to single issuer, actual | 1.00% |
Investment portfolio excluding bank loans | ' |
Concentrations Of Credit Risk [Abstract] | ' |
Holding in aggregate market value permitted with written pre-authorization | 10.00% |
Minimum credit rating of any security purchased | 'Baa3/BBB- |
Allowable percentage holding in downgraded investments | 2.00% |
Percent of investment portfolio with a credit rating below the minimum required credit rating of Baa3/BBB- | 1.30% |
Total investment portfolio | Bank loans | ' |
Concentrations Of Credit Risk [Abstract] | ' |
Total investment portfolio, fair value | 10.90% |
Commitments_and_contingencies_1
Commitments and contingencies (Lloyd's syndicate) (Details) | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | ||
In Thousands, unless otherwise specified | USD ($) | USD ($) | Lloyd's Syndicate 1183 | Lloyd's Syndicate 1183 | Lloyd's Syndicate 1183 | Talbot FAL Facility | Talbot FAL Facility | Talbot FAL Facility | Talbot FAL Facility | ||
USD ($) | GBP (£) | USD ($) | USD ($) | USD ($) | Lloyd's Syndicate 1183 | Lloyd's Syndicate 1183 | |||||
Minimum | Maximum | ||||||||||
USD ($) | USD ($) | ||||||||||
Components Of Required Capital [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||
Loss contingency, loss level amount | ' | ' | ' | ' | ' | ' | ' | $403,700 | $428,700 | ||
Cash, investments and letters of credit amount | ' | ' | 428,700 | ' | 428,700 | ' | ' | ' | ' | ||
Credit facility, commitment | 1,575,000 | 2,090,000 | ' | ' | ' | 25,000 | [1] | 25,000 | [1] | ' | ' |
Funds at Lloyd's and Lloyd's Central Fund | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||
Maximum premium levies assessable, percent | ' | ' | 3.00% | 3.00% | ' | ' | ' | ' | ' | ||
Estimated underwriting capacity | ' | ' | ' | 620,000 | ' | ' | ' | ' | ' | ||
Exchange rate | ' | ' | '£1 equals $1.6192 | '£1 equals $1.6192 | ' | ' | ' | ' | ' | ||
Maximum premium levies assessable, amount | ' | ' | $30,117 | ' | ' | ' | ' | ' | ' | ||
[1] | Talbot operates in the Lloyd’s market ("Lloyds") through a corporate member, Talbot 2002 Underwriting Capital Ltd (“T02â€), which is the sole participant in Syndicate 1183. Lloyd’s sets T02’s required capital annually based on Syndicate 1183’s business plan, rating environment, reserving environment together with input arising from Lloyd’s discussions with, inter alia, regulatory and rating agencies. Such capital, called Funds at Lloyd’s (“FALâ€), comprises: cash, investments and undrawn letters of credit provided by various banks. |
Commitments_and_contingencies_2
Commitments and contingencies (Aquiline commitment) (Details) (Aquiline Capital Partners II GP Offshore Ltd, USD $) | 9 Months Ended |
In Thousands, unless otherwise specified | Sep. 30, 2013 |
Aquiline Capital Partners II GP Offshore Ltd | ' |
Related Party Transaction [Line Items] | ' |
Percentage of Assignor's interest assumed | 100.00% |
Total capital commitment | $50,000 |
Remaining capital commitment | $19,292 |
Related_party_transactions_Det
Related party transactions (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 |
Aquiline Capital Partners LLC | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Shares owned by related party | 4,946,643 | ' | 4,946,643 | ' | ' |
Warrants to purchase shares | 2,756,088 | ' | 2,756,088 | ' | ' |
Group Ark Insurance Holdings Ltd | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Gross premiums written | $0 | $6,167 | $2,848 | $7,582 | ' |
Premiums receivable | 603 | ' | 603 | ' | 251 |
Reinsurance premiums ceded | 19 | 0 | 23 | 0 | ' |
Loss reserves recoverable | 4,420 | 3,694 | 4,420 | 3,694 | ' |
Earned premium adjustments | 718 | 5,019 | 2,147 | 5,751 | ' |
Tiger Risk Partners LLC | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Brokerage expenses | ' | 58 | ' | 2,418 | ' |
Accounts payable and accrued expenses | ' | ' | ' | ' | 964 |
Conning Inc | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Accounts payable and accrued expenses | 179 | ' | 179 | ' | 201 |
Investment management fees | 165 | 207 | 396 | 611 | ' |
Aquiline Capital Partners II GP Offshore Ltd | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Accounts payable and accrued expenses | 0 | ' | 0 | ' | 0 |
Percentage of Assignor's interest assumed | ' | ' | 100.00% | ' | ' |
Total capital commitment | ' | ' | 50,000 | ' | ' |
Partnership fees incurred | 505 | 674 | 625 | 2,560 | ' |
Capital contributions | $6,185 | $430 | $13,089 | $5,328 | ' |
Earnings_per_share_Details
Earnings per share (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Basic earnings per share | ' | ' | ' | ' |
Net income | $229,063 | $264,044 | $419,503 | $510,540 |
Net (income) loss attributable to noncontrolling interest | -45,694 | -56,746 | 17,831 | -11,386 |
Net income available to Validus | 183,369 | 207,298 | 437,334 | 499,154 |
less: Dividends and distributions declared on outstanding warrants | -1,552 | -1,663 | -17,662 | -5,121 |
Income available to common shareholders | 181,817 | 205,635 | 419,672 | 494,033 |
Weighted average number of common shares outstanding | 99,834,563 | 93,368,775 | 103,451,396 | 97,016,034 |
Basic earnings per share available to common shareholders | $1.82 | $2.20 | $4.06 | $5.09 |
Diluted earnings per share | ' | ' | ' | ' |
Net income | 229,063 | 264,044 | 419,503 | 510,540 |
Net (income) loss attributable to noncontrolling interest | -45,694 | -56,746 | 17,831 | -11,386 |
Net income available to Validus | 183,369 | 207,298 | 437,334 | 499,154 |
less: Dividends and distributions declared on outstanding warrants | 0 | 0 | -17,662 | 0 |
Income available to common shareholders | $183,369 | $207,298 | $419,672 | $499,154 |
Weighted average number of common shares outstanding | 99,834,563 | 93,368,775 | 103,451,396 | 97,016,034 |
Weighted average number of common shares outstanding, diluted | 103,613,766 | 98,236,490 | 105,264,913 | 102,333,515 |
Diluted earnings per share available to common shareholders | $1.77 | $2.11 | $3.99 | $4.88 |
Other details: | ' | ' | ' | ' |
Anti-dilutive securities excluded from the calculation of diluted earnings per share | 125,728 | 2,724 | 464,516 | 231,621 |
Warrants | ' | ' | ' | ' |
Diluted earnings per share | ' | ' | ' | ' |
Weighted average number diluted shares outstanding adjustment | 2,606,669 | 3,248,788 | 0 | 3,116,298 |
Stock options | ' | ' | ' | ' |
Diluted earnings per share | ' | ' | ' | ' |
Weighted average number diluted shares outstanding adjustment | 782,158 | 716,693 | 1,090,298 | 777,245 |
Unvested restricted shares | ' | ' | ' | ' |
Diluted earnings per share | ' | ' | ' | ' |
Weighted average number diluted shares outstanding adjustment | 390,376 | 902,234 | 723,219 | 1,423,938 |
Segment_information_Details
Segment information (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||||||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 | ||||
subsidiaries | |||||||||
segments | |||||||||
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ||||
Number of wholly owned subsidiaries | ' | ' | 2 | ' | ' | ||||
Number of operating segments | ' | ' | 3 | ' | ' | ||||
Underwriting income | ' | ' | ' | ' | ' | ||||
Gross premiums written | $356,760 | $390,215 | $2,163,833 | $1,854,593 | ' | ||||
Reinsurance premiums ceded | -39,415 | -45,743 | -348,027 | -271,847 | ' | ||||
Net premiums written | 317,345 | 344,472 | 1,815,806 | 1,582,746 | ' | ||||
Change in unearned premiums | 213,943 | 130,632 | -205,999 | -208,816 | ' | ||||
Net premiums earned | 531,288 | 475,104 | 1,609,807 | 1,373,930 | ' | ||||
Underwriting deductions | ' | ' | ' | ' | ' | ||||
Losses and loss expenses | 177,965 | 155,455 | 587,780 | 541,136 | ' | ||||
Policy acquisition costs | 94,900 | 98,623 | 275,663 | 252,884 | ' | ||||
General and administrative expenses | 81,089 | 70,547 | 232,335 | 198,557 | ' | ||||
Share compensation expenses | 10,527 | 7,345 | 19,483 | 19,583 | ' | ||||
Total underwriting deductions | 364,481 | 331,970 | 1,115,261 | 1,012,160 | ' | ||||
Underwriting income (loss) | 166,807 | 143,134 | 494,546 | 361,770 | ' | ||||
Net investment income | 20,009 | 25,489 | 71,868 | 79,134 | ' | ||||
Other (loss) income | -2,806 | 7,324 | 4,297 | 22,209 | ' | ||||
Finance expenses | -27,132 | -9,362 | -89,408 | -39,347 | ' | ||||
Operating income (loss) before taxes and income from operating affiliates | 156,878 | 166,585 | 481,303 | 423,766 | ' | ||||
Tax (expense) benefit | -5 | -1,343 | 220 | -1,886 | ' | ||||
Income from operating affilates | 1,463 | 6,235 | 8,779 | 13,194 | ' | ||||
Net operating income (loss) | 158,336 | 171,477 | 490,302 | 435,074 | ' | ||||
Net realized gains on investments | -6,320 | 9,063 | -1,190 | 22,749 | ' | ||||
Net unrealized gains (losses) on investments | 69,967 | 86,345 | -78,618 | 53,442 | ' | ||||
Income (loss) from investment affiliate | 1,044 | -160 | 4,274 | -558 | ' | ||||
Foreign exchange (losses) gains | 6,036 | 1,103 | 4,735 | 3,617 | ' | ||||
Transaction expenses | 0 | -3,784 | [1] | 0 | -3,784 | [1] | ' | ||
Net income | 229,063 | 264,044 | 419,503 | 510,540 | ' | ||||
Net (income) loss attributable to noncontrolling interest | -45,694 | -56,746 | 17,831 | -11,386 | ' | ||||
Net income (loss) available (attributable) to Validus | 183,369 | 207,298 | 437,334 | 499,154 | ' | ||||
Selected ratios: | ' | ' | ' | ' | ' | ||||
Net premiums written / Gross premiums written | 89.00% | 88.30% | 83.90% | 85.30% | ' | ||||
Losses and loss expenses | 33.50% | 32.70% | 36.50% | [2] | 39.40% | [2] | ' | ||
Policy acquisition costs | 17.90% | 20.80% | 17.20% | [2] | 18.40% | [2] | ' | ||
General and administrative expenses | 17.20% | [2] | 16.40% | [2] | 15.60% | [2],[3] | 15.90% | [2],[3] | ' |
Expense ratio | 35.10% | 37.20% | 32.80% | 34.30% | ' | ||||
Combined ratio | 68.60% | 69.90% | 69.30% | 73.70% | ' | ||||
Total assets | 10,317,368 | 8,463,820 | 10,317,368 | 8,463,820 | 10,020,264 | ||||
Validus Re Segment | ' | ' | ' | ' | ' | ||||
Underwriting income | ' | ' | ' | ' | ' | ||||
Gross premiums written | 130,925 | 145,010 | 1,232,272 | 1,052,726 | ' | ||||
Reinsurance premiums ceded | -13,006 | -10,426 | -226,292 | -137,504 | ' | ||||
Net premiums written | 117,919 | 134,584 | 1,005,980 | 915,222 | ' | ||||
Change in unearned premiums | 157,873 | 107,728 | -122,303 | -177,215 | ' | ||||
Net premiums earned | 275,792 | 242,312 | 883,677 | 738,007 | ' | ||||
Underwriting deductions | ' | ' | ' | ' | ' | ||||
Losses and loss expenses | 62,250 | 66,890 | 319,298 | 244,286 | ' | ||||
Policy acquisition costs | 47,662 | 37,785 | 142,195 | 113,659 | ' | ||||
General and administrative expenses | 19,785 | 16,938 | 69,649 | 48,332 | ' | ||||
Share compensation expenses | 2,479 | 2,076 | 5,421 | 5,914 | ' | ||||
Total underwriting deductions | 132,176 | 123,689 | 536,563 | 412,191 | ' | ||||
Underwriting income (loss) | 143,616 | 118,623 | 347,114 | 325,816 | ' | ||||
Net investment income | 15,628 | 19,644 | 61,770 | 64,915 | ' | ||||
Other (loss) income | -1,892 | 1,543 | 11,237 | 4,229 | ' | ||||
Finance expenses | -3,640 | -789 | -12,133 | -6,628 | ' | ||||
Operating income (loss) before taxes and income from operating affiliates | 153,712 | 139,021 | 407,988 | 388,332 | ' | ||||
Tax (expense) benefit | 143 | -2 | 1,755 | -11 | ' | ||||
Income from operating affilates | 0 | 0 | 0 | 0 | ' | ||||
Net operating income (loss) | 153,855 | 139,019 | 409,743 | 388,321 | ' | ||||
Net realized gains on investments | -10,137 | 6,643 | -5,790 | 17,708 | ' | ||||
Net unrealized gains (losses) on investments | 23,144 | 19,232 | -36,883 | 35,400 | ' | ||||
Income (loss) from investment affiliate | 1,044 | -160 | 4,274 | -558 | ' | ||||
Foreign exchange (losses) gains | 2,168 | 8 | 7,448 | 2,461 | ' | ||||
Net income | 170,074 | 164,742 | 378,792 | 443,332 | ' | ||||
Net (income) loss attributable to noncontrolling interest | 0 | 0 | 0 | 0 | ' | ||||
Net income (loss) available (attributable) to Validus | 170,074 | 164,742 | 378,792 | 443,332 | ' | ||||
Selected ratios: | ' | ' | ' | ' | ' | ||||
Net premiums written / Gross premiums written | 90.10% | 92.80% | 81.60% | 86.90% | ' | ||||
Losses and loss expenses | 22.60% | 27.60% | 36.10% | [2] | 33.10% | [2] | ' | ||
Policy acquisition costs | 17.30% | 15.60% | 16.10% | [2] | 15.40% | [2] | ' | ||
General and administrative expenses | 8.10% | [2] | 7.80% | [2] | 8.50% | [2],[3] | 7.40% | [2],[3] | ' |
Expense ratio | 25.40% | 23.40% | 24.60% | 22.80% | ' | ||||
Combined ratio | 48.00% | 51.00% | 60.70% | 55.90% | ' | ||||
Total assets | 5,854,354 | 4,729,344 | 5,854,354 | 4,729,344 | ' | ||||
AlphaCat Segment | ' | ' | ' | ' | ' | ||||
Underwriting income | ' | ' | ' | ' | ' | ||||
Gross premiums written | 3,481 | 2,934 | 146,757 | 21,607 | ' | ||||
Reinsurance premiums ceded | -525 | 0 | -525 | 0 | ' | ||||
Net premiums written | 2,956 | 2,934 | 146,232 | 21,607 | ' | ||||
Change in unearned premiums | 34,210 | 2,591 | -46,459 | -9,832 | ' | ||||
Net premiums earned | 37,166 | 5,525 | 99,773 | 11,775 | ' | ||||
Underwriting deductions | ' | ' | ' | ' | ' | ||||
Losses and loss expenses | 15,615 | 0 | 16,928 | 0 | ' | ||||
Policy acquisition costs | 3,787 | 547 | 10,011 | 1,185 | ' | ||||
General and administrative expenses | 5,728 | 2,087 | 13,757 | 5,521 | ' | ||||
Share compensation expenses | 152 | 84 | 314 | 195 | ' | ||||
Total underwriting deductions | 25,282 | 2,718 | 41,010 | 6,901 | ' | ||||
Underwriting income (loss) | 11,884 | 2,807 | 58,763 | 4,874 | ' | ||||
Net investment income | 967 | 1,193 | 2,821 | 2,672 | ' | ||||
Other (loss) income | 3,791 | 7,674 | 17,439 | 22,237 | ' | ||||
Finance expenses | -11,895 | -56 | -46,429 | -495 | ' | ||||
Operating income (loss) before taxes and income from operating affiliates | 4,747 | 11,618 | 32,594 | 29,288 | ' | ||||
Tax (expense) benefit | 0 | 0 | 0 | 0 | ' | ||||
Income from operating affilates | 1,463 | 6,235 | 8,779 | 13,194 | ' | ||||
Net operating income (loss) | 6,210 | 17,853 | 41,373 | 42,482 | ' | ||||
Net realized gains on investments | 4,084 | 300 | 4,084 | 216 | ' | ||||
Net unrealized gains (losses) on investments | 44,145 | 62,432 | -31,029 | 12,316 | ' | ||||
Income (loss) from investment affiliate | 0 | 0 | 0 | 0 | ' | ||||
Foreign exchange (losses) gains | 388 | 30 | -663 | 47 | ' | ||||
Net income | 54,827 | 80,615 | 13,765 | 55,061 | ' | ||||
Net (income) loss attributable to noncontrolling interest | -45,694 | -56,746 | 17,831 | -11,386 | ' | ||||
Net income (loss) available (attributable) to Validus | 9,133 | 23,869 | 31,596 | 43,675 | ' | ||||
Selected ratios: | ' | ' | ' | ' | ' | ||||
Net premiums written / Gross premiums written | 84.90% | 100.00% | 99.60% | 100.00% | ' | ||||
Losses and loss expenses | 42.00% | 0.00% | 17.00% | [2] | 0.00% | [2] | ' | ||
Policy acquisition costs | 10.20% | 9.90% | 10.00% | [2] | 10.10% | [2] | ' | ||
General and administrative expenses | 15.80% | [2] | 39.30% | [2] | 14.10% | [2],[3] | 48.50% | [2],[3] | ' |
Expense ratio | 26.00% | 49.20% | 24.10% | 58.60% | ' | ||||
Combined ratio | 68.00% | 49.20% | 41.10% | 58.60% | ' | ||||
Total assets | 1,446,941 | 768,612 | 1,446,941 | 768,612 | ' | ||||
Talbot Segment | ' | ' | ' | ' | ' | ||||
Underwriting income | ' | ' | ' | ' | ' | ||||
Gross premiums written | 246,468 | 260,755 | 855,516 | 837,536 | ' | ||||
Reinsurance premiums ceded | -49,998 | -53,801 | -191,922 | -191,619 | ' | ||||
Net premiums written | 196,470 | 206,954 | 663,594 | 645,917 | ' | ||||
Change in unearned premiums | 21,860 | 20,313 | -37,237 | -21,769 | ' | ||||
Net premiums earned | 218,330 | 227,267 | 626,357 | 624,148 | ' | ||||
Underwriting deductions | ' | ' | ' | ' | ' | ||||
Losses and loss expenses | 100,100 | 88,565 | 251,554 | 296,850 | ' | ||||
Policy acquisition costs | 44,899 | 61,640 | 127,092 | 142,181 | ' | ||||
General and administrative expenses | 37,402 | 36,605 | 100,506 | 100,910 | ' | ||||
Share compensation expenses | 2,992 | 2,200 | 6,754 | 5,347 | ' | ||||
Total underwriting deductions | 185,393 | 189,010 | 485,906 | 545,288 | ' | ||||
Underwriting income (loss) | 32,937 | 38,257 | 140,451 | 78,860 | ' | ||||
Net investment income | 4,395 | 5,260 | 13,496 | 16,475 | ' | ||||
Other (loss) income | 73 | 680 | 564 | 2,033 | ' | ||||
Finance expenses | -107 | -73 | -256 | -224 | ' | ||||
Operating income (loss) before taxes and income from operating affiliates | 37,298 | 44,124 | 154,255 | 97,144 | ' | ||||
Tax (expense) benefit | -513 | -11 | -1,184 | -562 | ' | ||||
Income from operating affilates | 0 | 0 | 0 | 0 | ' | ||||
Net operating income (loss) | 36,785 | 44,113 | 153,071 | 96,582 | ' | ||||
Net realized gains on investments | -267 | 2,120 | 516 | 4,825 | ' | ||||
Net unrealized gains (losses) on investments | 2,678 | 4,681 | -10,706 | 5,726 | ' | ||||
Income (loss) from investment affiliate | 0 | 0 | 0 | 0 | ' | ||||
Foreign exchange (losses) gains | 4,238 | 1,146 | -1,877 | 1,334 | ' | ||||
Net income | 43,434 | 52,060 | 141,004 | 108,467 | ' | ||||
Net (income) loss attributable to noncontrolling interest | 0 | 0 | 0 | 0 | ' | ||||
Net income (loss) available (attributable) to Validus | 43,434 | 52,060 | 141,004 | 108,467 | ' | ||||
Selected ratios: | ' | ' | ' | ' | ' | ||||
Net premiums written / Gross premiums written | 79.70% | 79.40% | 77.60% | 77.10% | ' | ||||
Losses and loss expenses | 45.80% | 39.00% | 40.20% | [2] | 47.60% | [2] | ' | ||
Policy acquisition costs | 20.60% | 27.10% | 20.30% | [2] | 22.80% | [2] | ' | ||
General and administrative expenses | 18.50% | [2] | 17.10% | [2] | 17.10% | [2],[3] | 17.00% | [2],[3] | ' |
Expense ratio | 39.10% | 44.20% | 37.40% | 39.80% | ' | ||||
Combined ratio | 84.90% | 83.20% | 77.60% | 87.40% | ' | ||||
Total assets | 2,892,477 | 2,931,174 | 2,892,477 | 2,931,174 | ' | ||||
Corporate, Non-Segment | ' | ' | ' | ' | ' | ||||
Underwriting income | ' | ' | ' | ' | ' | ||||
Gross premiums written | -24,114 | -18,484 | -70,712 | -57,276 | ' | ||||
Reinsurance premiums ceded | 24,114 | 18,484 | 70,712 | 57,276 | ' | ||||
Net premiums written | 0 | 0 | 0 | 0 | ' | ||||
Change in unearned premiums | 0 | 0 | 0 | 0 | ' | ||||
Net premiums earned | 0 | 0 | 0 | 0 | ' | ||||
Underwriting deductions | ' | ' | ' | ' | ' | ||||
Losses and loss expenses | 0 | 0 | 0 | 0 | ' | ||||
Policy acquisition costs | -1,448 | -1,349 | -3,635 | -4,141 | ' | ||||
General and administrative expenses | 18,174 | 14,917 | 48,423 | 43,794 | ' | ||||
Share compensation expenses | 4,904 | 2,985 | 6,994 | 8,127 | ' | ||||
Total underwriting deductions | 21,630 | 16,553 | 51,782 | 47,780 | ' | ||||
Underwriting income (loss) | -21,630 | -16,553 | -51,782 | -47,780 | ' | ||||
Net investment income | -981 | -608 | -6,219 | -4,928 | ' | ||||
Other (loss) income | -4,778 | -2,573 | -24,943 | -6,290 | ' | ||||
Finance expenses | -11,490 | -8,444 | -30,590 | -32,000 | ' | ||||
Operating income (loss) before taxes and income from operating affiliates | -38,879 | -28,178 | -113,534 | -90,998 | ' | ||||
Tax (expense) benefit | 365 | -1,330 | -351 | -1,313 | ' | ||||
Income from operating affilates | 0 | 0 | 0 | 0 | ' | ||||
Net operating income (loss) | -38,514 | -29,508 | -113,885 | -92,311 | ' | ||||
Net realized gains on investments | 0 | 0 | 0 | 0 | ' | ||||
Net unrealized gains (losses) on investments | 0 | 0 | 0 | 0 | ' | ||||
Income (loss) from investment affiliate | 0 | 0 | 0 | 0 | ' | ||||
Foreign exchange (losses) gains | -758 | -81 | -173 | -225 | ' | ||||
Transaction expenses | ' | -3,784 | [1] | ' | -3,784 | [1] | ' | ||
Net income | -39,272 | -33,373 | -114,058 | -96,320 | ' | ||||
Net (income) loss attributable to noncontrolling interest | 0 | 0 | 0 | 0 | ' | ||||
Net income (loss) available (attributable) to Validus | -39,272 | -33,373 | -114,058 | -96,320 | ' | ||||
Selected ratios: | ' | ' | ' | ' | ' | ||||
Total assets | $123,596 | $34,690 | $123,596 | $34,690 | ' | ||||
[1] | The transaction expenses relate to costs incurred in connection with the acquisition of Flagstone Reinsurance Holdings, S.A. | ||||||||
[2] | Ratios are based on net premiums earned. | ||||||||
[3] | The general and administrative expense ratio includes share compensation expenses. |
Segment_information_Segment_ge
Segment information (Segment geographic) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | $356,760 | $390,215 | $2,163,833 | $1,854,593 | ||||
Percent of gross premiums written | 100.00% | 100.00% | 100.00% | 100.00% | ||||
United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 61,632 | 74,871 | 588,711 | 418,183 | ||||
Percent of gross premiums written | 17.30% | 19.20% | 27.20% | 22.50% | ||||
Worldwide excluding United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 47,586 | [1] | 33,169 | [1] | 184,780 | [1] | 156,722 | [1] |
Percent of gross premiums written | 13.30% | [1] | 8.50% | [1] | 8.40% | [1] | 8.50% | [1] |
Australia and New Zealand | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -6,780 | [1] | 10,091 | [1] | 30,795 | 46,768 | ||
Percent of gross premiums written | -1.90% | [1] | 2.60% | [1] | 1.40% | 2.50% | ||
Europe | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 13,421 | 20,441 | 105,131 | 105,706 | ||||
Percent of gross premiums written | 3.80% | 5.20% | 4.90% | 5.70% | ||||
Latin America and Caribbean | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 40,633 | 37,413 | 122,693 | 113,151 | ||||
Percent of gross premiums written | 11.40% | 9.60% | 5.70% | 6.10% | ||||
Japan | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -1,688 | 2,561 | 46,887 | 37,193 | ||||
Percent of gross premiums written | -0.50% | 0.70% | 2.20% | 2.00% | ||||
Canada | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 3,978 | 3,698 | 12,775 | 11,485 | ||||
Percent of gross premiums written | 1.10% | 0.90% | 0.60% | 0.60% | ||||
Rest of the world | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 25,978 | [2] | 34,742 | [2] | 88,314 | [2] | 95,760 | [2] |
Percent of gross premiums written | 7.30% | [2] | 8.90% | [2] | 4.10% | [2] | 5.20% | [2] |
Sub-total, non United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 123,128 | 142,115 | 591,375 | 566,785 | ||||
Percent of gross premiums written | 34.50% | 36.40% | 27.30% | 30.60% | ||||
Worldwide including United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 46,217 | [1] | 33,702 | [1] | 309,225 | [1] | 220,984 | [1] |
Percent of gross premiums written | 13.00% | [1] | 8.60% | [1] | 14.30% | [1] | 11.90% | [1] |
Other location non-specific | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 125,783 | 139,527 | 674,522 | [3] | 648,641 | [3] | ||
Percent of gross premiums written | 35.30% | 35.80% | 31.20% | [3] | 35.00% | [3] | ||
Validus Re Segment | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 130,925 | 145,010 | 1,232,272 | 1,052,726 | ||||
Validus Re Segment | United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 39,618 | 53,138 | 470,745 | 347,492 | ||||
Validus Re Segment | Worldwide excluding United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 16,973 | 7,085 | 69,482 | [1] | 51,289 | [1] | ||
Validus Re Segment | Australia and New Zealand | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -9,482 | 4,887 | 21,116 | 37,474 | ||||
Validus Re Segment | Europe | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 4,252 | 10,251 | ' | 67,206 | ||||
Gross premiums written | ' | ' | 64,986 | ' | ||||
Validus Re Segment | Latin America and Caribbean | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 5,902 | 3,299 | 5,885 | 8,456 | ||||
Validus Re Segment | Japan | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -2,637 | 781 | 41,939 | 31,597 | ||||
Validus Re Segment | Canada | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 1,469 | 260 | 4,503 | 2,753 | ||||
Validus Re Segment | Rest of the world | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 5,641 | 6,303 | 29,211 | [2] | 23,857 | [2] | ||
Validus Re Segment | Sub-total, non United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 22,118 | 32,866 | 237,122 | 222,632 | ||||
Validus Re Segment | Worldwide including United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 29,611 | 17,375 | 180,621 | [1] | 166,550 | [1] | ||
Validus Re Segment | Other location non-specific | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 39,578 | 41,631 | 343,784 | [3] | 316,052 | [3] | ||
AlphaCat Segment | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 3,481 | 2,934 | 146,757 | 21,607 | ||||
AlphaCat Segment | United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 2,546 | 2,211 | 50,935 | 12,643 | ||||
AlphaCat Segment | Worldwide excluding United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 0 | [1] | 0 | [1] | 14,801 | [1] | 278 | [1] |
AlphaCat Segment | Australia and New Zealand | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 33 | [1] | 217 | [1] | 2,216 | 217 | ||
AlphaCat Segment | Europe | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 377 | 512 | 2,514 | 1,332 | ||||
AlphaCat Segment | Latin America and Caribbean | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 0 | 0 | 0 | 0 | ||||
AlphaCat Segment | Japan | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 0 | 0 | 653 | 0 | ||||
AlphaCat Segment | Canada | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 500 | 0 | 818 | 0 | ||||
AlphaCat Segment | Rest of the world | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [2] |
AlphaCat Segment | Sub-total, non United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 910 | 729 | 21,002 | 1,827 | ||||
AlphaCat Segment | Worldwide including United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 25 | [1] | -6 | [1] | 74,820 | [1] | 7,137 | [1] |
AlphaCat Segment | Other location non-specific | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 0 | 0 | 0 | [3] | 0 | [3] | ||
Talbot Segment | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 246,468 | 260,755 | 855,516 | 837,536 | ||||
Talbot Segment | United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 21,573 | 21,004 | 77,630 | 62,812 | ||||
Talbot Segment | Worldwide excluding United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 34,751 | [1] | 28,113 | [1] | 109,562 | [1] | 115,836 | [1] |
Talbot Segment | Australia and New Zealand | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 2,905 | [1] | 5,356 | [1] | 7,930 | 9,798 | ||
Talbot Segment | Europe | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 9,778 | 10,426 | 41,523 | 39,871 | ||||
Talbot Segment | Latin America and Caribbean | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 38,084 | 36,735 | 124,120 | 112,329 | ||||
Talbot Segment | Japan | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 1,066 | 1,916 | 5,258 | 6,003 | ||||
Talbot Segment | Canada | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 2,749 | 3,696 | 8,790 | 9,366 | ||||
Talbot Segment | Rest of the world | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 22,167 | [2] | 30,572 | [2] | 62,803 | [2] | 74,036 | [2] |
Talbot Segment | Sub-total, non United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 111,500 | 116,814 | 359,986 | 367,239 | ||||
Talbot Segment | Worldwide including United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 18,246 | [1] | 17,571 | [1] | 63,998 | [1] | 50,737 | [1] |
Talbot Segment | Other location non-specific | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 95,149 | 105,366 | 353,902 | [3] | 356,748 | [3] | ||
Corporate, Non-Segment | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -24,114 | -18,484 | -70,712 | -57,276 | ||||
Eliminations | United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -2,105 | -1,482 | -10,599 | -4,764 | ||||
Eliminations | Worldwide excluding United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -4,138 | [1] | -2,029 | [1] | -9,065 | [1] | -10,681 | [1] |
Eliminations | Australia and New Zealand | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -236 | [1] | -369 | [1] | -467 | -721 | ||
Eliminations | Europe | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -986 | -748 | -3,892 | -2,703 | ||||
Eliminations | Latin America and Caribbean | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -3,353 | -2,621 | -7,312 | -7,634 | ||||
Eliminations | Japan | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -117 | -136 | -963 | -407 | ||||
Eliminations | Canada | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -740 | -258 | -1,336 | -634 | ||||
Eliminations | Rest of the world | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -1,830 | [2] | -2,133 | [2] | -3,700 | [2] | -2,133 | [2] |
Eliminations | Sub-total, non United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -11,400 | -8,294 | -26,735 | -24,913 | ||||
Eliminations | Worldwide including United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -1,665 | [1] | -1,238 | [1] | -10,214 | [1] | -3,440 | [1] |
Eliminations | Other location non-specific | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | ($8,944) | ($7,470) | ($23,164) | [3] | ($24,159) | [3] | ||
[1] | Represents risks in two or more geographic zones. | |||||||
[2] | Represents risks in one geographic zone. | |||||||
[3] | The Other location non-specific category refers to business for which an analysis of exposure by geographic zone is not applicable such as marine and aerospace risks and can span multiple geographic areas and are not fixed locations in some instances. |
Subsequent_events_Details
Subsequent events (Details) (USD $) | 0 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 0 Months Ended | 1 Months Ended | 0 Months Ended | ||||||||
In Thousands, except Per Share data, unless otherwise specified | Feb. 06, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Oct. 30, 2013 | Oct. 31, 2013 | Oct. 30, 2013 |
Common shares | Common shares | Common shares | Common shares | Common share equivalents | Common share equivalents | Common share equivalents | Subsequent Event | Subsequent Event | Subsequent Event | ||||||||
Common shares | Common shares | Common share equivalents | |||||||||||||||
Subsequent Event [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash dividends declared per share | ' | $0.30 | $0.25 | $0.25 | $0.25 | $2.90 | $0.75 | $0.30 | $0.30 | $0.30 | ' | $0.30 | $0.30 | $0.30 | $0.30 | ' | $0.30 |
Stock Repurchase Program, Authorized Amount | $500,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $500,000 | ' |
Share Repurchase Program Cumulative Aggregrate Purchase Value | $1,206,845 | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1,564,029 | ' | ' | ' | ' | $1,567,380 | ' |